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Obesity and its comorbidities are a significant threat to public health, 
necessitating the development of new therapies to treat and prevent obesity. Body 
weight is maintained by balancing food intake and energy expenditure, a process 
mediated by the central nervous system (CNS). The paraventricular nucleus of the 
hypothalamus (PVH) is a crucial component of the CNS maintenance of energy 
balance; lesioning the PVH or disrupting its development produces hyperphagia and 
energy expenditure deficits in rodents and humans. The PVH is a heterogenous nucleus 
with many neuronal populations that may regulate energy homeostasis differently. To 
interrogate these neuronal populations, we used Cre-dependent viral tools to 
chemogenetically activate or to silence neuronal populations of the PVH. We used 
genetically engineered mice and immunohistochemistry to identify the overlap of 
subpopulations of the PVH as well as retrograde and anterograde tracing to determine 
the inputs and outputs of the PVH.  
Insulin receptor substrate-4 (IRS4) and insulin receptor substrate-2 proteins act 
synergistically in the hypothalamus to maintain energy balance. Our in situ hybridization 
studies determined that IRS4 is expressed in the PVH, prompting us to investigate 
IRS4PVH neurons and their role in energy balance. The IRS4PVH neuronal population is 
distinct from oxytocin (OXT), nitric oxide synthase (NOS1), melanocortin 4-receptor 
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(MC4R) and prodynorphin (PDYN) neurons, all of which regulate energy balance. We 
found that activating IRS4PVH neurons suppresses feeding and increases energy 
expenditure, while silencing IRS4PVH neurons results in hyperphagic obesity. IRS4PVH 
neurons project to regions of the hindbrain necessary for energy homeostasis such as 
the parabrachial nucleus (PBN), solitary nucleus (NTS), median eminence and the 
intermediolateral column of the spinal cord. The IRS4PVH neurons are innervated by 
brain regions such as the lateral hypothalamic area, ventromedial hypothalamus, 
amygdala, supraoptic nucleus, bed nucleus of the stria terminalis, preoptic area, arcuate 
nucleus and PBN. We therefore determined that PVH and peri-PVH neurons expressing 
IRS4 regulate energy homeostasis. 
Although we determined that calcitonin receptor (CalcR) expression in the PVH is 
not required for energy balance or the anorectic response to the salmon calcitonin 
ligand, we did find that CalcRPVH neuron activity is important in energy homeostasis. 
Using chemogenetic activation and tetanus toxin mediated silencing of CalcRPVH 
neurons, we determined that activating CalcRPVH neurons suppresses feeding and 
increases ambulatory activity, while silencing CalcRPVH neurons results in hyperphagic 
weight gain. CalcRPVH neurons project to regions involved in regulating energy 
homeostasis such as the PBN, NTS and median eminence. CalcRPVH neurons are 
distinct from many of the neuronal populations of the PVH that regulate energy balance 
such as those that express NOS1, arginine vasopressin, OXT and thyrotropin-releasing 
hormone with some overlap with corticotrophin-releasing hormone expressing PVH 
neurons. There is a notable overlap between the MC4R expressing PVH neurons and 
CalcRPVH neurons, which may account for the hyperphagic obesity observed when 
    
xii 
 
CalcRPVH neurons are silenced. In addition, deleting MC4R from CalcR cells produced 
hyperphagic obesity in male and female mice. Lastly, we aimed to elucidate the roles 
that specific projection fields of PVH neurons play in energy homeostasis. Using a 
retrograde AAV-Cre and chemogenetics, we have begun to parse the energy balance 
roles of PVH neurons that project to the PBN and NTS specifically. Overall, our studies 
have improved our understanding of the roles specific PVH neurons play in energy 
homeostasis and the neuronal circuits in which they exert their effects. 




Introduction: Central Mechanisms of Energy Balance Control 
The obesity epidemic is a growing problem in the United States, with 2013-2014 
estimates indicating a prevalence of obesity of approximately 35% for adult males and 
40.4% for adult females in the US. Comorbid diseases such as type 2 diabetes mellitus, 
hypertension, cardiovascular disease and stroke have seen significant increases as 
well.1 Further, healthcare costs associated with obesity were estimated to be $149.4 
billion in 2014.2 To manage this widespread metabolic disease, anti-obesity agents 
have been developed and studied for their therapeutic value, many of them targeting 
the central nervous system (CNS), the gastrointestinal system and other systems that 
influence hormonal release and the resting metabolic rate.3 A particular target of interest 
of the CNS is the hypothalamus, which is essential for the regulation of energy 
homeostasis and food intake through its interaction with peripheral signals such as 
leptin, insulin and ghrelin and its neural circuitry.4,5 Therefore, several pharmacological 
agents have been developed to target signaling systems within the CNS, including 
those found within the hypothalamus. 
There are currently many medications and treatments created for the purpose of 
managing obesity through the CNS. Lorcaserin was a weight loss drug that reduced 
appetite through the activation of the serotonin 2C (5HT2C) receptor.6-8 Although it was 
effective over long-term treatment, lorcaserin had several side effects including 
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headaches, fatigue, nausea and dizziness.3,7,9,10 It was eventually removed from the 
market at the request of the FDA in February 2020 due to increased incidence of 
pancreatic, colorectal and lung cancers in clinical trials.11  
Liraglutide is an injectable treatment that acts as a glucagon-like peptide-1 
receptor agonist that increases insulin release from the pancreas and reduces glucagon 
release and serves as an anorectic as well as a treatment for type 2 diabetes.12-14 This 
treatment is effective in producing sustained weight loss for about 2 years and is 
recommended for patients with at least a body mass index (BMI) of 30 kg/m2 or in 
individuals with at least a BMI of 27kg/m2 and another weight related comorbid 
disease.13 In addition to causing abdominal pain, nausea, constipation, and diarrhea, 
liraglutide may increase chances of developing pancreatitis, gallbladder disease and 
potentially carcinoma of the thyroid.13,15  
There are also several treatments that require a combination of drugs in order to 
improve their effectiveness as a weight loss treatment. One such combined treatment 
includes phentermine, which reduces appetite, and topiramate which is typically used to 
treat seizures and migraine headaches.3,16,17 The phentermine/topiramate-extended 
release (ER) combined treatment functions as a noradrenergic and gamma 
aminobutyric acid (GABA) receptor activator and a kainite/α-amino-3-hydroxy-5-methyl-
4-isoxazolepropionic acid glutamate receptor inhibitor to suppress appetite.3,18,19 Aside 
from producing side effects such as constipation, dizziness and insomnia, this treatment 
is contraindicated for individuals with glaucoma or hyperthyroidism and can cause 
metabolic acidosis, hypokalemia and elevated creatinine levels.3,20 Furthermore, women 
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who are pregnant run the risk of their child developing birth defects such as oral clefts if 
they take the phentermine/topiramate-ER combined treatment.21  
Another obesity treatment combines naltrexone, which is typically used to treat 
alcohol and drug dependence and bupropion, which is used to treat depression.22-24 
Naltrexone is a competitive agonist of the μ-opioid receptor, the κ-opioid receptor and 
bupropion is a selective serotonin reuptake inhibitor.25,26 Bupropion stimulates neurons 
that reduce appetite in the hypothalamus. These neurons release beta-endorphins, 
which reduce anorexigenic effects of bupropion. Naltrexone enhances the effects of 
bupropion, as it blocks beta-endorphin, producing a synergistic reduction in food 
intake.27 Side effects for this treatment include nausea, constipation, diarrhea, increased 
blood pressure, heart rate and insomnia and possible liver damage, as well as a 
potential increase in suicidal thoughts.25,26  Further, the effectiveness of this therapy 
appears to reduce after one year of treatment.28  
Recombinant human leptin or metreleptin is an effective leptin replacement in the 
rare individuals that experience hyperphagic obesity due to leptin deficiency.29-31 
Metreleptin monotherapy for patients that exhibit non-leptin deficient obesity is 
ineffective for generating weight loss.32 When metreleptin is combined with the amylin 
analog pramlintide, obese patients experience increased satiation, reduced feeding and 
a loss in body weight with only mild to moderate nausea.33-37 However, the synergy 
between metreleptin and pramlintide loses efficiency in individuals that exceed a body 
mass index of 35 kg/m2.38 It is suggested through studies in rats that this may be the 
result of increased leptin resistance in obese individuals and that the threshold for 
amylin-induced leptin sensitization is greatly increased.38  
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While it would be ideal for treatments to engage with specific hypothalamic 
targets, most drugs act more broadly and current treatments are either ineffective for 
many patients or have several aversive side effects that interfere with patient 
compliance or pose a threat to the wellbeing of the patient. It is therefore necessary to 
continue to investigate hypothalamic nuclei and their related neurocircuitry to aid in the 
development of other possible therapeutics that more effectively maintain energy 
homeostasis without producing excessive or dangerous off target effects. 
 
Role of the hypothalamic circuits and the regulation of energy homeostasis 
 Feeding behavior and energy expenditure is regulated through a variety of 
redundant neuronal systems within the hypothalamus and brainstem which serve to 
maintain energy homeostasis.39 The hypothalamus receives and incorporates nutrient 
signals, satiety signals from the gut and signals from energy stores to balance food 
intake and energy expenditure in order to maintain sufficient body fat storage.4 
Overeating when energy stores are sufficient results in enhanced satiety and an 
inhibition of the food reward system, resulting in a reduction in feeding behavior. 
Conversely, when energy stores are insufficient, the hypothalamus responds by 
promoting the food reward system and decreasing the response to satiety signals, 
resulting in an increase in feeding behavior.40,41 The energy homeostatic feeding 
mechanisms to maintain body weight have been evolutionarily conserved, as it is crucial 
to survival to sustain energy stores. In contrast, non-homeostatic feeding is driven by 
the consumption of palatable foods which is mediated by the midbrain dopamine and 
opioidergic food reward pathways. 42 Palatable foods are typically those that have a 
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preferred or desirable taste and are often high in fat or carbohydrate content, which can 
promote overconsumption due to activation of food reward pathways.43,44 Systems have 
evolved to produce strong drives and a reward system in favor of food consumption, 
which can lead to excessive eating in environments with an abundant food source.45 In 
addition to regulating feeding behavior, the hypothalamus regulates energy expenditure 
through influencing the autonomic nervous system and the endocrine system through 
the hindbrain, spinal cord and pituitary. The hypothalamus serves to modulate the basal 
metabolic rate, thermogenesis, spontaneous physical activity and exercise in order to 
counterbalance the intake of food.39,46,47 In essence, the body is continuously working 
through the hypothalamus to balance energy intake against energy that is expended. 
Energy homeostasis is achieved CNS monitoring of peripheral signals that inform 
the brain of current energy stores and in turn regulating feeding behavior as well as 
energy expenditure.4,5 One of the best characterized peripheral  energy status signals is 
the hormone leptin, which is released from adipose tissue in proportion to body fat and 
mediates energy homeostasis through the brain by regulating food intake and body 
weight.48-53 This regulation based on current adiposity stores is called “adiposity 
negative feedback”.48 Insulin, which is a hormone secreted from the pancreas, also 
regulates energy homeostasis.54  It also participates in adiposity negative feedback and 
serves to reduce feeding behavior through targeting the brain, though to a lesser degree 
than leptin.55 Gut peptides also regulate satiety through inducing meal termination, such 
as cholecystokinin (CCK) and glucagon-like peptide 1 (GLP-1).56,57 CCK and GLP-1 are 
released from the gastrointestinal system due to food intake and communicate with the 
CNS through gut originating projections of the vagus nerve to the solitary tract (NTS) of 
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the hindbrain.57-59 In contrast to CCK and GLP-1, ghrelin is a gastric hormone that is 
secreted prior to a meal that motivates food intake behavior.60 High leptin 
concentrations function to improve the response to satiety signals such as CCK, 
resulting in a decrease in meal size, while the converse is true when leptin levels are 
low.61-63 Leptin achieves this through activating leptin receptors in hindbrain regions 
such as the NTS and in the hypothalamus such as the arcuate nucleus (ARC).64,65 
Essentially, energy homeostasis is managed through the influence of peripheral signals 
and neurocircuitry related to satiety and food reward located in nuclei within the 
hypothalamus and hindbrain. 
 
The paraventricular nucleus of the hypothalamus is essential to energy 
homeostasis 
One hypothalamic region of crucial significance to energy homeostatic 
neurocircuitry is the paraventricular nucleus of the hypothalamus (PVH), which receives 
regulatory inputs from regions of the hypothalamus, including the ARC, as well as from 
the forebrain and hindbrain.5 It has been found that lesions to the PVH or disruption of 
its development produces hyperphagic obesity and glucose dysregulation in humans 
and mice.66-71 Normal development of the PVH requires the expression of the single-
minded homolog 1 (Sim1) transcription factor as homozygous deficiency of Sim1 in 
mice is lethal. Loss of a single copy of Sim1 leads to abnormal PVH development with 
hyperphagic obesity as well as an increased sensitivity to high fat diet.67,69,72-74 Similarly, 
ablation of Sim1 neurons produces obesity that is due to hyperphagia, although it 
should be noted that Sim1 is also expressed in other brain regions important to energy 
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balance, such as the supraoptic nucleus (SON), medial amygdala and the nucleus of 
the lateral olfactory tract (NLOT). 68,75 The PVH exerts its regulatory control on energy 
homeostasis by sending primarily glutamatergic projections to regions in the hindbrain 
and spinal cord which serve to regulate food intake and energy expenditure. Further, 
the PVH mediates neuroendocrine effects through projections to the median eminence 
(ME) to influence pituitary function.5,76,77 In order to understand the regulatory role of the 
PVH in energy balance circuitry, it will be necessary to investigate the inputs and 
outputs of the PVH by analyzing the regions involved in energy homeostasis upstream 
and downstream of the nucleus. 
 
Regions that receive outputs from the PVH 
The Solitary Nucleus  
Much of food intake behavior is influenced by peripheral signaling influencing 
circuitry within the CNS. The nucleus of the solitary tract (NTS) of the hindbrain serves 
as a gateway and integrator of these peripheral signals to the CNS.78-80 The NTS is in 
direct contact with the area postrema (AP), a brain region that receives peripheral signal 
inputs through the fourth ventricle, which lacks the protection of the blood brain 
barrier.81,82 Lesioning of the AP/NTS eliminates the anorexia induced by amylin, a 
known anorectic released from the pancreas following the ingestion of a meal, 
highlighting the role the AP and NTS play in responding to peripheral satiety signals.83 
The NTS is therefore the site at which input is received from both the AP and gut 
signals derived from the vagus that indicate acute and chronic states of 
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nutrition.81,82,84,85 These signals are then passed to the dorsal motor nucleus of the 
vagus (DMV) to regulate vagal reflexes and gut motility.81 In addition to receiving 
peripheral and vagal inputs following the ingestion of a meal, the NTS also serves to 
modulate the activity of neurons of the hypothalamus to produce a satiety response. 81 
For example, cholecystokinin expressing NTS neurons that project to the parabrachial 
nucleus (PBN) suppress feeding with associated aversion while CCKNTS neurons that 
project to the PVH produce feeding suppression that is non-aversive.86-89 
Several neuronal subpopulations of the PVH found to be involved in food intake 
and energy expenditure regulation in mice such as those that express nitric oxide 
synthase 1 (NOS1), insulin receptor substrate 4 (IRS4) and calcitonin receptor (CalcR) 
send axonal projections to the NTS.76,90-92 The NTS is also downstream of the ARC to 
PVH signaling pathway, as application of leptin activates oxytocin (OXT) neurons of the 
PVH that project to the NTS.93 This potentially indicates projections from certain 
subpopulations of the PVH to the NTS could regulate satiety signaling. The NTS in turn 
relays satiety information to the PBN through glutamatergic projections.94,95 In addition 
to potentially regulating food intake, projections from the PVH to the NTS may also 
influence energy expenditure through its interaction with the sympathetic nervous 
system. The PVH modulates sympathetic output through polysynaptic connections to 
the dorsal raphe, NTS and the spinal cord.96,97 Further, the PVH and NTS have been 
found to be polysynaptically connected to brown adipose tissue (BAT), which is a tissue 
involved with thermogenesis.98-102 Vagus nerve viscerosensory afferents synapse onto 
second order neurons in the NTS, which in turn mediate reflex changes in BAT energy 
expenditure and BAT sympathetic nerve activity due to visceral afferent 
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signaling.98,103,104 The NTS receives inputs from regions of the forebrain and brainstem 
that may serve to integrate metabolic signals to regulate BAT thermogenesis.78 Overall, 
given the known roles the NTS plays in regulating satiety and energy expenditure, it 
appears likely that PVH inputs to the NTS play at least a partial role in the regulation of 
energy homeostasis. 
 
The Parabrachial Nucleus 
 The PBN of the hindbrain serves as an integrator of signals from the 
hypothalamus, brainstem and spinal column, and functions as a relay center that 
receives visceral and gustatory information.5 The PBN modulates feeding behavior 
through projections to the hypothalamus, bed nucleus of the stria terminalis and the 
central nucleus of the amygdala (CeA).105-107 The PVH is composed of several neuronal 
populations involved in energy homeostasis that send projections to the PBN. The 
NOS1PVH, IRS4PVH and CalcRPVH neurons send projections to the medial (MPBN) and 
LPBN, all of which have been found to regulate feeding behavior and influence energy 
homeostasis.76,90,92 Amylin and CCK activate a pathway involving the AP/NTS, lateral 
parabrachial nucleus (LPBN) and CeA, as lesioning of the LPBN reduces the ability of 
amylin and CCK to inhibit food intake and reduces activation in the LPBN and CeA.108 
This suggests that stimulation may begin in the NTS, travel to the LPBN and transmit to 
the CeA.108-111 Calcitonin gene-related peptide (CGRP) expressing neurons of the PBN 
also project to the amygdala and are thought to mediate stress induced anorexia.105 
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The CGRP neuronal population of the PBN is a critical regulator of feeding 
behavior. CGRPPBN neurons receive stimulating inputs from ascending caudal hindbrain 
projections and remote activation of CGRPPBN neurons results in a reduction or 
complete cessation of feeding. 80,112 Chronic stimulation of CGRPPBN neurons can lead 
to death by starvation.80,105,112 Further, agouti-related peptide (AgRP) expressing 
neurons of the ARC that project directly to the PBN play a role in regulating anorexia 
and activation of CGRPPBN neurons following the ablation of AGRP neurons will result in 
anorexia that can lead to starvation.80,105 Inhibition of CGRPPBN neurons does not affect 
normal food intake, suggesting that these neurons are tonically inhibited by GABAergic 
inputs from AGRP neurons.105 The PBN contains neurons with the function to protect 
rodents against ingesting substances that are unfamiliar or possibly toxic through fear of 
unfamiliar substances and conditioned taste aversion.113 Rodents are apprehensive of 
consuming food with a novel taste and will only continue to eat if the food does not 
produce an aversive response.113 Viral and genetic methods have demonstrated that 
neurons of the PBN such as the CGRPPBN neurons are activated by lithium chloride and 
lipopolysaccharide, both of which are toxic and lesioning the PBN disrupts conditioned 
taste aversion from developing. 105,114,115 These studies highlight the aversive nature in 
which certain neuronal populations of the PBN reduce feeding behavior when activated.  
Melanocortin 4 receptor (MC4R) neurons of the PVH send dense projections to 
the PBN.77 Optogenetic activation of MC4RPVH neuronal projections to the PBN 
suppresses food intake in a non-aversive manner, indicating that the PBN participates 
in ARC to PVH food intake circuitry.116 Further, stimulating PVHMC4R neurons that 
project to the PBN in hungry mice produces a place preference, indicating that 
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stimulation of this circuit produces feeding behavior that would be associated with a 
pleasant feeling of fullness.116 This is in contrast to the CGRPPBN neurons, which are 
involved with producing an aversive response to feeding when activated.113 This 
suggests that MC4RPVH neurons may engage with a different subpopulation of PBN 
neurons and indicates that the PBN is involved in regulating both aversive and non-
aversive feeding behavior. 
 
The Spinal Cord 
The spinal cord is a site important for sympathetic output, and as such is a 
crucial component to regulating energy expenditure.117 The PVH has been found to 
indirectly connect to brown adipose tissue (BAT), providing the potential to regulate 
thermogenesis and energy expenditure.99-102,118 The raphe pallidus and NTS also 
receive projections from the PVH and have been implicated in regulating sympathetic 
outflow to BAT.96,99 Further, the intermediolateral column of the spinal cord (IML) in the 
thoracic spinal cord receives direct projections from the PVH and regulates sympathetic 
activity.97 Some of the PVH neurons project to cardiovascular responsive sites in the 
IML of the upper thoracic spinal cord.119,120 NOS1PVH, OXTPVH, and IRS4PVH neurons 
project to the choline acetyltransferase (ChAT) preganglionic neurons of the IML, all of 
which have varying influence on energy expenditure regulation.76,90 These PVH 
projections to the IML may regulate BAT mediated thermogenesis through direct 
projections to ChAT cells which also function to regulate the metabolic rate and 
locomotor activity.76,90  
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Pseudorabies viral tracing revealed that PVH neurons (more so from the 
posterior portion of the PVH) polysynaptically connect to the liver and epididymal white 
fat (eWAT) tissue in mice.121 More specifically, arginine vasopressin (AVP), OXT, 
corticotropin-releasing hormone (CRH) and thyrotropin-releasing hormone (TRH) 
expressing neurons of the PVH sent polysynaptic projections to the eWAT tissue, while 
OXT and CRH polysynaptically projected to the liver.121 Projections to the liver could 
influence hepatic glucose output and carbohydrate storage, while projections to eWAT 
tissue could influence lipolysis and glucose uptake.122,123 Tracing further suggests that 
the lateral hypothalamus, ARC, NTS and noradrenergic cell group A5 were upstream of 
the PVH neurons that projected to the liver and eWAT, suggesting that the PVH serves 
as an integrator for this downstream signaling.121 These studies serve to provide a 
possible avenue through which the PVH regulates the energy expenditure component of 
energy homeostasis using the sympathetic nervous system. 
 
The Pituitary 
The PVH contains neurons that are critical for neuroendocrine and autonomic 
regulation and is composed of magnocellular neurons and parvocellular neurons which 
have been characterized through immunohistochemical and anatomical labeling along 
with electrophysiological techniques.124,125 The large magnocellular neurons project to 
the posterior pituitary gland and include vasopressin neurosecretory cells which 
regulate body fluid balance.124-128 Magnocellular OXTPVH neurons project to the median 
eminence and posterior pituitary to regulate the reproductive axis.128-131 
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Parvocellular neurons project to either the median eminence or the caudally 
projecting pre-autonomic cells, such as neurons that project to the medullary (NTS and 
rostral ventrolateral medulla) or spinal (such as the IML cell column) autonomic 
centers.124 These include CRHPVH neurons which are essential in controlling the 
hypothalamic-pituitary-adrenal (HPA) axis and project to the median eminence.125,132-135 
The TRHPVH parvocellular neurons regulate the thyroid axis through projections to the 
median eminence.136 Both the CRH and TRH parvocellular neurons release their 
contents into the median eminence for hypophysial portal circulation.125,136 Growth and 
development are partially regulated by somatostatin neurons of the PVH that project to 
the median eminence.129 There are also parvocellular AVP neurons, that release their 
contents in the median eminence, and those contents can then travel to the anterior 
pituitary through the hypophyseal portal system.125,129 The released AVP works in 
synergy with released CRH to produce adrenocorticotropic hormone (ACTH).125 The 
PVH is therefore an essential component of the neuroendocrine system through the 
HPA axis, providing many neuronal inputs to the pituitary to influence peripheral 
systems.   
 
Regions that send inputs to the PVH 
Local inputs to the PVH 
Transynaptic labelling mediated by injecting a tracer into the adrenal medulla has 
found that the PVH is surrounded by GABAergic interneurons that connect to the 
parvocellular neurons of the dorsal and lateral regions of the of the PVH.137 The PVH is 
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regularly active and the GABAergic neurons surrounding the PVH provide tonic 
inhibition to the neurons of the PVH. Further, these GABA expressing neurons 
surrounding the PVH are in turn surrounded by a population of neuronal nitric oxide 
synthase (nNOS) expressing neurons.137 It is thought that the nNOS neurons 
surrounding the nucleus may enhance the synaptic function of GABAergic neurons and 
influence sympathetic outflow through the parvocellular sympathetic neurons of the 
PVH.137,138 Therefore, with the direct application of NOS inhibitors or the GABA 
antagonist bicuculline to the PVH, sympathetic tone increase along with an increase in 
blood pressure.139 In addition to inputs immediately surrounding the PVH, it is 
hypothesized that intra-PVH connections exist which allow for communication and 
modulation between neuronal subpopulations of the PVH.140,141 This further complicates 
dissecting the function and mapping the neurocircuitry of the PVH, as it can be difficult 
to discern the influences of these intra-PVH neurons as opposed to inputs originating 
from regions external to the PVH. 
 
The hindbrain 
The PVH receives inputs from many regions of the brainstem which are primarily 
glutamatergic.142 In addition to receiving vagal afferents to sense satiety peptides, the 
NTS receives information concerning volume, pressure and oxygen saturation from 
cardiovascular afferents. The NTS receives information from cardiovascular receptors 
such as chemoreceptors, arterial baroreceptors and venous volume receptors.143-146 
The NTS then transmits this cardiovascular information to the presympathetic neurons 
in the PVH.147-150 Glutamatergic afferents from the NTS terminate in close proximity to 
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the presympathetic and magnocellular neurons of the PVH as well as the GABAergic 
and nNOS expressing neurons immediately surrounding the PVH.142 Therefore, inputs 
from the NTS to the PVH may directly or indirectly influence the activity of sympathetic 
nerves along with regulating feeding behavior.  
The lateral PBN is another region that provides substantial glutamatergic inputs 
to the PVH.151 We have previously discussed the PBN and its role in regulating feeding 
behavior, meaning the PBN may modulate energy balance through its inputs to the PVH 
in addition to receiving modulatory inputs from the PVH. Further, activation of neurons 
in the PBN occurs following various stressors and may play a role in regulating the HPA 
axis, as stimulation of lateral PBN neurons induces the release of ACTH.152-155 
Additionally, the PBN is involved in LiCl mediated taste aversion.113,115 This provides a 
possible means through which the PBN induces glucocorticoid mediated enhancement 
of aversive learning through the PVH.  
The periaqueductal gray (PAG) rostral and caudal ventrolateral subdivisions 
send dense glutamatergic projections to the PVH.151 The rostral subdivision of the PAG 
has been shown to respond to acute sources of stress and receives projections from 
regions found to regulate HPA function, such as the medial prefrontal cortex, lateral 
septum and other nuclei of the hypothalamus.156-159 The rostral PAG also receives input 
dorsolateral column of the PAG, which associated with panic and escape behaviors and 
induces the corticosterone response.160 This suggests that the PAG may activate 
neuroendocrine and stress responses in the PVH through rostral PAG outputs. The 
PVH also receives dense innervation from caudal ventrolateral subdivision of the 
PAG.156,161 The caudal ventrolateral subdivision of the PAG responds to acute stressors 
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such as painful and noxious stimuli, swim stress and cold temperatures.156,162-164 
Further, the ventrolateral PAG receives inputs from regions that are HPA excitatory and 
inhibitory such as the prefrontal cortex and the amygdaloid nucleus.151,159 Taken 
together, glutamatergic inputs from caudal ventrolateral PAG to the PVH may influence 
the stress response as well as the HPA axis.151 
 
The Forebrain 
In addition to receiving input from caudal brain regions, the PVH is also an 
integrator of signals from the hypothalamus and forebrain.5,140,165 Tracing studies 
indicate that glutamatergic neurons from the ventromedial hypothalamic nucleus (VMH) 
project to the anterior portion of the PVH, while the posterior region of the PVH receives 
primarily glutamatergic inputs from the VMH, dorsomedial hypothalamus (DMH), lateral 
hypothalamus and posterior hypothalamus.165 The medial preoptic nucleus also 
innervates the PVH, but does not do so with glutamatergic neurons.165 Many of the 
hypothalamic and forebrain inputs received by the PVH are from regions that express 
receptors that are important for regulating energy balance aside from the previously 
mentioned ARC. The VMH contain neurons that express receptors for central and 
peripheral signals such as leptin receptor (LepRB), melanocortin 3 and 4 receptors, 
insulin receptor and cholecystokinin B receptor and the DMH expresses both LepRB 
and MC4R.5,166-169  
The DMH has been implicated in regulating the stress response through inputs to 
the PVH, as stimulating the DMH enhances ACTH release.170 The DMH is also thought 
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to be involved in the milk ejection reflex through excitatory projections to the PVH that 
induce activity in oxytocin expressing neurons during milk ejection.140,171 Similarly, 
neurons in the bed nucleus of the stria terminalis (BNST) have been thought to be 
involved in regulating the milk ejection reflex through OXTPVH neurons.140,172 The BNST 
has been shown to interact with the HPA axis through the PVH, as lesioning studies of 
the BNST in regions that densely project to the PVH have been shown to increase CRH 
mRNA expression.173  
The medial preoptic area (MPOA) potentially exerts influence over the 
magnocellular neurosecretory system through projections to oxytocin and vasopressin 
expressing neurons in the PVH.174,175 The MPOA may also provide excitatory and 
inhibitory inputs to parvocellular neurons of the PVH and could influence the HPA stress 
response.176 Finally, the PVH receives moderate direct input from the amygdala and 
appear to have excitatory influences on the HPA axis and play a role in responding to 
emotional stressors.138,177,178 
 
Role of the melanocortin system and energy balance through the PVH 
 One area of primary importance to the regulation of feeding behavior through the 
PVH is the ARC. The ARC is in direct contact with the median eminence, which 
exposes the nucleus to peripheral circulating peptides in the 3rd ventricle. This allows for 
hormones such as insulin, leptin and ghrelin to regulate energy homeostasis through 
cells in the ARC.179 The ARC is composed of subpopulations that respond to these 
signals through the expression of insulin receptors (INSR), leptin receptors (ObR) and 
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ghrelin receptors (GHSR) to then stimulate or suppress feeding.180-182 Among these 
ARC neurons are the pro-opiomelanocortin (POMC) cells, which release α-melanocyte 
stimulating hormone (α-MSH) and functions to inhibit food intake and regulate body 
weight through binding with melanocortin receptors such as the melanocortin-4 
receptors (MC4R) in the PVH and activating the MC4RPVH neuron. These POMC 
neurons are activated by leptin and are inhibited when leptin levels are deficient.183,184 
POMC neurons are also activated by insulin, while ghrelin inhibits them.180-182 Counter 
to the POMC neurons are those that co-express AgRP, neuropeptide Y (NPY) and 
GABA.50,185 AgRP neurons function as an antagonist to the MC4R receptor, blocking α-
MSH from inducing anorectic behavior through the receptor, while NPY interacts with 
Y1 and Y5 receptors on neurons in the PVH to increase food intake behavior. 
AgRP/NPY neurons also produce the GABA neurotransmitter, which suppresses α-
MSH secretion from POMC neurons through inhibiting POMCARC neurons.180,181 These 
AgRP/NPY/GABA neurons function to stimulate feeding when activated by signals such 
as ghrelin and are conversely inhibited when exposed to leptin and insulin.181,182,186-189 
This produces a bimodal system that contains these two non-overlapping AgRPARC and 
POMCARC neuronal populations that work antagonistically, with AgRPARC neurons 
inhibiting satiety promoting postsynaptic neurons (Figure 1.1). Optogenetic and 
chemogenetic activation of POMCARC produces hypophagia and weight loss.190,191 
Converse to this, optogenetic and chemogenetic stimulation of AgRPARC neurons result 
in hyperphagia and an increase in weight gain.190-192 This is due to the interaction of 
POMCARC and AgRPARC with MC4R expressing neurons in the PVH.190-194  
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The cellular heterogeneity of the PVH 
 Pharmacological and genetic studies have demonstrated that MC4R neurons 
play a role in promoting satiety and weight loss when activated.75,77,184,195-198 Germline 
loss of MC4R expression in mice and humans produces extreme hyperphagic obesity 
and shows similar phenotypes to deficiencies in the Sim1 gene.199,200 These phenotypes 
include early onset hyperphagia, increased sensitivity to a high fat diet and an overall 
increase in growth.75,195,201 In wildtype mice, applying melanocortin agonists results in a 
reduction in feeding and meal size.202 In an experiment, MC4Rs were re-expressed in 
Sim1 neurons of mice that previously lacked MC4R expression, and this resulted in the 
rescue of normal, non-hyperphagic feeding.75 Sim1 expression is abundant in the PVH 
as well as the amygdala, but it was found that re-expressing MC4Rs in the PVH of mice 
with previously deleted MC4R expression was both necessary and sufficient to regulate 
feeding behavior.75,77 These MC4RPVH neurons expressed Sim1, were glutamatergic 
and not GABAergic, and were distinct from prodynorphin, corticotropin-releasing 
hormone, vasopressin and oxytocin expressing neurons in the PVH.77 Further, 
MC4RPVH neurons make synaptic connections to neurons of the parabrachial nucleus, a 
region known to relay visceral information to the forebrain.77,88,116 While appetite 
regulation through MC4R expression has been found to be primarily due to the 
MC4RPVH expressing neurons, regulation of energy expenditure and glucose is a quality 
of MC4R expressing neurons in the brainstem and spinal cord.75,77,117 
 While MC4RPVH neurons are critical for the regulation of feeding, they alone do 
not account for all the energy homeostatic qualities attributed to Sim1PVH neurons. For 
example, MC4RPVH neurons alone do not account for PVH mediated food intake 
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regulation entirely, as inhibiting MC4RPVH neurons using chemogenetics results in a 
hyperphagia that is only about half of what is produced by chemogenetic inhibition of 
Sim1PVH neurons. This suggests that there are other neuronal populations of the PVH 
that contribute to the regulation of feeding behavior along with the MC4RPVH neuronal 
population.116,191 Further, AgRPARC neurons GABAergically inhibit non-MC4R neurons 
of the PVH and optogenetic experiments suggest that AgRPARC neurons may also drive 
food intake through non-MC4R neurons.116,191 There are several neuronal populations in 
the PVH that project to hindbrain and spinal cord regions that could potentially influence 
energy expenditure through the sympathetic nervous system.76,90 Further, the PVH is 
composed of several neurons that project to the median eminence, suggesting 
interaction with the pituitary and metabolic regulation through neuroendocrine 
control.76,136,203 It is due to the heterogeneity of the PVH and the many possible ways in 
which it regulates energy homeostasis that researchers aim to identify and characterize 
the various subpopulations of the PVH and their role in maintaining energy balance. The 
following is a non-exhaustive examination of the PVH neurons that have been identified 
to influence energy homeostasis. 
 
Nitric oxide synthase 1 
 NOS1 neurons of the PVH are a large subset of Sim1PVH neurons, which send 
projections to regions of the hindbrain including the PBN and NTS which are known to 
be important for regulating food intake.76,93,204,205 NOS1PVH neurons also project to the 
upper thoracic spinal cord, including the ChAT expressing region of the IML, suggesting 
potential connections with and regulation of preganglionic sympathetic neurons and 
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thus energy expenditure regulation.76,99 These neurons send projections to the median 
eminence (ME), indicating that they contain parvocellular neurons that influence the 
function of the pituitary and magnocellular projections that release signals into the 
systemic circulation directly through the posterior pituitary.76 NOS1PVH neurons were 
found to suppress feeding in a similar manner to Sim1PVH neurons when 
chemogenetically activated.76 Further, activation of these neurons led to modest 
increases in energy expenditure and activity level. A subpopulation of the NOS1PVH 
neurons are the oxytocin (OXT) expressing neurons of the PVH.76 As the NOS1PVH 
neurons are a very large population in the PVH, it is unclear if the suppression of food 
intake due to activating these neurons is the result of activating a yet undiscovered 
subpopulation of these neurons, necessitating further investigation of PVH populations 
that overlap with the NOS1PVH neuronal population. 
 
Oxytocin  
In the PVH, oxytocin (OXT) is produced in magnocellular neurons that primarily 
project to the posterior lobe of the pituitary gland, where it is released into the blood.128 
OXT release into the neurohypophysial system has been thought to play a role in the 
regulation of mammalian reproduction physiology such as milk ejection during lactation 
and uterine contractions during the birthing process.130,131 OXT also initiates maternal 
responses and bonding following birth and may influence social cognition such as social 
bonding, facial recognition and the ability to assess emotional states of others through 
facial cues.130,206-211 OXT is also produced in parvocellular PVH neurons, which project 
to the median eminence as well as regions of the forebrain.212,213 
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Retrograde tracing using cholera toxin B demonstrated that OXTPVH neurons 
project to the NTS of rats.91 OXTPVH neurons that project to the NTS may participate in 
ARC to PVH signaling to the NTS due to their activation following leptin administration, 
suggesting potential regulation of feeding.93 Further, Sim1 haploinsufficient mice have 
decreased expression of OXT and are obese.74 Ablation of OXT or OXT receptors from 
mice however, does not strongly influence the regulation of body weight unless given a 
high-fat diet. This only promotes a diet induced obesity that is not due to hyperphagia, 
rather due to a decrease in energy expenditure.214,215 Ablation of OXT neurons through 
Cre-dependent diphtheria toxin in adult mice also does not promote hyperphagic 
obesity.216 Tracing studies using synaptic terminal-specific retrobeads and viral vectors 
on transgenic mice have revealed that OXTPVH neurons send few projections to the NTS 
or PBN.76,217 Further, chemogenetic activation of OXTPVH neurons does not influence 
food intake, suggesting that OXTPVH neurons are not responsible for the feeding 
behavior regulation attributed to the PVH.76 OXTPVH neurons do not express significant 
MC4R and attempting to selectively re-express MC4R in OXT neurons in MC4R-null 
mice does not reverse the hyperphagic obesity phenotype seen in MC4R-null mice.77 
Activating OXTPVH neurons does not suppress food intake initiated by activating PVH-
projecting AgRP neurons, which contrasts with the activation of MC4RPVH neurons that 
results in the inhibition of hyperphagia facilitated by AgRP.116 These findings suggest 
that OXTPVH neurons do not influence the melanocortin signaling system. Activating 
OXTPVH neurons does have a modest influence on energy expenditure, as 
chemogenetic activation of these neurons increases oxygen consumption and activity 
levels.76 This regulation of energy expenditure may be due to the OXTPVH neurons 
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found within the NOS1PVH field of neurons, which project to sympathetic preganglionic 
neurons in the thoracic spinal cord and regulate ChAT neurons in the IML.76 
 
Glucagon like peptide receptor  
GLP-1 is a post-translational cleavage product of preproglucagon which is 
encoded by the Gcg gene. It as an incretin hormone that is produced primarily in L-cells 
of the intestine as well as a subpopulation of neurons in the NTS.218,219 GLP-1 promotes 
weight loss and augments glucose dependent insulin secretion through the pancreas.220 
GLP-1 receptor (GLP1R) expression is essential in the CNS, more specifically in 
glutamatergic rather than GABAergic neurons, for GLP1R agonists such as liraglutide to 
produce its physiological effects such as reduced food intake and body weight.56,221-226 It 
is thought that liraglutide exerts its anorectic effects through GLP1R neurons in the ARC 
and liraglutide applied to the VMH activates brown adipose tissue thermogenesis, 
suggesting that GLP1R signaling may influence energy expenditure regulation as 
well.222,227,228 The GLP-1 producing neurons in the NTS send projections to 
hypothalamic regions including the PVH, a region that expresses GLP1R.229-232 Direct 
application of GLP-1 to the PVH suppresses food intake behavior and administration of 
a GLP-1 antagonist increases food intake.233 It has also been determined that 
endogenous GLP-1 regulates food intake through the PVH, and that this may be due to 
the activation of CRH and nesfatin-1 neurons.229  Ablation of GLP1R in Sim1 neurons in 
mice has negligible effects on food intake and body weight and a minor influence on 
energy expenditure, suggesting that alternate neuronal circuits may compensate for the 
deletion of GLP1R in Sim1 neurons early in development.234-236  
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 Through the use of Gcg-Cre transgenic mice, researchers investigated these 
neurons using chemogenetic and optogenetic methods. They determined that NTS to 
PVH GLP-1 signaling sufficiently suppresses food intake and does so independently of 
glutamate co-released from GCG neurons.237 GLP1R activation has been determined to 
increase excitatory synaptic strength to CRH neurons through enhancing subunit 
membrane trafficking of the AMPA receptor.237 While ablation of GLP1R expression 
from Sim1 neurons early in development does not show strong effects on food intake, 
post-natal ablation of GLP1R from the PVH results in an increase in body weight gain 
and food intake, suggesting that GLP1R signaling is necessary for the regulation of 
energy homeostasis when compensation early in development is not allowed to 
occur.234,237 Further, chronic perturbation of GLP1RPVH neurons using virally delivered 
tetanus toxin in mice resulted in hyperphagic obesity. Chemogenetic inhibition of 
GLP1RPVH neurons produced enhanced feeding behavior, while acute activation of 
these neurons suppresses appetite without influencing energy expenditure.238 
 
Arginine Vasopressin 
Arginine Vasopressin (AVP) expression in the PVH is found in both parvocellular 
and magnocellular neurons.239 Magnocellular AVP neurons regulate osmotic balance 
regulation and the secretion of AVP from these neurons is regulated by selective 
osmoreceptors, with AVP concentrations increasing as plasma osmolarity 
increases.240,241. Further, baroreceptors modulate the release of AVP in response to 
arterial volume changes and physiological stress has also shown to increase the 
release of AVP.242-245 The AVP expressing parvocellular cells send their terminals to the 
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external zone of the median eminence near the capillaries of the hypophyseal portal, 
allowing them to secrete AVP into the portal blood.239 AVP has been shown to work 
synergistically with corticotropin releasing hormone (CRH) to influence the secretion of 
ACTH.246,247  
AVP synthesized in the parvocellular neurons of the PVH has been implicated in 
the regulation of blood glucose, feeding and locomotor activity.248-252 Studies have found 
that AVP stimulates glycogen phosphorylation to break down glycogen and increase the 
concentration of glucose.250 Infusion of AVP in humans has resulted in increases of 
plasma glucose and glucagon concentrations.250 It has been found that 
chemogenetically activating AVPPVH neurons acutely reduces feeding behavior and the 
anorectic melanocortin agonist MTII activates AVPPVH neurons. Further, AVPPVH 
neurons may serve as a regulatory node for melanocortin mediated feeding circuitry, as 
their ablation partially reverses melanocortin induced anorexia.253 
 
Thyrotropin-releasing hormone 
 Thyrotropin-releasing hormone (TRH) is both a neurotransmitter and 
neurohormone that is critical in the regulation of the hypothalamic-pituitary-thyroid 
(HPT) axis.136 The parvocellular TRHPVH neurons that participate in the neuroendocrine 
system release TRH into the pericapillary space of the external zone of the median 
eminence and communicate with the anterior pituitary, inducing the synthesis and 
release of TSH.136,254 In turn, the TSH induces the secretion of thyroid hormones 
thyroxine (T4) and triiodothyronine (T3), which signal peripheral tissues to promote 
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cellular metabolism and energy expenditure.136,255,256 This results in the control of the 
basal metabolic rate through the regulation of metabolism in most tissues in the body 
including heart and skeletal muscle.257 Cold exposure results in the release of TRH, 
which in turn releases thyroid hormones to promote thermogenesis in thermogenic 
organs including brown adipose tissue (BAT), white adipose tissue and skeletal 
muscle.257-262 Non-hypophysiotropic TRHPVH neurons also promote thermoregulation 
through neural connections with BAT, likely contributing to the regulation of 
thermogenesis through the autonomic nervous system.262,263 ICV administration of TRH 
in Syrian hamsters resulted in an increase in BAT activity and an increase in core 
temperature without influencing thyroid hormone levels, suggesting a central effect 
mediated through the sympathetic nervous system.262,264  
 Under normal circumstances, thyroid hormones are typically maintained at a 
constant level in order to maintain an appropriate metabolic rate.265-267 Under conditions 
of starvation, energy stores are preserved through the suppression of T4 and T3 which in 
turn induces an increase in the biosynthesis and secretion of hypophysiotropic TRH.268 
This raises the threshold for feedback inhibition of the thyroid hormones and results in 
an increase in the secretion of TSH.269 Increased plasma concentrations of thyroid 
hormones, however, suppress synthesis and release of TRH, resulting in a reduction in 
the threshold for feedback regulation of thyroid hormones and therefore a suppression 
in TSH secretion, causing a reduced release of thyroid hormones.269 Additionally, leptin 
released by adipocytes increases TRH levels when in a fed state. Leptin directly 
stimulates TRH in the PVH through inducing the phosphorylation of signal transducer 
and activator of transcription 3 (STAT3) in TRH neurons, while fasting inhibits TRH 
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neurons.270-272 The phospho-STAT3 regulates prepro-TRH transcription through binding 
to the prepro-TRH promoter.270,273,274 Leptin indirectly stimulates TRH neurons through 
upregulating POMC expression and inhibition both AgRP and NPY expression in the 
ARC.187,275-278 Leptin resistance in rats as a result of diet-induced obesity inactivates the 
indirect pathway, however the HPT axis activity is maintained in obese rodents and 
humans.268,279,280 It was found that increased thyroid hormone levels in obese rats was 
due primarily to central leptin activity and that T3 feedback inhibition of prepro-TRH 
gene is a result of leptin induced pSTAT3 signaling.268 It is because of this relationship 
between T3 and pSTAT3 signaling that the HPT axis can maintain its normal activities 
during an obese state.268 Interestingly, chemogenetic activation of TRHPVH neurons 
promotes food intake, which contrasts with the food intake suppression observed 
following the activation of other studied PVH neuronal populations such as the NOS1PVH 
neurons.76,281 This may be due to the excitatory inputs TRHPVH neurons provide to the 
AgRP neurons in the ARC that promote feeding behavior.281 
 
Corticotropin releasing hormone 
The corticotropin releasing hormone (CRH) system mediates the behavioral and 
endocrine response to stress through the hypothalamic-pituitary-adrenal axis.203 CRH is 
produced by parvocellular neurons of the PVH and is released in the median eminence 
into the primary capillary plexus of the hypophyseal portal system.282,283 The CRH is 
then transported to the anterior lobe of the pituitary, where corticotropes are stimulated 
to release ACTH, which in turn stimulates the release of hormones such as 
glucocorticoids.246,284,285 ICV injections of CRH in genetically obese and lean mice 
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results in decreased feeding, oxygen consumption and activity level, however the role 
CRHPVH neurons play in feeding when interrogated directly is not clearly understood.286-
289 Other sources have suppressed feeding behavior through chemogenetic activation 
of CRHPVH neurons.237 It has been proposed through combined 
chemogenetic/optogenetic studies, that activation of CRHPVH neurons by glucagon-like 
peptide-1 expressing neurons of the NTS contributes to food intake suppression.237 
However, another study counters this, as it finds that there is very little overlap between 
CRH and GLP1R neurons in the PVH.238 In addition, CRHPVH neuron activity is rapidly 
reduced following refeeding after a fast indicating that CRHPVH neuron activity may be 
more responsive to alterations in stress than feeding directly.238 Finally, chronic 
silencing of CRHPVH neurons failed to produce the hyperphagic obesity observed in 
silencing GLP1RPVH neurons.238 
 
Prodynorphin 
 Prodynorphin (PDYN)-expressing neurons of the PVH are a subpopulation of 
Sim1PVH neurons that receive projections from AGRPARC neurons but are distinct from 
the MC4R neurons of the PVH.290 The summation of the contributions of the PDYNPVH 
and MC4RPVH neurons to the regulation of body weight account for the majority of the 
obesity prevention attributed to the SIM1PVH neurons. PDYNPVH neurons are 
independent from MC4RPVH neurons but are necessary to maintain normal body weight 
and energy balance.290 Inhibition of both PDYNPVH and MC4RPVH neurons results in a 
hyperphagia that is similar to the activation of AgRPARC neurons.190,192,290 This suggests 
that the PDYNPVH and MC4RPVH neurons are primarily engaged by AgRPARC neurons 
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that project to the PVH to regulate feeding. Silencing PDYNPVH neurons results in 
increased food intake in mice to a similar extent as mice with MC4RPVH neurons 
inhibited. Inhibition of both neuronal populations of the PVH results in a hyperphagia 
that is similar to that which results from inhibition of Sim1PVH neurons, which supports 
that the PDYNPVH and MC4RPVH neurons make up the majority of satiety neurons of the 
PVH.68,290 Further, chronic inhibition of both neuronal populations result in an additive 
increase in body weight. The majority of the satiety phenotype of the PDYNPVH neurons 
is a result of its projections to the PBN, as optogenetic inhibition of the terminals of 
PDYNPVH neurons in the PBN results in a similar hyperphagic phenotype to the 
chemogenetic inhibition of all PDYNPVH neurons.290 Channelrhodopsin-2-assisted circuit 
mapping reveals that PDYNPVH and MC4RPVH neurons project to the parabrachial 
complex, but the PDYNPVH neurons synapse onto the pre-locus coeruleus and the 
MC4RPVH neurons synapse onto the central lateral parabrachial nucleus, indicating they 
are two non-overlapping glutamatergic circuits.116,290 PDYNPVH neurons are therefore 
responsive to caloric need and are both necessary and sufficient to regulate feeding. 
 
Future Directions: 
 Numerous studies have demonstrated that the PVH is essential for the regulation 
of energy homeostasis through its regulation of food intake and energy 
expenditure.4,5,291 Disruption of the PVH either through developmental or mechanical 
lesions result in hyperphagic obesity and glucose dysregulation in both humans and 
rodents.66-71 The PVH is composed of diverse cell populations that are defined by their 
expression of neuropeptides, enzymes and cell surface receptors.5,217 Although many 
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neuronal populations of the PVH have been identified as contributors to feeding and 
energy balance regulation through cell specific manipulations, there is still much to learn 
about the different ways in which subpopulations of the PVH participate in energy 
homeostatic neurocircuitry. This therefore necessitates further investigation of the 
significant neuronal subpopulations within the PVH and how they differentially influence 
energy balance through physiological processes such as the regulation of feeding 
behavior, energy expenditure and the neuroendocrine system.  
 In pursuit of this goal, we investigated neuronal populations of the PVH for their 
energy homeostatic properties. We studied the insulin receptor substrate-4 (IRS4) 
expressing neurons of the PVH, as previous studies showed that insulin receptor 
substrate-2 (IRS2) and IRS4 work synergistically to maintain energy balance and our in 
situ hybridization studies showed an abundance of IRS4 expression in the PVH.90,292 
We utilized viral tools to acutely activate and chronically silence IRS4PVH neurons to 
determine the necessity and sufficiency of IRS4PVH neurons in regulating energy 
balance as well as retrograde and anterograde tracers to determine which regions are 
upstream and downstream of the IRS4PVH neurons.90 We also studied the calcitonin 
receptor (CalcR) expressing neurons of the PVH, as direct application of the anorectic 
salmon calcitonin (sCT) to the PVH of rats suppresses feeding behavior and CalcR is 
highly expressed in the PVH.293 We then conducted studies in which we deleted CalcR 
expression in Sim1 expressing neurons in order to determine if CalcR expression in 
these neurons is necessary for the anorectic response of sCT as well as whether it was 
necessary to maintain energy homeostasis.294 Following these experiments, we 
investigated CalcR expressing neurons as a population of the PVH. Similarly to the 
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previous project, we us activation and inhibition techniques to investigated the 
sufficiency and necessity of CalcRPVH neurons to regulate energy homeostasis, as well 
as conducted anterograde tracing using viral tools. As the MC4RPVH neuronal 
population was found to overlap with CalcRPVH neurons, we also silenced MC4RPVH 
neurons for the purposes of comparison.92 Further, as MC4R expression in the PVH is 
crucial for maintaining normal feeding behavior and body weight, we deleted MC4R 
expression from CalcR neurons to study the importance of MC4R expression in CalcR 
neurons in energy balance and their responsiveness to the anorectic melanotan II 
(MTII).77 While these studies identify novel PVH neuronal populations which are 
involved in energy balance, they do not demonstrate the role the downstream projection 
targets of these PVH neurons play in energy homeostatic circuitry.  
 The PVH is thought to regulate food intake through projections to hindbrain 
regions such as the PBN and NTS, two regions that are known integrators of satiety 
signals.76-78,295 The PVH is also thought to regulate energy expenditure through the 
modulation of sympathetic outputs through polysynaptic connections through the dorsal 
raphe, the NTS and spinal cord.96,97,99,296,297 While we have identified several neuronal 
subpopulations of the PVH that project to both regions, we have yet to confirm their 
specific roles in the regulation of food intake and energy expenditure. For example, 
chemogenetic activation of NOS1PVH neurons suppresses food intake and promotes 
energy expenditure and projects to both the PBN and NTS. This method indicates the 
summation of the physiological effects produced by NOS1PVH neurons interacting with 
brain regions downstream but fails to discern the physiological effects attributed to 
projections to the PBN or NTS specifically.76 We therefore need to utilize methods that 
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allow us to specifically manipulate neuronal cells of the PVH based on their downstream 
targeted regions. Optogenetics has been an effective tool for this sort of investigation, 
demonstrating that optogenetic stimulation of PBN projection terminals of MC4RPVH 
neurons results in a non-aversive suppression in feeding behavior as an example.116 
This method, however, is not effective for investigating PVH neurons that project to the 
NTS, as it is not feasible to implant optic fibers in such caudal regions without a skull for 
stabilization. Therefore, we have developed methods using retrograde viral vectors that 
will allow us to investigate the contribution of specific PVH neuronal circuits in the 
regulation of energy balance. This method will allow us to use specific manipulations in 
order to determine the energy homeostatic roles of PVH neurons that project to PBN 
and NTS. These studies will improve our understanding of how the PVH regulates 
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Figure 1.1: Melanocortin signaling through the ARC to PVH circuit. The ARC 
contains neurons that co-express AgRP, NPY and GABA as well as POMC neurons. 
The AgRP/NPY/GABA neurons promote food intake through downstream receptors in 
the PVH, while the POMC neurons generate the anorectic α-MSH to suppress food 
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intake through interaction through activation of the MC4R expressing neurons in the 
PVH. AgRP acts as an antagonist for the MC4R receptor, blocking the activities of α-
MSH while NPY increases feeding through interaction with Y1 and Y5 receptors in the 
PVH. Stimulation of the MC4RPVH neurons with α-MSH activates efferent outputs to 
regions in the hypothalamus and hindbrain to mediate food intake behavior and the 
regulation of body weight. AgRP/NPY neurons also produce the neurotransmitter 
GABA, which inhibits POMCARC neurons to suppress α-MSH secretion from POMC 
neurons. AgRP/NPY/GABA neurons of the ARC and MC4RPVH neurons express GHSR, 
ObR and INSR. Ghrelin functions to stimulate AgRP/NPY/GABA neurons, while it 
inhibits the activities of POMC neurons in the ARC. Conversely, insulin and leptin 
promote POMC activity and inhibit AgRP/NPY/GABA neurons. 3V= third ventricle, 














Paraventricular, Subparaventricular and Periventricular Hypothalamic IRS4-
Expressing Neurons are Required for Normal Energy Balance1 
Abstract 
Understanding the neural components modulating feeding-related behavior and energy 
expenditure is crucial to combating obesity and its comorbidities. Neurons within the 
paraventricular nucleus of the hypothalamus (PVH) are a key component of the satiety 
response; activation of the PVH decreases feeding and increases energy expenditure, 
thereby promoting negative energy balance. In contrast, PVH ablation or silencing in 
both rodents and humans leads to substantial obesity. Recent studies have identified 
genetically-defined PVH subpopulations that control discrete aspects of energy balance 
(e.g. oxytocin (OXT), neuronal nitric oxide synthase 1 (NOS1), melanocortin 4-receptor 
(MC4R), prodynorphin (PDYN)). We previously demonstrated that non-OXT NOS1PVH 
neurons contribute to PVH-mediated feeding suppression. Here, we identify and 
characterize a non-OXT, non-NOS1 subpopulation of PVH and peri-PVH neurons 
expressing insulin-receptor substrate 4 (IRS4PVH) involved in energy balance control. 
 
1 Chapter 2 was previously published in Scientific Reports – Nature: Sutton AK, 
Gonzalez IE, Sadagurski M, et al. Paraventricular, subparaventricular and 
periventricular hypothalamic IRS4-expressing neurons are required for normal energy 
balance. Sci Rep. 2020;10(1):5546. 
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Using Cre-dependent viral tools to activate, trace and silence these neurons, we 
highlight the sufficiency and necessity of IRS4PVH neurons in normal feeding and energy 
expenditure regulation. Furthermore, we demonstrate that IRS4PVH neurons lie within a 
complex hypothalamic circuitry that engages distinct hindbrain regions and is innervated 
by discrete upstream hypothalamic sites. Overall, we reveal a requisite role for IRS4PVH 
neurons in PVH-mediated energy balance which raises the possibility of developing 
novel approaches targeting IRS4PVH neurons for anti-obesity therapies. 
 
Introduction 
Genetic polymorphisms associated with obesity are disproportionately clustered 
in pathways affecting neural function and architecture in the central nervous system 
(CNS).1 Within the brain, the paraventricular nucleus of the hypothalamus (PVH) is a 
primary hypothalamic node that integrates neural and humoral information regarding 
energy balance and sends output signals to structures in the hindbrain and spinal cord 
to control satiety and energy expenditure.2-4 Dysregulation of the entire PVH with site-
directed lesions or inhibition of PVH melanocortin-4 receptor (MC4R) action produce 
profound obesity.5-7 However, while disruption of MC4RPVH activity leads to obesity due 
to hyperphagia, lesions of the entire PVH are associated with both feeding and energy 
expenditure dysregulation.7-9 While MC4RPVH activity is necessary and sufficient to alter 
feeding behavior, MC4R action in the PVH cannot be ascribed to neural populations 
expressing oxytocin (OXT), vasopressin (AVP), or corticotropin-releasing hormone 
(CRH).7 Manipulation of other PVH populations, such as neuronal nitric oxide synthase 
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1 (NOS1PVH) neurons, is sufficient to alter both feeding and energy expenditure.10 This 
raises the possibility that distinct PVH cell types might independently or coordinately 
regulate feeding and/or energy expenditure. Even though substantial efforts have been 
made to define PVH neuronal populations and their distinct roles in energy balance 
control, few studies have revealed PVH populations that are capable of regulating 
multiple aspects of energy balance (i.e. energy expenditure and feeding), apart from the 
NOS1PVH population. 
Nos1 expression marks a relatively large percentage of PVH neurons that send 
projections to hindbrain and spinal cord sites. Chemogenetic activation of NOS1PVH 
neurons suppresses feeding and increases energy expenditure by promoting both 
increased physical activity and thermogenesis.10 OXTPVH neurons are almost entirely 
contained within the NOS1PVH field, yet their activation drives only small changes in 
energy expenditure and does not suppress feeding.10 NOS1PVH-dependent changes in 
energy expenditure are likely independent of MC4R-signaling in the PVH, since 
activation of MC4RPVH neurons suppresses feeding but does not affect energy 
expenditure and selective PVH expression of Mc4R in an otherwise Mc4R-null 
background has little impact on energy expenditure.8,11 Given the important contribution 
of both energy expenditure and feeding dysregulation in the development of obesity, the 
identification of distinct targets that have the capability to modulate both aspects of 
energy balance is particularly pertinent. 
Recent reports indicate that insulin receptor substrate-4 (IRS4) acts in synergy 
with insulin receptor substrate-2 (IRS2) in the hypothalamus to maintain normal 
bodyweight.12 We discovered that Irs4 is expressed in and adjacent to the PVH and that 
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the paraventricular and periventricular IRS4-expressing cell population (referred to as 
IRS4PVH) is both necessary and sufficient for normal feeding and bodyweight, 
suggesting a functional role for PVH and peri-PVH Irs4-expressing neurons in the 
control of energy homeostasis. Additionally, we find that NTS-projecting and PBN-
projecting IRS4PVH neurons are densely innervated by local PVH neurons, supporting a 
role for an intra-PVH network in the regulation of energy balance. Monosynaptic afferent 
neural tracing suggests that the inputs to IRS4PVH neurons vary depending on the brain 
regions to which an IRS4PVH subset projects. Overall, our study proposes a novel 
framework for the regulation of bodyweight consisting of multiple interconnected PVH 
populations that are potentially under independent control to modulate distinct energy 
balance parameters including feeding and energy expenditure. 
 
Results 
Irs4 expression marks a distinct PVH subpopulation 
Hypothalamic IRS4 and IRS2 synergistically contribute to body weight maintenance.12 
Since in situ hybridization (Allen Mouse Brain Atlas13) reveals dense Irs4 expression in 
and adjacent to the PVH, we sought to determine the role of IRS4PVH neurons in energy 
homeostasis using Cre-dependent technologies in combination with a novel IRS4-iCre 
knock-in mouse model in which Cre recombinase expression is tethered to Irs4 (Figure 
2.1 A). The Irs4 gene is located on the X chromosome. Since random X inactivation 
may lead to variable Cre activity in female mice, male mice were used exclusively in all 
studies. In situ hybridization of both Cre and Irs4 mRNA in the PVH of IRS4-iCre mice 
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was used to verify the appropriate expression of Cre recombinase in the IRS4-iCre 
mouse line and demonstrated substantial overlap of Irs4 and Cre mRNA transcripts in 
the PVH (Figure 2.1 B). To investigate IRS4PVH neuron overlap with other known PVH 
populations, IRS4PVH neurons were labeled by injection of a Cre-dependent GFP 
reporter virus into the PVH of IRS4-iCre mice (Figure 2.1 C). This approach eliminates 
the possibility of overrepresentation of the IRS4PVH reporter population due to 
developmental Irs4 expression and aligns with subsequent Cre-dependent viral 
technologies used to manipulate IRS4PVH neurons in adult mice. Brains stained for GFP 
(indicating IRS4-iCre activity) and neurophysin I, the carrier protein for oxytocin, indicate 
that adult IRS4PVH neurons do not substantially overlap with OXTPVH neurons (Figure 
2.1 D). To determine if IRS4PVH neurons are contained within the NOS1PVH population, 
we stained brain slices from IRS4-iCre mice injected with AAV-Flex-GFP for NOS1 
peptide and GFP and found that IRS4PVH neurons are a separate population from 
NOS1PVH cells (Figure 2.1 E). As AVPPVH neurons are also able to modestly control 
feeding, we examined the overlap of AVP and IRS4 within the PVH.14 Indeed, GFP-
identified PVH neurons representing IRS4-iCre activity do not overlap substantially with 
immunoreactivity for copeptin, the carrier molecule for AVP (Figure 2.1 F). To 
investigate the potential overlap between IRS4PVH neurons and other subpopulations of 
the PVH recently reported to contribute to energy homeostasis, we conducted in situ 
hybridization for Irs4 mRNA in combination with Crh, Pdyn, and thyrotropin-releasing 
hormone (Trh) mRNAs (Figure 2.2). The majority of IRS4PVH neurons do not express 
Crh (9.76 + 2.94% of IRS4PVH with Crh, n = 3 mice) or Pdyn (15.77 + 1.19% of IRS4PVH 
with Pdyn, n = 3 mice), and a modest fraction of CRHPVH and PDYNPVH neurons express 
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Irs4 mRNA (26.08 + 2.38% and 28.14 + 7.43% respectively). We do find that some 
IRS4PVH neurons express Trh (40.54 + 1.10%), and more than half of the TRHPVH 
neuronal population expresses Irs4 mRNA (60.43 + 3.14%). Taken together, these data 
suggest that Irs4 expression marks a circumscribed population of PVH neurons defined 
by the relative absence of OXT, AVP, and NOS1, but some overlap with CRH, PDYN, 
and TRH. 
 
IRS4PVH neurons are capable of regulating both feeding and energy expenditure 
Given the published role of IRS4 in energy homeostasis and its expression in the PVH, 
we sought to determine the ability of these neurons to regulate distinct aspects of 
energy balance. To achieve this, we employed Cre-dependent DREADD (Designer 
Receptors Exclusively Activated by Designer Drugs) viruses to acutely modulate 
neuronal activity in response to peripheral injection of an otherwise inert compound, 
clozapine N-oxide (CNO).15 To achieve remote activation of IRS4PVH neurons, we 
performed bilateral PVH injections of AAV-Flex-hM3Dq in IRS4-iCre mice (Figure 2.3 
A,B). Following recovery, PVH-directed AAV-Flex-hM3Dq injected IRS4-iCre mice were 
fasted during the day and injected with either vehicle or CNO at the onset of the dark 
cycle, a time when feeding normally occurs. Activation of IRS4PVH neurons results in 
robust suppression of feeding (Figure 2.3 C, p = 0.0005, paired t-test, t = 5.680). 
Feeding effects are not attributable to CNO or its metabolites as a separate cohort of 
wildtype mice injected with AAV-Flex-hM3Dq failed to suppress feeding with no change 
in nuclear Fos expression following injection of CNO (Figure 2.4 A,B). As pan-activation 
of PVH neurons suppresses feeding and increases energy expenditure, we placed 
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IRS4PVH mice injected with AAV-Flex-hM3Dq in metabolic chambers to measure energy 
expenditure and locomotor activity following CNO-mediated activation.10 In the absence 
of food, activation of IRS4PVH neurons increases energy expenditure, VO2 and total 
activity without a significant change in RER (Figure 2.3 D–H; VO2: p = 0.0027, t = 4.897; 
VO2 lean body mass (LBM): p = 0.0025, t = 5.001; Energy Expenditure p = 0.0026, 
t = 4.946; total X activity: p = 0.0007, t = 6.297; all paired t-test). To examine the effect of 
IRS4PVH activation on resting energy expenditure (REE), we measured VO2 at 
timepoints before and after CNO injection in which physical activity was similar (Figure 
2.3 I–K), as performed previously.10 This demonstrates that IRS4PVH activation results in 
increased VO2 (normalized to bodyweight or LBM) that is independent of increased 
physical activity (VO2 REE p = 0.0022, t = 5.113; VO2/LBM p = 0.0019, t = 5.254). Thus, 
activation of IRS4PVH neurons suppresses dark-cycle feeding and promotes energy 
expenditure in the absence of food. 
 
IRS4PVH neurons project to hindbrain and spinal cord regions 
To identify the neural circuits engaged by IRS4PVH neurons, we used injection of a Cre-
dependent adenovirus, synaptophysin-mCherry (syn-mCherry) in the PVH area to label 
the IRS4PVH synaptic terminals. Unilateral injection of syn-mCherry (Figure 2.5 A) in the 
PVH area of IRS4-iCre mice identifies robust IRS4PVH projections to hindbrain projection 
targets including the parabrachial nucleus (PBN, Figure 2.5 B), nucleus of the solitary 
tract (NTS), and the dorsal motor nucleus of the vagus (DMV) (Figure 2.5 C). IRS4PVH 
neurons also send projections to the median eminence, a site important for endocrine 
control of pituitary function (Figure 2.5 D). In addition to hindbrain regions, syn-mCherry 
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projections were identified in the intermediolateral column (IML) of the thoracic spinal 
cord in close proximity to choline acetyltransferase (ChAT)-producing neurons, 
suggesting a circuit mechanism for the regulation of sympathetic activity by IRS4PVH 
neurons (Figure 2.5 E). Of note, these results are strikingly similar to projections 
originating from NOS1PVH neurons, despite the fact that these populations do not 
appear to overlap in the PVH.10 
 
Projection-specific modified rabies tracing identifies unique inputs to IRS4PVH 
subpopulations 
As IRS4PVH neurons project to various brain regions implicated in feeding and energy 
expenditure, we hypothesized that the afferent input to distinct IRS4PVH circuits might 
differ based on IRS4PVH neuronal projection site. To test this hypothesis, we labeled 
monosynaptic inputs to either NTS-projecting or PBN-projecting IRS4PVH neurons in the 
same animal using a modified rabies virus approach that requires Cre-dependent helper 
virus (AAV-Flex-TVA-B19G) expression. Due to the limited efficacy and applicability of 
available helper virus reagents for our desired approach, we generated a Cre-
dependent helper virus that co-expresses both the TVA receptor and B19 glycoprotein 
(B19G) via a self-cleaving 2A peptide linker (Figure 2.6 A). Modified rabies virus (EnvA-
ΔG-mCherry (rabies-mCherry, Figure 2.6 B) or EnvA-ΔG-GFP (rabies-GFP, Figure 
2.6C)) cannot enter cells without the TVA receptor and is modified to express a 
fluorescent protein (mCherry or GFP) instead of B19G.16,17 Therefore, infection of the 
modified rabies virus requires viral expression of the TVA receptor and retrograde 
transport of rabies-mCherry or rabies-GFP requires viral expression of the B19G (Figure 
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2.6 D). The fidelity of this system is demonstrated by a lack of rabies-mCherry 
expression in the brain of Sim1-Cre mice in which the helper virus injection missed the 
PVH (determined by a lack of 2A staining in the PVH), despite rabies-mCherry injection 
into the NTS (Figure 2.7 A,B). In this approach, neurons upstream of primary infected 
neurons theoretically do not express Cre recombinase, and therefore do not produce 
B19G; this limits rabies-mCherry or rabies-GFP expression to monosynaptic inputs to 
IRS4PVH neurons. 
Cre-dependent expression of the TVA receptor throughout the cell body and synaptic 
terminals of transduced neurons allows terminal-specific rabies infection.18 To 
determine if subpopulations of IRS4PVH neurons might be engaged by discrete afferent 
inputs, we performed dual rabies virus injections at anatomically separable projection 
targets in the same mouse (Figure 2.6 D). Three weeks following helper virus injection, 
rabies-mCherry was injected in the NTS whereas rabies-GFP was injected in the PBN. 
Following 5 days of incubation, we found that IRS4PVH neurons that project to the NTS 
or PBN are largely distinct as evidenced by the lack of significant fluorescence 
colocalization in the PVH (colocalized cells: n = 27 ± 5.7 cells, n = 2 mice). The fact that 
some co-localization between GFP and mCherry occurs in the PVH suggests the 
existence of PVH neurons capable of regulating both the NTS and PBN presumably 
either through collateralization or intra-PVH microcircuitry (Figure 2.6 E–G). 
Consistent with published literature examining PVH circuitry, our rabies monosynaptic 
labeling demonstrates that the arcuate nucleus (ARC) is an upstream site of NTS-
projecting IRS4PVH neurons (Figure 2.6 H,HII).19 Additional hypothalamic sites engaging 
NTS-projecting IRS4PVH neurons include the lateral hypothalamic area (LHA, Figure 2.6 
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HI) and the dorsomedial hypothalamus (DMH, Figure 2.6 H), whereas sites upstream of 
PBN-projecting IRS4PVH neurons largely include the ventromedial hypothalamus (VMH) 
and LHA (Figure 2.6 H). Although monosynaptic rabies tracing is not a quantitative 
methodology, a small number of LHA neurons co-express GFP and mCherry, 
suggesting LHA modulation of both IRS4PVH-PBN and IRS4PVH-NTS circuits (Figure 2.6 
HI, n = 8 ± 11.3 cells, n = 2 mice). In contrast, very few afferent neurons in the ARC co-
express GFP and mCherry (n = 2 ± 2.1 cells, n = 2 mice). Forebrain sites including the 
preoptic area (POA, Figure 2.6 LII) and bed nucleus of the stria terminalis (BNST, Figure 
2.6 LI) include largely non-overlapping populations upstream of both IRS4PVH circuits, 
suggesting distinct forebrain circuits may modulate IRS4PVH neuronal function. 
 
IRS4PVH neurons are necessary for normal feeding and energy balance 
To test the necessity of IRS4PVH neuron activity in physiologic body weight regulation, 
we permanently silenced IRS4PVH neurons using a Cre-dependent tetanus toxin virus 
(AAV-Flex-TetTox) that cleaves the SNARE protein, synaptobrevin, and inhibits 
synaptic vesicle release.20 This construct has been modified to express the A subunit 
and does not travel retrogradely, therefore limiting neuronal silencing to IRS4 Cre-
expressing neurons.21 We performed bilateral PVH injections of AAV-Flex-TetTox in 
IRS4-iCre mice (Figure 2.8 A,B). In comparison to control Cre-dependent viral injections 
into the PVH of IRS4-iCre mice (PVHFlex) or AAV-Flex-TetTox injections in the PVH of 
wildtype mice (WTTetTox), mice with IRS4PVH neuronal silencing show modest obesity 
within one week of injection (Figure 2.8 C: PVHTetTox v. WTTetTox p = 0.0162; Figure 2.8 
D: PVHTetTox v. WTTetTox p = 0.0008, PVHTetTox v. PVHFlex p = 0.0003; mixed effects 
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analysis followed by Tukey’s post-hoc). Obesity following elimination of IRS4PVH 
signaling is likely driven primarily by early hyperphagia, demonstrated by increased food 
intake in the second week of the study (Figure 2.8 E, PVHTetTox v. WTTetTox p = 0.0303; 
one-way ANOVA followed by Tukey’s post-hoc). Mice with silenced IRS4PVH neurons 
demonstrate a non-significant trend towards decreased energy expenditure during the 
second and third weeks of the study (Figure 2.8 G,I,J, energy expenditure p = 0.074; 
RER p = 0.075; one-way ANOVA), without changes in total X activity (Figure 2.8H). 
Body composition analysis indicates that IRS4PVH neuronal silencing leads to an 
increased fat percentage at both early (Figure 2.8 F, left; PVHTetTox v. PVHFlex 
p = 0.0259, one-way ANOVA followed by Tukey’s post-hoc) and late (Figure 2.8 F, right; 
PVHTetTox v. WTTetTox p = 0.0377; one-way ANOVA followed by Tukey’s post-hoc) time 
points after injection. Unilateral IRS4PVH neuronal silencing was also associated with 
increased bodyweight throughout the course of the experiment, with trends toward 
similar effects on feeding and energy expenditure (Table 2.1, one-way ANOVA followed 
by Tukey’s post-hoc if applicable) 
 
IRS4PVH neurons are dispensable for melanocortin-induced feeding suppression 
Given the important role of the PVH in mediating melanocortin-induced satiety, and the 
identification of numerous ARC inputs to IRS4PVH neurons, we hypothesized that 
IRS4PVH neurons might contain melanocortin 4 receptors (MC4R) and participate in 
melanocortin agonist-induced anorexia. To test this, we performed in situ hybridization 
for Mc4r and Irs4 in wildtype mice (Figure 2.9 A). Although most IRS4PVH neurons do 
not contain Mc4r mRNA (9.67% + 1.11% of IRS4PVH with Mc4R, n = 3 mice), a 
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significant fraction of MC4RPVH neurons do express Irs4 mRNA (53.66% + 1.13%). To 
test the physiologic importance of melanocortin action in IRS4 neurons, we attempted to 
delete MC4R expression from IRS4 neurons by crossing IRS4-iCre and the Cre-
dependent lox-Mc4R mouse line.7 Unfortunately, developmental expression of Cre 
recombinase from the IRS4-iCre allele resulted in germline deletion of Mc4R (data not 
shown). We then tested the ability of the melanocortin agonist melanotan-II (MTII) to 
suppress dark cycle feeding in mice with AAV-Flex-TetTox or control injections in the 
PVH at 4–5 weeks post-injection. Despite the inability to transmit information from 
IRS4PVH neurons (and therefore a significant portion of MC4RPVH neurons), MTII 
injection (150 ug/mouse) still suppressed both two and four hour feeding in all cohorts of 
mice, suggesting that IRS4PVH neuron activity is not required for the melanocortin 
feeding response (Figure 2.9 B,C; two-way repeated measures ANOVA vehicle vs. 
MT2; two hour PVHTetTox p = 0.0312, t = 2.714, WTTetTox p = 0.0001, t = 4.763, PVHFlex 
p < 0.0001, t = 6.113; four-hour PVHTetTox p = 0.0535, t = 2.486, WTTetTox p = 0.0025, 
t = 3.681, PVHFlex p = −0.0004, t = 4.355). 
 
Discussion 
The combination of genetic mouse models with site-specific delivery of 
chemogenetic and optogenetic tools has greatly advanced our understanding of the role 
of the PVH in modulating energy balance through feeding and/or energy expenditure. 
Nonetheless, few studies have genetically identified specific PVH populations crucial for 
these functions. Our previous work suggests the importance of a non-OXT Nos1PVH 
population in feeding regulation.10 Here, we identify a different (non-OXT and non-
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NOS1PVH) population expressing insulin receptor substrate-4 (Irs4) that is necessary for 
normal bodyweight maintenance. 
Genetic deletion of Irs4 results in modest obesity and altered glucose 
homeostasis; whether this phenotype reflects simply a loss of Irs4 function or 
developmental compensation in response to Irs4 loss is unknown.12,22 In our approach, 
we used site and temporal specific manipulations in adult organisms to circumvent 
developmental issues and directly examine the function of IRS4-expressing cells 
predominantly within the PVH. Whereas chemogenetic activation reveals the potential 
function of IRS4PVH neuronal function in adult mice, neuronal silencing with tetanus toxin 
addresses the physiologic necessity of this population in various energy balance 
parameters. Indeed, permanent inhibition of IRS4PVH-specific synaptic release results in 
obesity due to altered feeding and a trend toward lower energy expenditure. 
An important caveat to this study flows from its methodologic approach. 
Stereotaxic injections to defined brain regions are not always exclusively limited to cells 
within a classically defined neuroanatomical region. In our study we have excluded data 
for physiologic analyses from animals with significant extra-PVH viral transduction. All 
analyses were performed using data from animals with limited extra-PVH viral 
expression. However, post-hoc immunocytochemistry of brain sections from analyzed 
animals revealed transduction of IRS4 Cre-expressing cells adjacent to the PVH. The 
contribution of these subparaventricular and periventricular IRS4 cells to the outputs 
measured cannot be determined from the current study. In our study there were no 
cases of PVH-targeted injections that were limited to just the subparaventricular or 
periventricular IRS4-expressing cells that would allow physiologic comparisons with the 
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PVH and peri-PVH-transduced cohort. Highly refined injections limited to cells solely in 
the PVH or solely in adjacent areas would be needed to completely define the 
contributions of these peri-PVH IRS4-expressing cells to energy balance control. 
Cre-dependent efferent tract tracing suggests that the circuitries engaged by 
IRS4PVH neurons used to regulate feeding and energy expenditure are similar to those 
identified for both NOS1PVH and MC4RPVH neurons and include the PBN and NTS and 
sparse projections to the spinal cord.7,10,11 While our current studies cannot discriminate 
which projection site is relevant for controlling feeding and energy expenditure, it is 
possible that IRS4PVH neurons projecting to the PBN contribute to feeding modulation 
since the PBN is the relevant output in MC4R-mediated feeding suppression.11 
However, our data indicate that IRS4PVH neurons and MC4RPVH neurons overlap only in 
part, and that MC4R-mediated feeding suppression is unaffected by IRS4PVH neuronal 
silencing. Therefore, it remains possible that other projection output sites may drive the 
IRS4PVH-mediated satiety response. 
Given their minimal overlap in the PVH, the functional redundancy of the IRS4PVH 
and NOS1PVH neuronal populations in energy expenditure and feeding control is 
intriguing. A recent report suggests that nonoverlapping MC4RPVH and PDYNPVH neuron 
populations function together to coordinate a full PVH satiety response.23 The 
contribution of other non-MC4R PVH neurons in energy expenditure control is less 
clear. Here, we demonstrate that despite neuronal silencing of IRS4PVH neurons, which 
includes half of the MC4RPVH population, the satiety response to the melanocortin 
agonist MT-II remains intact. Thus, the anorectic response to melanocortin agonist is 
not dependent on IRS4PVH neurons, even though they compromise ~50% of the 
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MC4RPVH population. Although most IRS4PVH neurons do not express Pdyn, 
chemogenetic activation of IRS4PVH will activate a subset of PDYNPVH neurons. Whether 
this subset is responsible for the feeding effects seen following IRS4PVH activation 
remains to be determined. IRS4 and TRH overlap significantly in the PVH. However, 
feeding suppression following IRS4PVH activation is unlikely mediated by TRHPVH 
neurons since activation of this population has been shown to promote feeding by 
targeting orexigenic AgRP neurons in the ARC.24 Future studies will be needed to 
determine whether the IRS4/TRHPVH subset modulates energy expenditure through 
direct effects on autonomic output or alterations in the pituitary-thyroid axis. In addition, 
whether distinct PVH populations control feeding and energy expenditure via disparate 
projection sites (e.g. PBN vs. NTS vs. spinal cord) requires additional investigation. 
The PVH is a hypothalamic relay station for energy balance control. It receives 
dense innervation from sites critical for feeding and energy expenditure regulation, 
integrates this incoming energy balance information and then transmits an output signal 
to hindbrain sites to achieve appropriate physiologic and behavioral responses.19,25-27 
Whether PVH inputs can be mapped on to distinct PVH outputs (either anatomical or 
physiological) is not known. Here, we used monosynaptic rabies tracing to identify the 
possibility of unique afferent inputs to NTS-projecting versus PBN-projecting IRS4PVH 
neurons. We demonstrate that NTS-projecting IRS4PVH neurons receive dense 
innervation from the ARC, confirming this approach in a historically defined circuit. 
Additionally, PBN-projecting IRS4PVH neurons receive innervation from the VMH. Given 
the role for direct PVH connections to the PBN in mediating MC4R-induced satiety, it is 
possible that the VMH-IRS4PVH-PBN circuit is relevant in feeding control, though future 
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studies will be necessary to test the function of this circuit and better characterize its 
genetic signature.11 It is of interest that a few LHA neurons appear to be upstream of 
both PBN and NTS-projecting IRS4PVH neurons. Given the role for the LHA in controlling 
both energy expenditure and feeding behavior, this raises the possibility that the PVH 
input neurons originating in the LHA might be coordinating distinct energy balance 
parameters via divergent IRS4PVH circuits.28-30 
PVH neurons are predominantly glutamatergic and highly interconnected through 
PVH interneurons that may coordinate neural activity between PVH subsets.31-33 Our 
modified rabies tracing findings suggest that projection-defined IRS4PVH neurons are 
likely innervated by other local PVH populations based on the dense expression of 
rabies virus throughout the PVH (Figure 2.6 E–G). Since some PVH populations 
suppress feeding without affecting energy expenditure (i.e. MC4RPVH), whereas others 
increase energy expenditure absent of feeding regulation (i.e. OXTPVH), it seems likely 
that separate circuitries exist to coordinate these nodes. By extension, this suggests 
that some PVH populations (such as OXTPVH) are differentially connected and/or 
insulated from other PVH circuits in terms of feeding regulation. One potential model for 
PVH action could include a final common output from the PVH that is responsible for 
coordinating feeding regulation. In such a scenario, NOS1PVH and/or IRS4PVH neurons 
might lie upstream of or parallel to MC4RPVH neurons and coordinate feeding 
suppression via projections to the PBN. Certainly, connections between separate PVH 
populations are well documented.34-36 Moreover, the dense PVH interconnectivity 
highlighted by projection-specific monosynaptic retrograde tracing suggests the 
possibility that anatomically and functionally separable IRS4PVH neuronal circuits can be 
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coordinately regulated in order to promote an orchestrated physiologic output through 
simultaneous transmission to multiple brain sites. 
Taken together, our results clearly demonstrate that IRS4PVH neurons are a 
genetically defined PVH population capable of controlling feeding behavior and overall 
energy balance, presumably through projections to hindbrain and spinal cord regions. 
Moreover, tetanus toxin sensitive vesicle fusion in IRS4PVH cells is essential in 
preventing hyperphagia and obesity. Furthermore, our studies support the concept of a 
complex, intra-PVH network that regulates hindbrain structures previously shown to 
control energy balance parameters. While the significance of this local communication 
between PVH subpopulations in the control of distinct aspects of energy balance 
remains to be elucidated, further characterization of the composition and connectivity of 
individual PVH populations is necessary to fully understand the control of feeding and 
energy expenditure by an essential hypothalamic output center. 
 
Materials and Methods: 
Experimental animals 
IRS4-ires-Cre (IRS4-iCre) mice were generated using methods previously described.37 
Briefly, genomic DNA including the 3’ UTR of the murine Irs4 gene was PCR amplified 
from R1 ES cells and cloned into a plasmid for insertion of an Frt-flanked neomycin 
selection cassette followed by an internal ribosomal entry sequence fused to a Cre 
recombinase transgene (iCre) between the STOP codon and the polyadenylation site. 
Constructs were linearized and electroporated into R1 ES cells by the University of 
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Michigan Transgenic Animal Model Core. Correctly targeted ES cells were identified by 
quantitative real-time PCR and Southern blots and then injected into C57Bl/6J 
blastocysts to generate chimeric animals. Chimeras were then bred to C57Bl/6J 
females to confirm germline transmission and generate the IRS4-neo-iCre mice. To 
remove the Frt-flanked neo cassette, IRS4-neo-iCre mice were then bred to Flp deleter 
mice (Jax 012930). 
Adult male mice (8–16 weeks old) were used for all studies. Irs4 is located on the X-
chromosome which confounds experiments using IRS4-iCre in females given the 
random lyonization of the X chromosome. All animals were bred and housed within our 
colony according to guidelines approved by the University of Michigan Committee on 
the Care and Use of Animals. Unless otherwise noted, mice were provided ad libitum 
access to food and water. All mice were acclimatized to intraperitoneal (i.p.) injections 
three days prior to any experimental i.p. injection. 
 
Generation of modified rabies virus 
Replication deficient modified rabies virus containing fluorescent reporters in place of 
the B19 glycoprotein (EnvA-ΔG-mCherry and EnvA-ΔG-GFP) were generated in the 








Stereotaxic injections were performed in IRS4-iCre and non-transgenic (WT) mice as 
previously described.10 Briefly, mice were placed in a digital stereotaxic frame (Model 
1900, Kopf Instruments) under isofluorane and provided with pre-surgical analgesia. 
Viral injections were performed using a pressurized picospritzer system coupled to a 
pulled glass micropipette (coordinates from bregma: PVH: A/P = −0.500, 
M/L = +/− 0.220, D/V = −4.800). For tract tracing experiments, 50 nl of the adenoviral 
synatophysin-mCherry terminal tracer (Ad-iN/syn-mCherry38) was unilaterally injected in 
IRS4-iCre mice. For functional analysis of IRS4PVH neurons, bilateral PVH injections of 
AAV-Flex-hM3Dq-mCherry (AAV-Flex-hM3Dq, purchased from UNC Vector Core), 
AAV-Flex-TetTox (purchased from the Stanford Viral Vector core) or control injections of 
AAV-Flex-GFP were performed in IRS4-iCre or WT mice (50 nl/side). For analysis of 
monosynaptic upstream inputs to IRS4PVH neurons, IRS4-iCre mice were unilaterally 
injected with AAV-Flex-TVA-B19G in the PVH and allowed to recover for at least 21 
days to ensure adequate helper virus expression throughout both cell bodies and 
terminals.39 Mice then underwent a second surgery with dual stereotaxic injections into 
ipsilateral PVH projection targets with rabies-GFP in the PBN (A/P = −4.770, 
M/L = +/− 1.35, D/V = −2.8) and rabies-mCherry injected into the NTS. NTS injections 
were performed as previously described, whereby the fourth ventricle was identified and 
used as a geographic landmark to determine the site of injection.10 A glass micropipette 
was lowered into the site (D/V: −0.550) and ~25 nl of virus was injected. Mice injected 
with the Ad-iN/syn-mCherry tracer were individually housed for five days following 
injection to allow for viral transduction and protein transport before perfusion, whereas 
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mice injected with modified rabies virus were perfused seven days following rabies virus 
injections. Mice injected with AAV-Flex-hM3Dq were allowed to recover for fourteen 
days following surgery before further experiments were performed. 
 
Effect of PVHIRS4 neuronal activation on feeding and energy expenditure 
Following recovery, IRS4-iCre + AAV-Flex-hM3Dq mice underwent feeding and energy 
expenditure assays as previously described.10 Briefly, to measure changes in energy 
expenditure, IRS4-iCre + AAV-Flex-hM3Dq mice were acclimatized for two consecutive 
days to the Comprehensive Laboratory Monitoring System (CLAMS, Columbus 
Instruments) in the University of Michigan’s Small Animal Phenotyping Core to obtain 
multi-parameter analysis including open circuit calorimetry and activity via optical beam 
breaks. Following acclimatization, food was removed from metabolic cages during the 
light cycle on experimental days beginning two hours prior to experiments. Mice 
received an i.p. injection of vehicle (10% β-cyclodextrin, Sigma) and CLAMS 
measurements were analyzed for the following four hours. Mice remained in the 
chambers with food access at the onset of the dark cycle and the experiment repeated 
at the same time the following day instead with i.p. injection of CNO (0.3 mg/kg in 10% 
B-cyclodextrin). While measurements were performed throughout the duration of the 
experiment, data shown are averaged over the 4 hours following injection of vehicle or 
CNO. Resting energy expenditure data shown was determined by analyzing data 
oxygen consumption values at data points in which activity levels were approximately 
matched during the four hours before and after CNO administration. In experiments 
aimed to identify feeding changes induced by IRS4PVH neuronal activation, mice were 
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fasted during the day and received an i.p. injection of vehicle at the onset of the dark 
cycle with the presentation of food. Food intake was measured at two and four hours 
after injection and the experiment repeated the following day upon injection of CNO at 
the onset of the dark cycle. In a separate cohort of mice, the effects of CNO were tested 
on wildtype mice injected with AAV-Flex-hM3Dq and compared to IRS4-iCre mice 
injected with AAV-Flex-hM3Dq. In these experiments, CNO or vehicle (0.9% sodium 
chloride) injections were counterbalanced and performed 4 days apart. 
 
Longitudinal bodyweight, food intake, and calorimetry measurements 
Mice injected with AAV-Flex-TetTox or control viruses were allowed to recover for 7 
days before weekly body weight and food intake measurements began. Energy 
expenditure was determined using the Comprehensive Laboratory Monitoring System 
(CLAMS, Columbus Instruments) in the University of Michigan’s Small Animal 
Phenotyping Core to obtain multi-parameter analysis including open circuit calorimetry 
and activity via optical beam breaks between 11–24 days post-injection. Mice were 
allowed to acclimatize to the chambers for two days, followed by VO2 and locomotor 
activity data collection for three consecutive days. Analysis of CLAMS data was 
averaged across all three days of recording. Body composition analysis (Minispec LF90 
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MT-II-induced feeding suppression 
Five weeks following viral injection, IRS4-iCre mice injected with AAV-Flex-TetTox and 
appropriate controls were fasted during the light cycle (10:00–18:00). At the onset of the 
dark cycle, mice received an i.p. injection of 0.9% sodium chloride (APP 
Pharmaceuticals, 63323-186-10) or melanotan-II (MT-II, 150 ug/mouse, Bachem) and 
ad libitum access to food. Food intake was measured two and four hours post injection. 
The following week, injections were counter balanced and corresponding food intake 
measured. 
 
Perfusion and Immunohistochemistry (IHC) 
At the end of all experiments, mice were perfused to verify viral injection sites. Briefly, 
mice were deeply anesthetized with an overdose of pentobarbital (150 mg/kg, IP) and 
transcardially perfused with sterile PBS followed by 10% neutral buffered formalin or 4% 
paraformaldehyde (for perfusions with spinal cord removal. Brains and spinal cords 
(syn-mCherry injections only) were removed, post-fixed, and dehydrated in 30% 
sucrose before sectioning into 30 μm slices on a freezing microtome (Leica). Coronal 
brain sections were collected in four representative sections whereas longitudinal 
thoracic spinal cord sections were collected in three representative sections and stored 
at −20 °C. For 2A peptide and cFos immunohistochemistry (IHC), free floating brain and 
spinal cord sections were pretreated with 30% H2O2 to remove endogenous peroxidase 
activity and then blocked with normal goat or donkey serum and incubated in primary 
antibody overnight (rabbit anti-2A 1:1,000, Millipore ABE457; rabbit anti-cFos). 
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Detection of primary antibody was performed by avidin-biotin/diaminobenzidine (DAB) 
method (Biotin-SP-conjugated Donkey Anti-Rabbit, Jackson Immunoresearch, 1:200; 
ABC kit, Vector Labs; DAB reagents, Sigma). mCherry and choline acetyltransferase 
(ChAT) were detected using with primary antibodies for dsRed (rabbit 1:1000, Clontech, 
632496) or TdTomato (rat, 1:1000, Kerafast 16D7) and ChAT (spinal cords only; goat, 
1:500, Millipore AB144P) respectively followed by secondary immunofluorescence 
detection with donkey anti-rabbit-Alexa 568 or donkey anti-goat-Alexa 488 (1:200, 
Invitrogen). For PVH colocalization, rabies experiments, cFos (non-DAB method) and 
TetTox-GFP expression, IHC immunostaining was performed using primary antibodies 
for cFos (rabbit, 1:1000, Cell Signaling 9F6), GFP (rabbit 1:20,000, Invitrogen A6455), 
nNos1 (sheep 1:1500, (24), kindly provided by Dr. Vincent Prevot), neurophysin (goat, 
1:1000, Santa Cruz Biotechnology, sc-7810) and copeptin (goat 1:1000, Santa Cruz 
Biotechnology, sc-7812). For all AAV-TetTox and AAV-hM3Dq injections, bilateral or 
unilateral PVH hit sites were verified and misses eliminated from data analysis, with 
viral injections that modestly leaked into the peri-PVH included in the PVH groups. Viral 
leak into any other area outside of this region were excluded. Imaging was performed 
using an Olympus BX-53 upright microscope with G6000 camera. 
 
In situ hybridization 
Mice were deeply anesthetized with an overdose of inhaled isofluorane and brains 
removed and flash frozen in 2-methylbutane. Brains were sectioned into 16 μm sections 
onto glass slides using a cryostat (Leica CM 1950) and stored at −80 °C. The probes 
were purchased from Advanced Cell Diagnostics, and the assays were performed 
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according to the manufacturer’s protocol. The sections were fixed in cold 10% formalin 
for 1 hour, followed by dehydration in 50% and 75% ethanol for 5 minutes each, and 
100% ethanol twice. Sections were dried at 40 °C for 30 minutes. For fluorescent 
staining, sections were pretreated in protease IV for 30 minutes, washed in PBS twice, 
and then incubated with the desired probes for 2 hours and then washed twice in 1x 
wash buffer (ACD, 310091) for 2 minutes each. Amplification and detection steps were 
performed using the RNAscope® Fluorescent Multiplex Reagent Kit (320850). Sections 
were incubated with Amp1 for 30 min, Amp2 for 15 min, Amp3 for 30 min, and Amp 4 Alt 
C for 15 min. There were 2 washes between each amplification, and all amplifications 
were performed at 40 °C in the EZ Hybridization oven. To demonstrate overlapping 
expression of IRS4 and Cre mRNA, IRS4 and Cre probes were used. To quantify 
overlapping expression of IRS4 and CRH, PDYN and TRH, fluorescent probes were 
used. For the tissues exposed to the IRS4, CRH, PDYN, TRH and Cre probes, the 
slides were stained with DAPI for 30 seconds before coverslipping using Prolong Gold 
antifade reagent (Invitrogen). To investigate MC4R and IRS4 expression in the PVH, 
chromogen staining was conducted using the RNAscope® 2.5 HD Duplex Reagent Kit 
(ACD 320701). The sections were treated with H2O2 for 10 min and then incubated with 
the protease K IV for 30 min. After hybridization with probes against MC4R and IRS4 
mRNA, the sections were washed 2 times, followed with amplification from Amp1 to 
Amp6 with 2 washes in between. To detect the red signal component, Red-B was 
diluted 1:60 in component Red-A and incubated on the tissue for 10 minutes at room 
temperature. Slides were then rinsed two times in wash buffer to stop the chromogen 
reaction. Amplification continued with Amp7 through Amp10, followed by detection of 
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the green signal, which was achieved by diluting component Green-B 1:50 in 
component Green-A and incubating for 10 minutes at room temperature. 
Counterstaining was performed by immersing the slides in 50% hematoxylin for 
30 seconds. The slides were then dried and mounted in VectaMount mounting medium 
(Vector Laboratories, INC). Imaging for fluorescent staining was performed using an 
Olympus BX-53 microscope with a G6000 camera. Imaging for the chromogen staining 
used an Olympus BX-51 microscope with a DP80 camera (Olympus). For the purposes 
of quantification, images from the coronal sections were processed uniformly using 
Photoshop (Adobe) to remove background and to mark cells that expressed a given 
probe. Cells (indicated by DAPI/hematoxylin stain) determined to be positive for each 
probe were quantified using ImageJ and summed for each mouse, with the percentages 
of overlapping expression averaged between the mice. 
 
Statistical analysis 
Paired t-tests, one-way ANOVAs followed by Tukey post-hoc tests (if applicable), two-
way ANOVAs followed by Sidak’s multiple comparisons (if applicable), or mixed model 
analyses were calculated using GraphPad Prism 8 as appropriate. Significance was 
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Figure 2.1: Irs4 expression defines a PVH subpopulation. In situ hybridization was 
performed on coronal slices from adult IRS4-iCre mice (A) for Irs4 (red) and Cre 
    
83 
 
(green), showing substantial overlap between Cre and Irs4 mRNA in the PVH (B). To 
identify overlap between IRS4PVH neurons and other PVH populations, mice were 
stereotaxically injected in the PVH with a Cre-dependent GFP reporter virus (AAV-Flex-
GFP, C) to visualize Cre-expressing neurons in the adult mouse. Immunohistochemistry 
(IHC) in the PVH demonstrates limited co-localization between GFP-labeled IRS4PVH 
neurons (green) and OXT (D), NOS1 (E), or AVP (F) neurons in the PVH. Dashed 
















Figure 2.2: Overlap of IRS4 with CRH, pDYN, and TRH in the PVH. Fluorescent in 
situ hybridization images demonstrate Irs4 expression (red) overlaid with Crh (AC, 
green), Pdyn (D-E, green), or Trh (G-I, green) and DAPI throughout. Co-expression of 
Irs4 (purple) with Crh (A-C, right), Pdyn (D-F, right), or Trh (G-I, right), whereas the 
mean percentage of cells expressing Crh, Pdyn, or Trh that were Irs4+ are represented 
in green (n=3). Dashed boxes represent insets that were digitally enlarged in bottom left 
of images. White arrowheads point to colocalized cells within insets. Scale bars 
represent 100 µm. 
 
 




Figure 2.3: Acute activation of IRS4PVH neurons decreases feeding and increases 
energy expenditure. IHC for mCherry identifies AAV-hM3Dq expression in IRS4PVH 
neurons throughout the PVH (A,B: yellow dotted line). (C) Two-hour food intake at the 
onset of dark following activation of IRS4PVH neurons with an i.p. injection of CNO 
(0.3 mg/kg) in comparison to vehicle. Activation of IRS4PVH neurons increases total 
oxygen consumption (D,E), energy expenditure (G), and activity (H) over a four-hour 
time period in the absence of food, whereas respiratory exchange ratio (RER) is not 
significantly different (F). (I–K) IRS4PVH neuronal activation increases activity-
independent changes in oxygen consumption (I,J), measured at time points four hours 
before (−CNO) or after (+CNO) activation when activity levels were relatively matched 
(K). Average values ± SEM are shown, significance was determined using a paired-t-
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test in comparison to vehicle values. **p < 0.01, ***p < 0.001; feeding n = 9, CLAMS 
n = 7; AH = anterior hypothalamus, SCN = suprachiasmatic nucleus, 















Figure 2.4: Activation of IRS4PVH neurons requires hM3Dq expression and CNO 
administration. Quantification of unilateral FOS induction demonstrates increased FOS 
in CNO-injected IRS4-iCre mice with Flex-hM3Dq expression compared to those 
injected with vehicle (p=0.006), whereas WT controls had no significant change in 
nuclear FOS with CNO administration. (A). Differences in four-hour (B) feeding is not 
observed between WT mice injected with vehicle or CNO at the onset of the dark cycle 
(p=0.2255, t=1.522), whereas a trend exists for decreased food intake in IRS4-iCre 
mice with Flex-hM3Dq expression in the PVH (p=0.1066, t=2.813). Average values ± 
SEM are shown for food intake values, average values ± SD are shown for FOS 
quantification. Significance was determined using a paired-t-test in comparison to 
vehicle values for food intake (WT n=4, IRS4-iCre n=3), and a one-way ANOVA 
followed by Tukey’s post-hoc for FOS quantification (n=2/group). 
 
 




Figure 2.5: IRS4PVH neurons project to hindbrain and spinal cord regions. (A) A 
Cre-dependent synaptophysin-mCherry adenovirus (syn-mCherry) was unilaterally 
injected in the PVH area of IRS4-iCre mice to trace synaptic terminals throughout the 
brain. (B,C) Syn-mCherry positive terminals are observed in hindbrain regions including 
the medial and lateral parabrachial nucleus (mPBN, lPBN, respectively, (B), as well as 
the dorsal motor nucleus of the vagus (DMV) and nucleus of the solitary tract (NTS, C). 
(D) IRS4PVH neurons also project to the median eminence (ME). (E) Syn-mCherry (red) 
identifies synaptic terminals in the intermediolateral column of the spinal cord (IML) in 
close proximity to neurons expressing choline acetyltransferase (ChAT, green). scp = 
superior cerebellar peduncle, 4 V = fourth ventricle, 3 V = third ventricle, AP = area 
postrema. 




Figure 2.6: Identification of monosynaptic inputs to NTS-projecting or PBN-
projecting IRS4PVH neurons using modified rabies virus. A Cre-dependent helper 
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virus construct (AAV-Flex-TVA-B19G) is used to insert rabies B19 glycoprotein (B19G) 
and the TVA receptor in IRS4PVH cell bodies and terminals. Modified rabies virus 
expresses a fluorescent tag (mCherry, B; GFP, C) instead of B19G. After initial infection 
with helper virus, rabies-mCherry is injected at one projection site (NTS), whereas 
rabies-GFP is injected at another (PBN) in the same mouse (D). IHC for mCherry and 
GFP identify largely non-overlapping NTS-projecting and PBN-projecting IRS4PVH 
neurons, respectively (E–G). Sites upstream of both NTS and PBN-projecting IRS4PVH 
neurons include the lateral hypothalamic area (LHA, H), supraoptic nucleus (SON, K), 
amygdala (K), bed nucleus of the stria terminalis (BNST, L), and the preoptic area 
(POA, L). The ventromedial hypothalamus (VMH) is upstream of PBN-projecting 
IRS4PVH neurons (HII, green), whereas both the arcuate nucleus (ARC, HII, red) and 
PBN (I, red) are upstream of IRS4PVH neurons projecting to the NTS. Glial damage 
represents injection site in the PBN (I, green) and NTS (J, red). 3 V = third ventricle, 
oc = optic chiasm, MeA = medial amygdala, BMA = basomedial amygdala, vBNST = 
ventral BNST, vlPOA = ventral lateral POA, MPOA = medial POA, MnPO = median 
preoptic nucleus, aca = anterior part of anterior commissure, DMH = dorsomedial 








Figure 2.7: Monosynaptic rabies virus tracing is Cre-dependent, dependent on 
helper virus expression, and capable of dual rabies infection. IHC in the PVH of 
Sim1-Cre +AAV-Flex-TVA-B19G mice validates a “miss” since 2A staining (reflective of 
AAV-Flex-TVA-B19G expression) is not detected (A). Still, NTS-directed rabies-
mCherry injection in the same mouse displays limited mCherry expression in the PVH, 
therefore confirming the requirement of AAV-Flex-TVA-B19G expression for modified 
rabies virus expression (AI). B) 2A expression in wildtype mice injected with AAV-Flex-
TVA-B19G demonstrates that Cre recombinase is required for helper virus expression. 
C) Injection of both rabies-mCherry and rabies-GFP in the same PBN projection target 
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in Sim1-Cre +AAV-FlexTVA B19G mice illustrates that both rabies viruses can be 
expressed in PBN-projecting PVH neurons (D). Sites upstream including the bed 
nucleus of the stria terminalis (BNST, E), preoptic area (POA), arcuate nucleus (ARC, 
F) and VMH (F) show limited co-labeling. G) Gliosis in the PBN due to rabies-
mCherry/rabies-GFP injection demonstrates that both rabiesGFP and rabies mCherry 
were mixed and injected at the same site. Dashed boxes indicate regions that are 
digitally enlarged and shown as insets. White arrowheads indicate colocalization in 
neurons with both rabies-GFP and rabies-mCherry. 3V=third ventricle, aca= anterior 
part of anterior commissure, DMH=dorsomedial hypothalamus, oc=optic chiasm, 








Figure 2.8: IRS4PVH neurons are necessary for normal feeding and bodyweight. A 
Cre-dependent adeno-associated virus expresses tetanus toxin A and GFP exclusively 
in Cre-expressing neurons to inhibit synaptic vesicle exocytosis and GFP visualization 
of the transduced cells (A). (B) Example hit site of IRS4-iCre mice injected with AAV-
Flex-TetTox (PVHTetTox). Bilateral IRS4PVH neuronal silencing in IRS4-iCre mice 
(PVHTetTox) results in both increased bodyweight (C) and increased bodyweight gain (D) 
in comparison to IRS4-iCre mice injected with a control AAV (PVHFlex) or wildtype mice 
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injected with AAV-Flex-TetTox (WTTetTox, mixed-model analysis followed by Tukey’s 
post-hoc). (E) PVHTetTox mice (blue) show increased 7-day food intake at early stages of 
the study (left) in comparison to WTTetTox mice (orange; one-way ANOVA followed by 
Tukey’s post-hoc) whereas later stage food intake shows a trend towards increased 
feeding (dark blue, one-way ANOVA). (F) PVHTetTox mice show have increased fat mass 
percentages (F) at early and late stages of obesity development (one-way ANOVA 
followed by Tukey’s post-hoc). (G–J) 3-day averages of CLAMS measurements were 
measured during weeks 2–4 of experiments and compared across groups. While 
PVHTetTox mice show a trend towards decreased energy expenditure (I), none of these 
groups are significantly different from one another (one-way ANOVA. Average values ± 
SEM are shown, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 compared to WTTetTox; 
Ƹp < 0.05, Ƹ Ƹp < 0.01, Ƹ Ƹ Ƹp < 0.001 compared to PVHFlex; BW/feeding: PVHTetTox 
n = 6, PVHFlex n = 17, WTTetTox n = 13; body composition: PVHTetTox early n = 6, PVHTetTox 
late n = 5, PVHFlex early n = 10, PVHFlex late n = 17, WTTetTox n = 11; CLAMS: PVHTetTox 









Figure 2.9: IRS4PVH neuron activity is dispensable for melanocortin agonist-
mediated satiety. In situ hybridization for Irs4 (A, blue) and Mc4r (A, red) mRNA in the 
PVH of adult wildtype mice. Melanocortin agonist-induced satiety was tested in mice 
with IRS4PVH neuronal silencing (B,C). Two-hour (B) and four-hour (C) feeding was 
significantly decreased following i.p. injection of the MC4R agonist MT-II (150 
ug/mouse) in all cohorts of mice, despite the silencing of IRS4PVH neurons in the 
PVHTetTox group. Average values ± SEM are shown, **p < 0.01, ***p < 0.001, 
****p < 0.0001; PVHTetTox n = 6, PVHFlex n = 17, WTTetTox n = 13. Significance was 
determined using a paired t-test between vehicle and MTII injected mice within the 
same cohort. Dashed boxes (AI, AII) indicate regions cropped and digitally enlarged. 
 
 




Table 2.1: Unilateral IRS4PVH silencing alters bodyweight physiology. Comparison 
of bodyweight and CLAMS results from IRS4PVH TetTox cohorts with viral injections that 
only targeted one side of the PVH (Unil. PVHTetTox) still demonstrate trends toward 
changes in physiology. Data represented includes results illustrated in Fig. 5. Data was 
analyzed using a one-way ANOVA followed by Tukey’s multiple comparisons if 
appropriate, or an unpaired t-test (number of cells infected with AAV-Flex-TetTox 
between PVHTetTox and Unil. PVHTetTox cohorts). Average values ± SEM are shown. 
*p<0.05, ***p<0.001 for PVHTetTox compared to WTTetTox; † p<0.05 for PVHTetTox 
compared to PVHFlex; § p<0.05 for PVHTetTox compared to Unil. PVHTetTox; &p<0.05 for 
PVHFlex compared to WTTetTox; $ p<0.05 for Unil. PVHTetTox compared to WTTetTox. 
PVHTetTox n=6 (BW, t=0; early food intake, CLAMS, early body composition), n=5 (BW, 
t=8wk, change in BW, late body composition), n=4 (late food intake); Unil. PVHTetTox n=6 
(BW t=0wk, early food intake), n=5 (BW t=8wk, change in BW, late food intake), n=4 
(CLAMS, body composition); WTTetTox n=13 (BW t=0wk, early food intake, CLAMS), 
n=11 (BW t=8wk, change in BW, body composition), n=9 (late food intake); PVHFlex 
n=17 (BW t=0, early food intake, late body composition), n=16 (BW t=8wk, change in 
BW), n=8 (late food intake, CLAMS), n=10 (early body composition). 




CalcR-Expressing Neurons of the PVH Modulate Energy Balance 
The following chapter discusses two related but separate projects concerning the 
calcitonin receptor (CalcR) expressing neurons in the PVH and is subdivided into two 
sections. The first section investigates the necessity of CalcR expression in the PVH in 
the anorectic response to a CalcR agonist and the impact on energy balance following 
deletion of CalcR from Sim1 neurons. The second section focuses on the physiologic 
function of CalcRPVH neurons by manipulating the neural activity of this PVH neuronal 
population. For this project, we used viral techniques to acutely active and chronically 
silence these neurons, as well as characterize them through their downstream 
projection targets and through their overlap with other known subpopulations of the PVH 
that are responsible for energy homeostasis. It is important to state that this second 
approach varies from the first in that it studies CalcRPVH neurons as a whole rather than 
through the expression and signaling activity of CalcR. This is a critical distinction, as 
manipulating CalcRPVH neurons activity will alter other yet unidentified mechanisms of 
this neuronal population aside from those mediated by CalcR. It is for this reason that 
identifying the overlap of CalcRPVH neurons with other studied neuronal populations of 
the PVH is crucial to understanding how CalcRPVH neurons may operate. 
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Investigating energy homeostatic role of CalcRPVH neurons through CalcR 
deletion from Sim1 neurons2 
Introduction: 
Calcitonin (CT) and amylin are peptides that are functionally and structurally 
related.1 In addition to reducing blood calcium levels and reducing glucose incorporation 
into the glycogen of soleus muscle, these peptides also play a role in regulating food 
intake.1-6 CT is a 32-amino acid peptide that is a product of CALC gene that is 
generated in and secreted from parafollicular cells of the thyroid gland in humans and 
mice.6 It was first associated with satiety when it was observed that following a meal, 
plasma CT concentrations increased.7,8 It was later found that the subcutaneous 
application of CT in mice, rats, monkeys and humans resulted in a reduction in feeding 
behavior.9 More so, intracerebroventricular (ICV) application of salmon calcitonin (sCT) 
(which has a higher potency than mammalian CT) as well as amylin was found to be 
more potent in reducing feeding than when applied peripherally, suggesting these 
peptides exert their anorectic activities through a centrally expressed receptor.10,11 The 
area postrema (AP) and solitary nucleus (NTS) are considered to be the most likely site 
through which peripherally applied sCT and amylin exert their anorectic effects.12,13 
Hypothalamic regions are also thought to be important for mediating the anorectic 
effects of centrally applied sCT and amylin. This was supported by the finding that sCT 
delivered via cannula to various regions of the hypothalamus, such as the 
 
2 This section contains material previously published in Cell Metabolism: Cheng W, 
Gonzalez I, Pan W, et al. Calcitonin Receptor Neurons in the Mouse Nucleus Tractus 
Solitarius Control Energy Balance via the Non-aversive Suppression of Feeding. Cell 
Metab. 2020;31(2):301-312 e305. 
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paraventricular nucleus of the hypothalamus (PVH), the suprachiasmatic part of the 
preoptic area (POA) and the perifornical area resulted in a significant decrease in food 
intake.14 It should be noted that aminoprocalcitonin (N-PCT), which is derived from 
procalcitonin, is expressed in brain regions of rats known to influence energy balance 
including the PVH. Intracerebroventricular application of N-PCT suppresses food intake 
behavior and weight gain in rats and induces CRH expression and production in the 
hypothalamus.15 
Amylin is a 37-residue peptide hormone that is co-released with insulin from the 
B-cells of the pancreas in response to feeding behavior.16-19 Amylin serves to promote 
gastric acid secretion, limit gastric emptying and reduces glucagon secretion from the 
pancreas.20 Further, amylin reduces feeding behavior through regulating meal size in a 
non-aversive manner.21,22 Due to its release from peripheral systems and through 
lesioning studies, it is supported that amylin interacts with the AP of the hindbrain and 
by extension the NTS due to lack of blood-brain barrier protection.12,22,23 Further, amylin 
maybe a necessary modulator of the anorectic action of Cholecystokinin (CCK).24,25 In 
obese humans, the application of the synthetic amylin analogue pramlintide inhibits 
feeding and reduces body weight.26-28 Leptin, which is a neurohormone secreted by 
adipocytes and act on the hypothalamus, is crucial for maintaining long-term energy 
homeostasis.29 Humans that are leptin-deficient experience hyperphagic obesity and 
treatment with metreleptin can reverse this obesity.30-32 In cases of obesity that is not 
due to leptin-deficiency, metreleptin alone is ineffective at producing weight loss.33 
Amylin is capable of restoring leptin sensitivity in obese patients and co-administration 
of amylin and leptin in rodents and pramlintide and metreleptin (recombinant methyl-
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human leptin) in humans synergistically generate reductions in food intake and weight 
loss as a treatment.34-38 This is not so in more extreme cases, as rats that have 
undergone extreme diet-induced obesity experience lesser effects from amylin/leptin 
treatment when compared to less obese rats.39 This is also found to be true in human 
patients, as pramlintide/metreleptin treatment was only notable effective in humans with 
a body mass index lower than 35 kg/m2.39  
 CT, sCT and amylin are ligands to the calcitonin receptor (CalcR), a G protein-
coupled receptor.40 It has been found to be expressed in many regions of the 
hypothalamus and hindbrain such as the PVH, arcuate nucleus (ARC), substantia nigra, 
bed nucleus of the stria terminalis, locus coeruleus and the NTS through in situ 
hybridization and immunohistochemistry.41,42 It heterodimerizes with receptor activity 
modifying proteins (RAMPs) which allows it have distinct binding efficiencies with 
different ligands.43,44 There are three flavors of RAMPs, which are RAMP1, RAMP2 and 
RAMP3.45 CalcR alone interacts with the CT peptide, while CalcR with RAMP1, RAMP2 
or RAMP 3 (termed AMY1, AMY2 and AMY3 respectively) interact with amylin as a 
ligand.46,47  
 As the direct application of sCT to the PVH suppresses feeding in rodents, we 
examined the role of calcitonin receptor (CalcR) expression in the PVH in food intake 
regulation.14 To investigate the role of PVH CalcR expression in feeding, we used 
Cre/Lox technology to delete CalcR expression from single-minded homolog 1 (Sim1) 
expressing neurons, which represent most if not all PVH neurons.48,49 Deletion of CalcR 
expression from Sim1 neurons does not perturb body weight, body composition or food 
intake. Further, deletion of CalcR from Sim1 neurons does not disrupt the anorexia or 
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weight loss induced by peripheral injection of sCT. Our study shows that CalcR 
expression in Sim1 neurons and thus the PVH is not essential to maintain energy 
homeostasis, nor is it necessary to produce the anorectic effects produced by sCT. 
Therefore, CalcR expression in another region of the brain must be necessary for sCT 
mediated anorexia.  
 
Materials and Methods: 
Animals 
Mice were bred in our colony at the University of Michigan Unit for Laboratory Animal 
Medicine. The University of Michigan Committee on the Use and Care of Animals have 
approved the procedures performed on these mice and our studies are in accordance 
with the Associate for the Assessment and Approval of Laboratory Animal Care and 
National Institutes of Health guidelines. Mice were provided with food and water ad 
libitum in rooms that were temperature controlled and maintained at 25oC with 12 hour 
light-dark cycles with daily health status checks. 
CalcRflox mice were crossed two times onto Sim1cre to produce Sim1cre/+;CalcRflox/flox 
mice, which were bred to CalcRflox/flox mice to produce Sim1cre/+;CalcRflox/flox 
(CalcrSim1KO) and CalcRflox/flox control mice.50,51 Sibling controls were used in these 
studies and all mouse models were on a C57BL/6 genetic background. Male and female 
mice were used in experiments that do not specify a single sex as used and no sex 
differences were detected in the observed phenotypes. 
 




From the time of weaning, CalcrSim1KO mice and their controls were singly housed and 
body weight and food intake was monitored weekly. For stimulation studies, these mice 
were at least two months old when treated with saline or sCT (4033011, Bachem) at the 
start of the dark cycle, with food intake monitored over the course of four hours. When 
measuring chronic feeding and changes in body weight, mice received saline injections 
for two days prior to injecting saline or sCT twice per day (5:30PM and 8:00 AM) for 3 
days, followed by saline injections for an additional two days to assess recovery from 
the treatment. 
 
Perfusion and Immunohistochemistry 
Mice (at least 8 weeks of age) were anesthetized using a lethal dose of pentobarbital 
and were transcardially perfused with phosphate-buffered saline (PBS) followed by 10% 
buffered formalin. Following removal, the brains were placed in 10% buffered formalin 
overnight and then dehydrated using 30% sucrose for 24 hours. A freezing microtome 
(Leica, Buffalo Grove, IL) was used to cut brains into 30um sections. For 
immunohistochemistry, brain sections were treated with 1% hydrogen peroxide/0.5% 
sodium hydroxide, 0.3% glycine, 0.03% sodium dodecyl sulfate, and blocking solution 
(PBS with 0.1% triton, 3% normal donkey serum). The sections were then incubated 
overnight in rabbit anti-FOS (Santa Cruz, sc-52; 1:1,000) and the following day were 
exposed to biotinylated secondary antibody (1:200 followed by avidinbiotin complex 
(ABC) amplification and 3,3-diaminobenzidine (DAB) reaction). Images were collected 
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using a BX-51 microscope with a DP80 camera (Olympus). Images were pseudocolored 
with Photoshop software (Adobe) and were quantified using ImageJ (NIH). 
 
RNA Extraction, Reverse Transcription and RT-qPCR 
At 8 weeks of age or older, CalcrSim1KO and control mice were euthanized using 
inhalation anesthetic isoflurane (McKesson, Piramal Critical Care #6679401725) in a 
drop jar. For RNA preparation, PVH tissue was microdissected and stored in a -80C 
freezer. An RNeasy Mini kit (QIAGEN) was used for RNA extraction and quantified 
using a NanoDrop 1000 (ThermoScientific). The RNA was treated with DNase (TURBO 
DNA-free Kit, ThermoFisher Scientific, Cat #AM1907) and was then quantified with a 
NanoDrop 1000. Approximately 500 ng of total RNA per sample was used for reverse 
transcription (iScript cDNA Synthesis Kit, Bio-Rad, Cat #1708891) with a thermocycler 
(Mastercycler pro S, Eppendorf). A StepOnePlus Real Time PCR System (Applied 
Biosystems) was used for quantitative PCR (qPCR) with SYBR Green PCR Master Mix 
(Applied Biosystems, Cat #4309155) and CalcR primers (Forward: 50 -
GCTGCTGGATGCTCAGTACA-30, Reverse: 50-AGTGTCGTCCCAGCACATC-30). As 
a reference gene, hypoxanthine guanine phosphoribosyl transferase (Hprt) gene was 
used (amplified using primers; Forward: 50-GATTAGCGATGATGAACCAGGTT-30, 
Reverse: 50-CCTCCCATCTCCTTCATGACA-30). cDNA was pooled from each sample 
and made into 5 serial dilutions to make a standard curve ladder which was used to 
determine the relative RNA concentration of each sample. The samples were run in 
duplicate and the values underwent a Grubbs’ test to discard outliers before running a 
statistical analysis.  





Mean ± standard error of the mean was used to report our data. Statistical analysis of 
the data was conducted using Prism software (version 7), as well as to ensure the data 
fit a normal distribution. Paired or unpaired t tests and two way ANOVA were used as 
described in the text and figure legends. P<0.05 indicates statistical significance.  
 
Results: 
CalcRflox mice were crossed with Sim1cre mice to produce CalcrSim1KO knockouts 
(Figure 3.1 A).50,51 We found that FOS signal in the PVH increased due to sCT 
stimulation in CalcRSim1KO mice despite the decreased expression of Calcr in the PVH 
of CalcRSim1KO mice (Figure 3.1 B-G). This indicates that activation of neurons in the 
PVH due to sCT stimulation is facilitated indirectly by other neurons expressing CalcR 
and that CalcR in the PVH may suppress sCT dependent activation of PVH neurons 
through a different population of neurons that express CalcR. We found that 
CalcrSim1KO mice did not have altered body weight, food intake or body composition 
(Figure 3.2 A-C). We can therefore conclude that CalcR expression in PVH neurons 
does not under normal conditions influence long-term energy balance. We studied food 
intake following sCT administration in CalcrSim1KO mice to determine the anorectic 
response of these animals to CalcR agonists. For overnight feeding studies, we found 
that administering sCT at the start of the dark cycle decreased feeding by over 40% 
after 4 hours following the injection (Figure 3.2 D). Further, 3 days of twice-daily 
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administration of sCT reduced food intake and decreased body weight in CalcrSim1KO 
mice and their controls (Figure 3. 2E-F). We have therefore determined that Calcr 
expression in Sim1PVH neurons are not needed for the anorectic effects of sCT.  
 
Discussion: 
Peripheral application of sCT and related peptides such as amylin have been 
found to suppress feeding behavior in rodents.11 More compelling was finding that direct 
injection of sCT to the PVH dramatically suppressed feeding behavior and therefore 
marked the PVH as a potential region in which CalcR expression was responsible for 
sCT induced anorexia.14 Our knockout studies, however, indicate that CalcR expression 
in the PVH is dispensable in the anorectic behavior induced by peripherally applied 
sCT. Further, CalcR expression in the PVH is not necessary to maintain energy 
balance. Because the PVH FOS responses to sCT in CalcrSim1KO mice were not 
reduced, this suggests that hypothalamic FOS induced by sCT could be facilitated 
indirectly through CalcR neurons that send projections to the hypothalamus, such as the 
CalcRNTS neurons. It is important to note, that Sim1 is not exclusively expressed in the 
PVH and that deletion of CalcR expression from Sim1 expressing neurons may delete 
CalcR from overlapping regions beyond the PVH, such as the amygdala.52 
While we have determined that CalcR expression in Sim1 neurons is not needed 
for sCT induced anorexia, CalcR expression in NTS neurons is necessary for this 
response and do so in a non-aversive manner.53 Further, activating CalcRNTS neurons 
through DREADDs technology suppresses food intake and body weight gain and does 
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so without promoting aversion much like the CCKNTS neurons that project to the PVH, 
which is in contrast to the CCKNTS neurons that project to the PBN, which have been 
found to be aversive when activated.54 These CalcRNTS neurons project to the PBN and 
activate non-calcitonin gene-related peptide cells in this region. Finally, silencing 
CalcRNTS neurons produces hyperphagic obesity and blunts the anorectic behavior 
produced by sCT. It has therefore been demonstrated that CalcR expression in the NTS 
is necessary for the regulation of energy balance, while this is not so in the PVH.53  
 Although we have determined that CalcR expression in the PVH is dispensable 
to the regulation of energy balance and the anorectic response to sCT, there is still 
value in investigating the CalcR expressing neurons of the PVH. Our in situ 
hybridization studies indicate that the PVH contains a large population of CalcRPVH 
neurons and could therefore potentially engage in aspects of energy balance associated 
with neurons of the PVH. Because of their abundance, CalcRPVH neurons may overlap 
with or could be distinct from other known populations of the PVH that have been 
identified to regulate energy homeostasis. In either case, through investigating the 
CalcRPVH neurons, we would further our goal to characterize the neurons of the PVH 
involved in energy balance circuitry. With this goal in mind, we generated a mouse line 
that allowed us to use viral tools to investigate these CalcRPVH neurons. 
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Paraventricular Calcitonin Receptor-Expressing Neurons Modulate Energy 
Homeostasis in Male Mice3 
Abstract 
The paraventricular nucleus of the hypothalamus (PVH) is a heterogeneous collection of 
neurons that play important roles in modulating feeding and energy expenditure. 
Abnormal development or ablation of the PVH results in hyperphagic obesity and 
defects in energy expenditure whereas selective activation of defined PVH neuronal 
populations can suppress feeding and may promote energy expenditure. Here, we 
characterize the contribution of calcitonin receptor-expressing PVH neurons (CalcRPVH) 
to energy balance control. We used Cre-dependent viral tools delivered stereotaxically 
to the PVH of CalcR2Acre mice to activate, silence and trace CalcRPVH neurons and 
determine their contribution to body weight regulation. Immunohistochemistry of 
fluorescently-labelled CalcRPVH neurons demonstrates that CalcRPVH neurons are 
largely distinct from several PVH neuronal populations involved in energy homeostasis; 
these neurons project to regions of the hindbrain that are implicated in energy balance 
control, including the nucleus of the solitary tract and the parabrachial nucleus. Acute 
activation of CalcRPVH neurons suppresses feeding without appreciably augmenting 
energy expenditure, whereas their silencing leads to obesity that may be due in part due 
to loss of PVH melanocortin-4 receptor (MC4R) signaling. These data show that 
CalcRPVH neurons are an essential component of energy balance neurocircuitry and 
 
3 This section was previously published in Endocrinology: Gonzalez IE, Ramirez-Matias 
J, Lu C, et al. Paraventricular Calcitonin Receptor-Expressing Neurons Modulate 
Energy Homeostasis in Male Mice. Endocrinology. 2021;162(6). 
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their function is important for body weight maintenance. A thorough understanding of 
the mechanisms by which CalcRPVH neurons modulate energy balance might identify 
novel therapeutic targets for the treatment and prevention of obesity. 
 
Introduction 
The paraventricular nucleus of the hypothalamus (PVH) is a brain region that is 
critical for normal feeding and energy expenditure. The PVH serves as a hypothalamic 
node that receives ascending neuronal and humoral energy balance inputs, integrates 
this information and then relays output signals to regions such as the hindbrain and 
spinal cord to drive physiologic responses to maintain energy homeostasis 55-57. The 
essential role of the PVH is revealed by mechanical lesions of this region that produce 
hyperphagic obesity and glucose dysregulation in both rodent models and humans 58,59. 
Whereas complete inactivation of SIM1, a transcription factor required for PVH 
development, is incompatible with life, Sim1 haploinsufficiency disrupts PVH formation 
and results in profound hyperphagic obesity 49,60-62. Post-natal ablation of SIM1-
expressing neurons leads to obesity with hyperphagia and a reduction in energy 
expenditure revealing a critical role for PVH cell function in the regulation of both 
feeding and energy expenditure 48. Indeed, chemogenetic activation of SIM1PVH neurons 
acutely suppresses feeding and increases oxygen consumption and locomotor activity 
63, while their inhibition leads to a robust increase in food intake 64. Given the 
importance of SIM1PVH neurons in energy balance and metabolic control, defining the 
energy balance contributions of subpopulations of SIM1PVH neurons may yield novel 
approaches to modulating discrete aspects of energy homeostasis. 
    
109 
 
The unique roles of several PVH neuronal subsets in energy balance have been 
identified using cell-specific manipulations with Cre-LoxP technology 63,65-67. We have 
shown that activation of PVH neurons expressing nitric oxide synthase-1 (NOS1PVH) 
suppresses feeding and increases oxygen consumption 63. Importantly, activation of 
oxytocin (OXT)-expressing PVH neurons, which are a subpopulation of the NOS1PVH 
neurons, has no effect on feeding but does promote energy expenditure albeit to a 
lesser degree than NOS1 neurons 63. In contrast to the NOS1PVH neurons, acute 
activation of melanocortin-4 receptor (MC4R)-expressing PVH neurons suppresses 
feeding but has no effect on energy expenditure 67. These experiments underscore the 
anatomical and functional differences between diverse PVH neuronal populations and 
suggest that the modulation of feeding and energy expenditure may be 
compartmentalized to subsets of PVH neurons. Therefore, manipulation of genetically-
defined PVH cells uncovers the physiological roles of these neuronal subpopulations 
and delineates the neural circuitries responsible for discrete aspects of energy balance 
control. 
Peripheral application of the polypeptide calcitonin suppresses feeding in several 
species 9,11,68,69. Calcitonin receptors (CalcR) are expressed in the PVH and direct 
application of salmon calcitonin (sCT) to the PVH dramatically suppresses feeding in 
rats suggesting that the activity of CalcRPVH neurons may contribute to energy balance 
control 14,42. To determine the role of CalcRs in PVH neurons in the anorectic actions of 
peripherally applied sCT, we deleted CalcRs selectively from the PVH using Cre-loxP 
technology.  We found that loss of CalcRs from the PVH did not alter energy balance at 
baseline or attenuate the anorectic response to peripherally applied sCT 53. Although 
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CalcR expression in the PVH is not necessary for the sCT-induced anorexia, the 
dramatic suppression of feeding following direct PVH application of calcitonin suggests 
that the PVH neurons that express CalcR likely play an important in energy 
homeostasis 14. To understand the contribution of CalcRPVH neurons to energy balance 
control, we used our CalcR2ACre transgenic mouse line and viral vectors to selectively 
target and manipulate CalcRPVH cells in male mice.  This approach uses CalcR 
expression as a means to genetically access CalcRPVH neurons and is not a surrogate 
for calcitonin signaling in the PVH.  Acute activation of CalcRPVH neurons suppresses 
feeding and promotes locomotor activity. To test the necessity of CalcRPVH neurons in 
the regulation of energy balance, we chronically silenced CalcRPVH neurons using Cre-
dependent expression of tetanus toxin. Silencing CalcRPVH neurons leads to obesity due 
to increased food intake and a possible alteration in energy expenditure. We find that 
CalcR and MC4R expression overlap in the PVH, suggesting that the obesity seen with 
CalcRPVH silencing may be in part due to loss of melanocortin action in the PVH. 
Overall, this study demonstrates that CalcRPVH neurons lie within energy balance 
neurocircuitry and their activity is important for body weight maintenance. Moreover, 
selectively modulating CalcRPVH neuronal activity may represent a potential novel 
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Material and Methods: 
Experimental Animals 
CalcR-2a-Cre (or CalcR2ACre) mice were previously generated and validated as 
described 70. Adult male CalcRcre2ACre mice (7-16 weeks old) were used for activation 
and silencing studies. Adult male mice (8-17 weeks old) expressing Cre recombinase in 
MC4R neurons (MC4RCre, JAX stock 030759; kindly provided by Dr. Brad Lowell) 71,72 
were used for the silencing studies.  As preliminary data revealed similar responses to 
CalcRPVH neuron manipulation in both sexes, we conducted our studies in male mice to 
avoid potential confounding issues of hormonal cyclicity and to align our approach with 
previously published data66. Immunohistochemical analysis of CalcRPVH neurons was 
performed using brains from CalcR2ACre mice crossed to a Cre-dependent GFP reporter 
(CalcR2ACre+GFP mice) 63,73 . In accordance with the Association for the Assessment and 
Approval of Laboratory Animal Care and National Institutes of Health guidelines, the 
procedures performed were approved by the University of Michigan Committee on the 
Care and Use of Animals. Animals were bred and housed within our colony, with ad 
libitum access to food and water provided (unless specified otherwise) in temperature-
controlled rooms that followed a 12-hour light/dark cycle. 
 
Stereotaxic injections 
Stereotaxic injections were conducted on CalcR2Acre, MC4RCre and non-transgenic 
wildtype (WT) mice as described previously 70,71 . Following induction of isoflurane 
anesthesia and application of pre-surgical analgesia (carprofen), mice were placed in a 
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digital stereotaxic frame (Model 1900, Kopf Instruments). A pressurized picospritzer was 
used to perform viral injections into the PVH (coordinates relative to bregma: A/P= -
.500, M/L= +/- .200, D/V= -4.77) through a pulled glass micropipette. For the 
anterograde tracing experiments, 50 nL of the adeno-associated virus with a Cre-
dependent synaptophysin-GFP (rAAV8-flex Syn-EGFP, titer: 5.69x1014 vg/mL, 
produced by the Viral Vector Core at the University of Michigan) terminal tracer was 
injected unilaterally into the PVH of CalcR2ACre mice. The synaptophysin-GFP 
anterograde tracer traffics preferentially to the synaptic terminals of the neurons which 
aids in the identification of downstream targets. To allow temporal and spatial control of 
CalcRPVH neural activity, we used Cre-dependent expression of the stimulatory Designer 
Receptors Exclusively Activated by Designer Drugs (DREADDs; hM3Dq). hM3Dq is a 
modified human muscarinic receptor coupled to the stimulatory Gq-protein which 
activates neurons upon binding the synthetic ligand clozapine N-oxide (CNO)74,75. Cre-
dependent AAV-Flex-hM3Dq-mCherry (AAV-Flex-hM3Dq, titer: 4x1012 virus 
molecules/mL, purchased from UNC Vector Core) was bilaterally injected (50 nL/side) 
into the PVH of CalcR2ACre mice to specifically manipulate these cells. Mice for the 
tracing and acute activation studies were given at least 21 days to recover and ensure 
sufficient viral expression in the cell bodies and their terminals. For CalcRPVH neuron 
silencing studies, Cre dependent tetanus toxin was used. Tetanus toxin cleaves 
synaptobrevin, a component of the SNARE core and prevents release of synaptic 
vesicles from targeted neurons 76,77. 50nL of AAV-Flex-TetTox (titer: 1.2x1012 virus 
molecules/mL, generated at the UNC vector viral core based on a plasmid kindly 
provided by Dr. Wei Xu, UTSW) or control viruses were injected bilaterally in CalcR2ACre 
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mice. For the MC4RPVH studies, MC4RCre and WT mice were bilaterally injected in the 
PVH with AAV-Flex-TetTox or a Cre-dependent GFP reporter virus (AAV-Flex-GFP). 
 
Effects of CalcRPVH neuronal activation on feeding behavior and energy expenditure 
Feeding and energy expenditure studies were performed at least 3 weeks after surgery 
to allow for surgical recovery and viral expression in CalcR2ACre and control mice 
(wildtype mice and CalcR2ACre mice injected with a control virus). For the acute feeding 
studies, mice received daily i.p. injections of vehicle 3 days prior to the experiment. On 
the day of the feeding studies, the mice were fasted from 10AM to 6PM and received 
i.p. injection of CNO or vehicle at the onset of the dark cycle with the presentation of 
food. Food intake was then measured one, two and four hours after the injection and 
the experiment was repeated at least 4 days later with the treatments switched 
(CalcR2ACre +AAV-Flex-hM3Dq mice N=12, Controls N=7). To measure energy 
expenditure, CalcR2ACre +AAV-Flex-hM3Dq mice were acclimated to daily saline 
injections for 3 days prior to entering a Comprehensive Laboratory Animal Monitoring 
System (CLAMS, Columbus Instruments) in the University of Michigan’s Small Animal 
Phenotyping Core for multi-parameter assessments. Mice were given 24 hours to 
acclimate to the CLAMS unit. On the second day of CLAMS, food was removed 
between 9AM and 5PM and the mice received i.p. injection of either vehicle (0.9% 
sodium chloride) or CNO (0.3 mg/kg in saline) at 12:00PM. On the fourth day of 
CLAMS, the mice received the alternate treatment (saline or CNO). Measurements 
were taken continuously during the experiment; energy expenditure measurements 
were then averaged over the course of 4 hours following the injection of either CNO or 
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vehicle (CalcR2ACre +AAV-Flex-hM3Dq N=10). To demonstrate that the activation of the 
CalcRPVH neurons required both DREADDs expression and CNO injection, we 
quantified nuclear FOS expression in the PVH of CalcR2ACre Flex-hM3Dq and control 
mice injected with either CNO or saline. Counts were conducted by summing the FOS 
positive cells in the PVH across 6 sections between Bregma -0.47mm and -1.07mm 
(CalcR2ACre +AAV-Flex-hM3Dq + Saline N=4, CalcR2ACre +AAV-Flex-hM3Dq + CNO 
N=8, Control + Saline  N=4, Control + CNO N=3). 
 
Long-term body weight, food intake and energy expenditure measurements 
Mice injected with AAV-Flex-TetTox or control viruses were weighed just prior to 
surgery and were given 7 days to recover before weekly food intake and body weight 
measurements were taken for the CalcR2ACre (CalcR2ACre+AAV-Flex-TetTox N=13, 
controls N=25) and MC4RCre (MC4RCre+AAV-Flex-TetTox N=11, MC4RCre+GFP N=6, 
WT+AAV-Flex-TetTox N=10) experiments. CLAMS was used to measure oxygen 
consumption, carbon dioxide production and locomotor activity via optical beam breaks 
between 8 and 10 weeks post-injection for CalcR2Acre mice (CalcR2ACre+AAV-Flex-
TetTox N=9, controls N=20). MC4RCre mice had CLAMS conducted between 3 to 4 
weeks post-injection (MC4RCre+AAV-Flex-TetTox N=8, MC4RCre+GFP N=5, WT+AAV-
Flex-TetTox N=7). Mice were placed in CLAMS for four days; data collected from the 
second and third days was used for analysis to allow acclimatization to occur during the 
first day. Body composition analysis was conducted just prior to CLAMS for the 
CalcR2Acre mice (CalcR2ACre+AAV-Flex-TetTox N=9, controls N=20) and between 7 and 
8 weeks post-injection for the MC4RCre mice (Minispec LF90 II, Bruker Optics)( 
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MC4RCre+AAV-Flex-TetTox N=11, MC4RCre+GFP N=6, WT+AAV-Flex-TetTox N=10). 
Nine weeks following viral injection, CalcR2ACre mice that received AAV-Flex-TetTox 
injections and the controls were acclimated to daily saline injections for 3 days prior to 
the day of the feeding experiment. They were then fasted during the light cycle between 
10AM and 6PM and at the beginning of the dark cycle (6PM), mice were given ad 
libitum access to food and either an i.p.  injection of salmon calcitonin at 100 ug/kg 
(sCT, Bachem, 4033011) or 0.9% sodium chloride. Food intake was then measured two 
and four hours following the injection. At least 4 days later, the injection treatments were 
switched, and food intake was measured (CalcR2ACre+AAV-Flex-TetTox N=9, controls 
N=20). 
 
In situ hybridization 
Mice were overdosed with the inhaled anesthetic isoflurane, then the brains were 
removed and flash frozen in 2-methylbutane. The brains were cut using a cryostat 
(Leica CM 1950) into 16 μm sections onto glass slides and were immediately stored at -
80oC. The assays were conducted according to the protocol provided by the RNAscope 
manufacturer (Advanced Cell Diagnostics). Sections were fixed for 1 hour in cold 10% 
formalin and then dehydrated in 50% and 75% ethanol, each for 5 minutes followed by 
two times in 100% ethanol. The sections were then dried for 30 minutes at 40oC. To 
determine the PVH expression of Mc4r and Calcr mRNAs in the PVH, chromogen 
staining was performed with an RNAscope® 2.5 HD Duplex Reagent Kit (ACD 322430). 
Sections were treated for 10 minutes with H2O2 and then incubated for 30 minutes with 
protease K IV. Following hybridization of Mc4r and Calcr mRNA probes, the sections 
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were washed twice and then underwent amplification with Amp1 to Amp2 with 2 washes 
in between. The red signal component was detected through diluting Red-B 1:60 in 
component Red-A, which was then incubated on the tissue at room temperature for 10 
minutes. The slides were rinsed two times in wash buffer to conclude the chromogen 
reaction. Amplification proceeded with Amp7 through Amp10, after which the green 
signal was detected by diluting Green-B 1:50 in component Green-A and incubating at 
room temperature for 10 minutes. The tissue was then counter stained by immersing 
the slides into 50% hematoxylin for 30 seconds, after which they were dried and 
mounted in VectaMount mounting medium (Vector Laboratories, INC). Imaging for the 
chromogen stained tissue was conducted with an Olympus BX-51 microscope with a 
DP80 camera (Olympus). To quantify cells expressing probe signal, images from 
coronal sections were processed in a uniform manner with Photoshop (Adobe) in order 
to remove the background and better visualize the individual probes. Hematoxylin 
stained cells that were determined to be positive for each probe were quantified using 
ImageJ and overlapping expression was compared to the expression of a singular 
probe within each of the mouse groups (N=3).  
 
Perfusion and Immunohistochemistry (IHC) 
To confirm the accuracy of each viral injection, at the conclusion of all surgical 
experiments, mice were deeply anesthetized with inhaled isoflurane and then 
transcardially perfused with sterile PBS and then 10% buffered formalin. Brains were 
removed, post-fixed in 10% buffered formalin and dehydrated in 30% sucrose. Brains 
were then sectioned into four representative series of 30um coronal slices using a 
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freezing microtome (Leica) and stored at -20oC. For immunohistochemistry (IHC), we 
blocked brain tissue using 3% normal donkey serum, followed by incubation in primary 
and then secondary antibodies. For the AAV-Flex-hM3Dq-mCherry experiments, 
mCherry expression was detected using a primary antibody for dsRed (rabbit 1:1000, 
Clontech, 632496) 78, followed by secondary immunofluorescence detection with 
donkey anti-rabbit-Alexa 568 (1:200, Invitrogen) 79 . For cFos imaging of CalcR2ACre 
+AAV-Flex-hM3Dq mouse brains, primary antibodies for cFos (rabbit 1:1000, Cell 
Signaling, 2250S) 80 and tdTomato (rat 1:1000, Kerafast, Inc. EST203, which also 
recognizes mCherry) 81 were used, followed by donkey anti-rabbit-Alexa 488 (1:200, 
Invitrogen) 82 and goat anti-rat-Alexa 568 (1:200, Invitrogen) 83 secondary antibodies. 
For the anterograde tracing and TetTox-GFP experiments, a primary antibody for GFP 
(chicken 1:1000, Aves GFP–1020) 84 was used followed by a goat anti-chicken-Alexa 
488 (1:200, Invitrogen) 85 secondary antibody. For the colocalization experiments 
(quantification took place in the PVH across 6 sections between Bregma -0.47mm and -
1.07mm, N=3 CalcR2ACre+GFP mice were used per peptide investigated), we used primary 
antibodies for GFP (chicken 1:1000, Aves GFP–1020 or rabbit 1:1000, Invitrogen 
A6455) 84,86 , nNos1 (sheep 1:1000, kindly provided by Dr. Vincent Prevot), OXT (rabbit 
1:4000, Peninsula Laboratories, LLC T-4084) 87 and AVP (rabbit 1:4000, Millipore 
AB1565) 88. To trap TRH and CRH in PVH cell bodies for IHC visualization, we utilized 
intracerebral (ICV) injections of colchicine (coordinates relative to bregma: 3rd ventricle 
A/P= -.340, M/L= -1.000, D/V= -2.400) into CalcR2ACre+GFP mice 89. We delivered 250 nL 
of colchicine solution (0.040mg/mL colchicine in water) to the 3rd ventricle of the mice 
and perfused two days later. For these mice, primary antibodies for Pro-TRH (rabbit 
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1:1000, Millipore ABN1658) 90 and CRH (rabbit 1:1000, Peninsula Laboratories, LLC T-
4037) 91 were used. Secondary immunofluorescence for the colocalization experiments 
was conducted using goat anti-chicken-Alexa 488 85 , donkey anti-goat-Alexa 488 92 , 
donkey anti-rabbit-Alexa 488 82 , donkey anti-sheep-Alexa 594  and donkey anti-rabbit-
Alexa 568 (1:200, Invitrogen) 93 . 
 
Data and Statistical Analysis 
For experiments utilizing mice with the stereotaxic viral injections data analysis was only 
performed using mice in which the viral expression was constrained to the PVH (as 
determined by post-hoc immunohistochemistry) in order to avoid confounding effects 
from viral transduction of cells outside the PVH. Unpaired t-tests, paired t-tests, one-
way and 2-way ANOVAs with Sidak’s or Tukey’s multiple comparisons test post-hoc 
tests (when appropriate), mixed model analyses and simple linear regression and 
correlation analysis were conducted using GraphPad Prism 8, as noted in the figure 
legends. P<0.05 indicates significance. 
 
Results 
Activation of CalcRPVH neurons regulates feeding but not energy expenditure 
The anorectic effect of sCT delivered directly to the PVH suggests that activation of 
CalcRPVH cells may suppress feeding. To determine the contribution of CalcRPVH 
neurons to energy balance control, we used chemogenetics to acutely activate 
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CalcRPVH neurons and examine the effects on food intake and energy expenditure 74,75. 
We bilaterally injected a Cre-dependent activating DREADD (designer receptors 
exclusively activated by designer drugs) virus (AAV-Flex-hM3Dq) into the PVH of 
CalcR2ACre mice (Figure 3.3 A). After at least three weeks to allow for surgical recovery 
and viral expression, CalcR2ACre Flex-hM3Dq mice were fasted during the day and were 
then injected with either vehicle or CNO at the beginning of the dark cycle, the time at 
which mice typically start to feed. CalcRPVH neuron activation significantly decreased 
food intake over the first 2 hours of feeding (Figure 3.3 B).  By 16 hours following the 
administration of CNO to the CalcR2ACre Flex-hM3Dq mice, cumulative food intake was 
comparable to controls, indicating that compensatory food intake occurred after the 
activating effects of the CNO dissipated (data not shown). Wildtype mice and CalcR2ACre 
mice injected with a control virus had no response to CNO (data were pooled as a 
single control group) demonstrating that neither CNO nor its metabolites alter food 
intake in this paradigm. CalcR2ACre Flex-hM3Dq mice injected with CNO expressed 
significantly more nuclear FOS in the PVH (Figure 3.3 D,E) than CalcR2ACre Flex-hM3Dq 
mice injected with saline (Figure 3.3 C,E) and control mice injected with CNO or saline 
(Figure 3.3 E) indicating a CNO+DREADD-dependent effect on neuron activity.  Thus 
activation of CalcRPVH neurons is sufficient to suppress feeding behavior and 
demonstrates that CalcRPVH neurons lie within the neurocircuitry that modulates 
feeding.  
As activation of some subsets of PVH neurons promotes oxygen consumption and 
locomotor activity 63,94 , we next assessed whether CalcRPVH neuron activation could 
alter energy expenditure. CalcR2ACre Flex-hM3Dq mice were placed into CLAMS to 
    
120 
 
measure oxygen consumption and locomotor activity following CNO activation. In the 
absence of food, activation of CalcRPVH neurons did not significantly change energy 
expenditure or respiratory exchange ratio (Figure 3.3 F-G). Although acute activation of 
CalcRPVH neurons increases locomotor activity slightly (Figure 3.3 H), this behavioral 
change is not sufficient to alter overall energy expenditure at least as measured by 
changes in oxygen consumed or carbon dioxide produced in the CLAMS. Taken 
together, these findings indicate that activation of CalcRPVH neurons suppresses feeding 
without an appreciable effect on energy expenditure.  
 
CalcRPVH neurons project to regions of the hindbrain and display unique neuropeptide 
expression 
Having established a potential role for CalcRPVH neurons in energy balance control, we 
sought to characterize the neural circuitry in which CalcRPVH neurons reside. A Cre-
dependent viral anterograde tracer, AAV-Flex-synaptophysin-GFP was unilaterally 
injected into the PVH of CalcR2ACre mice (Figure 3.4 A). Dense projection terminals from 
CalcRPVH neurons were found in hindbrain regions such as the parabrachial nucleus 
(PBN) and the nucleus of the solitary tract (NTS) (Figure 3.4 B,C) brain regions known 
to be involved in feeding and energy expenditure regulation. Projections to the PBN 
range between -5.07mm and -5.63mm relative to Bregma, with prominent signal in the 
medial PBN (MPBN) as well as the lateral PBN (LPBN) and its sub-nuclei including the 
central, external, lateral crescent, dorsal, internal lateral, and ventral lateral regions of 
the LPBN (Figure 3.4 B). NTS projections were found between Bregma -7.19mm and -
7.67mm, with signal in the gelatinous subnucleus, dorsolateral subnucleus, central 
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subnucleus, central subnucleus, intermediate tract nucleus, medial subnucleus, 
dorsomedial subnucleus, commissural subnucleus, interstitial subnucleus and limited 
signal in the parasolitary nucleus. Signal was also found in the area postrema (AP) and 
the dorsal motor nucleus of vagus nerve (10N) (Figure 3.4 C). CalcRPVH neurons also 
project to the external zone of the median eminence indicating engagement with the 
hypophyseal portal system and a potential role in pituitary regulation (Figure 3.4 D) 95. 
These tracing data demonstrate that CalcRPVH neurons are anatomically positioned to 
alter energy balance through projections to critical brain regions. 
DREADD-mediated control of CalcRPVH neuron activity is not a simple surrogate for 
calcitonin signaling but enforces activation of CalcRPVH neurons and presumably their 
neurotransmitter contents. To determine if CalcRPVH neuron manipulations may impact 
other previously described PVH cell systems, we employed immunohistochemistry 
(IHC) to examine co-expression of several neuropeptides in CalcRPVH neurons. To 
identify CalcRPVH cells, we used the CalcR2ACre mouse to drive Cre dependent GFP 
expression in all CalcR-expressing cells (CalcR2ACre +eGFP) and then co-stained for GFP 
in conjunction with primary antibodies that specifically bind to NOS1, OXT, AVP, CRH 
and TRH. As CRH and TRH are quickly trafficked to the synaptic terminals of their 
neurons, we treated CalcR2ACre+GFP mice with colchicine (intracerebroventricularly) to 
trap these peptides in the cell bodies. Co-expression of GFP with each antigen was 
performed using brain sections from three mice for quantification. We found that 
CalcRPVH neurons are largely distinct from NOS1 (8.3 + 1.1% of CalcR neurons express 
NOS1 and 5.9 + 0.8% of NOS1 neurons express CalcR), OXT (1.6 + 0.5% of CalcR 
neurons express OXT and 2.4 + 1.2% of OXT neurons express CalcR) and AVP (2.0 + 
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0.6% of CalcR neurons express AVP and 3.9 + 1.8% of AVP neurons express CalcR) 
neurons in the PVH (Figure 3.5 B-D). A small amount of overlap is observed with the 
TRHPVH neuronal population (4.7 + 0.7% of CalcR neurons express TRH and 22.1 + 
0.5% of TRH neurons express CalcR) and there is a greater degree of overlap with the 
CRHPVH population (11.1 + 0.7% of CalcR neurons express CRH and 38.8 + 0.7% of 
CRH neurons express CalcR) (Figure 3.5 E,F).  
 
CalcRPVH neurons are required for normal feeding and body weight maintenance 
Although chemogenetic manipulation of neurons reveals their capacity to alter energy 
balance, this approach is not informative regarding the contribution of a neuronal subset 
to basal physiology. To determine the importance of CalcRPVH neurons in maintaining 
energy homeostasis, we chronically silenced CalcRPVH neurons using Cre-dependent 
viral-expression of tetanus toxin (AAV-Flex-TetTox). AAV-Flex-TetTox or a Cre-
dependent AAV control virus was bilaterally injected into the PVH of CalcR2ACre mice 
(Figure 3.6A). Following the surgery, CalcR2ACre -Flex-TetTox mice gained more weight 
compared to the CalcR2Acre mice injected with the AAV control virus (Figure 3.6 B,C). 
Weight gain in the CalcR2ACre -Flex-TetTox was associated with increased fat mass and 
a trend towards increased lean mass relative to controls (Figure 3.6 D). The obesity in 
CalcR2ACre -Flex-TetTox mice was potentially driven by increased caloric intake, as food 
intake was significantly higher in CalcR2ACre -Flex-TetTox mice compared to controls 
when measured three weeks following the injection (Figure 3.6 E). This difference in 
food intake between the two groups is no longer discernable by week 7 (Figure 3.6 F), 
suggesting that compensatory responses to blunt persistent hyperphagia may have 
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occurred as obesity developed.  As was expected from our previous PVH-specific 
CalcR deletion studies 53, the anorectic effects of sCT was preserved in CalcR2ACre-Flex-
TetTox mice (Figure 3.6 G) demonstrating that the anorectic effect of peripheral sCT is 
not dependent on PVH CalcR expression or CalcRPVH neuronal function. 
Energy expenditure was also examined in CalcR2ACre -Flex-TetTox mice 8-10 weeks 
following injection of virus. To avoid the confounds of energy expenditure assessments 
of animals with different body weights, we plotted 24hr energy expenditure as a function 
of body weight. While the change in energy expenditure as a function of body weight in 
this cohort of CalcR2ACre -Flex-TetTox mice was slightly less than the controls, this 
observed trend is strongly influenced by the two heaviest animals in the dataset (Figure 
3.6 H). RER and locomotor activity levels (measuring X-total activity) over a 24 hour 
period were not significantly different between the CalcR2ACre -Flex-TetTox mice and 
controls (Figure 3.6 I-J). Taken together, CalcRPVH silencing studies suggest that 
CalcRPVH neurons likely modulate feeding with at most a small contribution to energy 
expenditure control.  
 
MC4R signaling may be an essential component of CalcRPVH neuron mediated energy 
balance 
MC4R expression in PVH neurons is critical for normal feeding and body weight 
regulation with loss of MC4R signaling in the PVH characterized by hyperphagia and 
significant obesity 50,67,73 . Given the increased food intake and obesity seen with 
silencing of CalcRPVH neurons, we examined the overlap of Mc4r and Calcr transcripts 
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in the PVH. In situ hybridization revealed that almost half of MC4RPVH neurons express 
Calcr mRNA (43.6 + 6.9%, n=3 mice) whereas less than a quarter of CalcRPVH neurons 
express Mc4r mRNA (16.7 + 1.3%, n=3 mice) (Figure 3.7 A). Therefore, CalcRPVH 
neuron silencing might significantly impact MC4RPVH neuron function.  In an effort to 
estimate the contribution of abrogated MC4R-signaling to the obesity phenotype 
provoked by CalcRPVH silencing, we selectively silenced MC4RPVH neurons and 
examined the effect on feeding and bodyweight regulation. We bilaterally injected 50nL 
of the AAV-Flex-TetTox into the PVH of MC4R-Cre mice (MC4RCre -Flex-TetTox) 
(Figure 3.7 B). For controls, WT mice were injected with the AAV-Flex-TetTox and 
MC4RCre mice were injected with an AAV-Flex-GFP virus. In line with a prior study 71, 
silencing of MC4RPVH neurons resulted in rapid development of obesity (Figure 3.7 
C,D). Fat mass and lean mass increased significantly in the MC4RCre -Flex-TetTox mice 
compared to the controls. Fat and lean mass also increased slightly in the MC4RCre -
Flex-GFP mice control group relative to WT controls which may be inherent to the 
genetic targeting of the Mc4r locus for Cre expression 71,96 (Figure 3.7 E).  MC4RCre -
Flex-TetTox mice consumed more food than WT controls on week 3 and week 7 post 
injection (Figure 3.7 F-G). It is important to note that MC4RCre -Flex-GFP mice also 
exhibited increased food intake relative to WT controls; the effect on feeding was similar 
to that seen for MC4RCre -Flex-TetTox mice, at least at 3 weeks following virus injection.  
Thus the significant weight gain seen with MC4RCre -Flex-TetTox relative to MC4RCre -
Flex-GFP mice control group (Figure 3.7 C,D) cannot be attributed solely to 
hyperphagia. Given the overlap of Calcr and Mc4r expression in the PVH, the silencing 
of CalcRPVH neurons would be expected to silence a significant fraction of MC4RPVH 
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neurons which likely contributes to the CalcR2ACre-Flex-TetTox obesity phenotype. 
These findings indicate that the CalcR+/MC4R+ subpopulation of the PVH is potentially 
responsible for some of the obesity observed when all CalcRPVH neurons are silenced.  
 
Discussion 
 Body weight maintenance is largely determined by actions of the central nervous 
system (CNS). Successfully targeting the CNS for obesity treatment or prevention will 
require a deeper understanding of the mechanisms and neurocircuitry that modulate 
feeding and energy expenditure 55. CalcR agonists, such as calcitonin and amylin, 
promote anorexia and weight loss in both humans and rodents 9,11,97,98. CalcR is 
expressed in many regions of the CNS known to regulate energy balance suggesting 
that the site(s) of action for CalcR agonists may be distributed. Recently, we used Cre-
loxP technology to delete CalcR from different regions of the brain in order to identify 
the neurocircuitry mediating the anorexic effects of peripherally administered CalcR 
agonists 53. Despite the significant expression of CalcR in the PVH, a brain region 
known to play critical roles in the energy balance control, deletion of CalcR from the 
PVH does not perturb physiologic feeding or body weight, and mice lacking CalcRs in 
the PVH have a normal anorectic response to peripherally applied sCT.  These findings 
indicate that CalcR expression in the PVH is not required for body weight maintenance 
or sCT-induced anorexia. Nevertheless, the anorexia induced by the direct application 
of sCT to the PVH suggests that the CalcR-expressing PVH neurons lie within feeding 
neural circuits and that CalcRPVH neuron activity may regulate feeding behavior 14. It is 
for this reason that we used site-directed, temporal manipulations to specifically 
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investigate the contribution of the CalcR-expressing neurons of the PVH to energy 
homeostasis.  
Acute activation of CalcRPVH neurons using chemogenetic tools was sufficient to 
suppress feeding thereby demonstrating that CalcRPVH neurons engage neural circuits 
that modulate feeding behavior. We and others have found that chemogenetic activation 
of a variety of genetically tagged PVH neurons is sufficient to alter feeding 63, 71.  It is 
important to note, however, that this is not a ubiquitous property of PVH cells, as direct 
activation of oxytocin expressing PVH neurons does not alter feeding, thus highlighting 
the compartmentalization of PVH cell function 63. Chemogenetic activation can reveal 
the functional potential of a group of neurons but does not elucidate its role in normal 
physiological states. To probe the contribution of CalcRPVH neurons to bodyweight 
regulation, we chronically silenced these neurons in adult animals and found that their 
activity was necessary for restraining feeding and bodyweight gain. In line with our 
previous findings that demonstrated that mice lacking CalcRs in the PVH respond 
normally to peripheral application of sCT, the anorectic properties of sCT are still 
present even when CalcRPVH neurons are silenced. The contribution of CalcRPVH 
neurons on feeding and body weight regulation are revealed by both activating and 
silencing manipulations, and demonstrate that these neurons lie within and modulate 
neural circuitry that is crucial to the regulation of energy homeostasis.  
While we have demonstrated that CalcRPVH neurons modulate feeding and 
locomotor activity and are necessary for bodyweight maintenance, we have yet to 
determine the neurocircuitry through which these neurons alter feeding and energy 
balance. PVH neurons, such as the NOS1PVH neurons, project to hindbrain regions 
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known to contribute to energy balance 54,63,73,99. Similarly, CalcRPVH neurons send 
projection terminals to the PBN, a hindbrain region strongly associated with both 
appetitive and aversive feeding circuitry 54,67. CalcRPVH neurons also send projections to 
the NTS, a region that integrates neuronal and hormone satiety signals that originate 
from the periphery 99. The NTS also influences sympathetic outflow through neurons 
with polysynaptic contact with brown adipose tissue (BAT) and can both activate and 
inhibit BAT thermogenesis 100-103. Our current studies do not distinguish the 
physiological responses driven by CalcRPVH neuronal projections to either the PBN or 
NTS specifically; terminal specific manipulations (e.g., via optogenetics) will be 
necessary to discriminate these effects. As the PVH is largely glutamatergic and intra-
PVH connections are known to exist, it remains possible that activation of a defined cell 
population could be cascaded through neighboring cells to effect physiological outputs 
55-57,104. In this regard, CalcRPVH neurons when activated may serve to transmit a signal 
within the PVH rather than directly to a downstream target. Technologies that 
manipulate discrete CalcRPVH outputs will be needed to better characterize the brain 
regions targeted by CalcRPVH neurons to modulate defined energy balance parameters. 
The PVH is composed of a variety of neuronal subpopulations that have been 
implicated in energy balance regulation 56,57,105. Discriminating these subsets of neurons 
by receptor or neuropeptide expression is important for understanding PVH function. 
Neurochemical characterization of genetically-tagged PVH neurons is a critical step in 
interpreting the mechanisms and potential novelty of functional manipulations and helps 
formulate hypotheses regarding the molecular mechanisms engaged to drive 
physiologic responses to changes in PVH activity. In the case of CalcRPVH neurons, we 
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found them to be distinct from the NOS1PVH, OXTPVH and AVPPVH neuronal 
subpopulations, each of which alter energy balance when acutely activated 63,65,106. This 
raises the intriguing possibility of the additive benefits of selectively activating 
combinations of these populations. Such studies would also reveal whether there is a 
threshold for the beneficial effects of PVH stimulation on feeding and energy 
expenditure.  
Subsets of CalcRPVH neurons express corticotropin releasing hormone (CRH) or 
thyrotropin releasing hormone (TRH), neuropeptides implicated in feeding and energy 
expenditure 107,108. ICV injection of CRH in genetically obese and lean mice decreases 
feeding, decreases oxygen consumption and decreases activity level 107. Mice lacking 
CRH, however, display a normal body weight 109 ; whether developmental loss of CRH 
provokes compensation in bodyweight neural circuitry to prevent obesity is not known. 
CRHPVH neuron activity is rapidly reduced following refeeding after a fast indicating that 
CRHPVH neuron activity may be more responsive to alterations in stress than feeding 
directly 71. In addition, chronic silencing of CRHPVH neurons is not associated with 
hyperphagia in contrast to what we find with CalcRPVH neuron silencing 71. There is a 
small amount of overlap between the CalcR and TRH neuronal populations of the PVH. 
TRHPVH neurons regulate the thyroid axis which directly contributes to resting energy 
expenditure 53,108. Chemogenetic activation of TRHPVH neurons stimulates feeding 
through projections to AGRP neurons, which is opposite to the anorectic effect of 
activating CalcRPVH neurons 110. Taken together, it seems unlikely that CRHPVH or 
TRHPVH neurons contained within the CalcRPVH field are responsible for the physiologic 
effects on body weight and feeding following CalcRPVH neuron manipulations. 
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The central melanocortin system is a critical component of energy balance 
control and direct manipulations of MC4Rs in the PVH have profound effects on feeding 
and body weight 50,67,73 . Since manipulation of CalcRPVH neurons altered feeding, we 
examined the overlap of MC4R and CalcRs in the PVH and found that nearly half of the 
MC4RPVH neurons co-express CalcR. Selective silencing of CalcRPVH neurons therefore 
effectively disables signaling from about half of the MC4RPVH neurons. Given the gene 
dosage effect associated with MC4R-mediated obesity, loss of ~1/2 of MC4RPVH 
through inactivation of CalcRPVH neurons would be predicted to produce a fraction of the 
overall obesity seen upon complete MC4RPVH inactivation. Consistent with this 
prediction, we find that the change in body weight in the MC4RPVH silenced mice is 
nearly twice as much as compared to the CalcRPVH silenced mice. This comparative 
approach is an indirect method of determining the necessity of MC4R expression in 
CalcRPVH neurons to mediate energy homeostasis. To definitively assess the 
contribution of melanocortin signaling CalcRPVH neurons to body weight control, specific 
deletion of MC4Rs from CalcRPVH neurons is required. Simply crossing the CalcR2ACre 
line to a loxP-flanked MC4R transgenic line would delete MC4R expression from all 
CalcR neurons, including those expressed outside the PVH, and confound the data 
interpretation (this will be further explored in Chapter 4). 
 There are important caveats associated with our experimental approach. 
Tethering Cre recombinase activity to CalcR gene expression allows us to target CalcR-
expressing neurons specifically, but subsequent activation or silencing of these neurons 
with chemogenetics or tetanus toxin expression impacts a variety of signaling systems 
within these cells.  Indeed, manipulations of CalcRPVH neuron activity with viral vectors 
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should not be viewed as a surrogate for calcitonin agonist signaling in these neurons.  
The interpretation of any physiologic effect attributed to CalcRPVH neuron activation or 
silencing must take into account that a range of signaling pathways and 
neurotransmitter release are being affected.  This highlights the importance of 
identifying other neuropeptides (e.g., CRH or TRH) and signaling systems (NOS1) that 
function within CalcRPVH neurons, as these systems likely contribute to the modulation 
of energy balance parameters revealed by our viral manipulations.   
Through Cre-dependent viral tools and Cre-LoxP technology, we find that 
CalcRPVH neuron activity is required for maintaining normal body weight in mice which 
highlights an important role for CalcRPVH neurons in energy homeostasis. CalcRPVH 
neurons are largely distinct from other known PVH neurons and project to brain regions 
known to be involved in energy balance control. A thorough understanding of CalcRPVH 
neurons and their neurocircuitry will deepen our understanding of central energy 
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Figure 3.1: FOS response to sCT in CalcrSim1KO mice. (A) Schematic diagram of 
cross of CalcRflox and Sim1cre mice to produce CalcrSim1KO mice. (B) Quantification of 
PVH FOS-IR cells 2 hours after injection of sCT (100 μg/kg, IP) in control (n=7) and 
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CalcrSim1KO (n=9) mice. (C) Calcr mRNA quantification through qRT-PCR in PVH 
microdissections from Ctrl (n=6) and CalcrSim1KO (n=7) mice. IHC for FOS expression 
was conducted on control mice injected with saline (D) and sCT (E) and CalcrSim1KO 
mice injected with saline (F) and sCT (G). Average values ± SEM are shown. FOS 
quantification was compared using a two-way ANOVA followed by Sidak’s multiple 
















Figure 3.2: Energy balance and response to anorectic agents in CalcrSim1KO mice. 
(A-C) Control and CalcrSim1KO mice were studied until 10 weeks of age for body weight 
(A), food intake (B), and body composition (14-18 weeks of age) (C); n=4-10 per group. 
All comparisons were p=not significant (ns). Responses to sCT (D-F) (n=13-17 per 
group): Food intake for the first 4 hours of the dark cycle (D) and daily food intake (E) 
and body weight (change relative to baseline) (F) while chronically treated with IP 
vehicle (Veh) or sCT twice daily in CalcrSim1KO mice (100 ug/kg sCT). Dotted vertical 
lines indicate the days of sCT treatment. Average values ± SEM are shown. For 10 
weeks of body weight a one-way ANOVA with Tukey’s multiple comparisons test was 
performed; for food intake and body composition a two-way ANOVA with Sidak’s 
multiple comparisons test was performed. For the sCT overnight food intake 
experiment, a one-way ANOVA with Tukey’s multiple comparisons test was performed. 
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For the chronic treatment of sCT analyzing food intake and body weight a two-way 











Figure 3.3: Effect of acute activation of CalcRPVH neurons using DREADDs on 
food intake and energy expenditure. A) Diagram of Cre-dependent hM3Dq 
DREADDs expression vector. IHC was used to detect expression of AAV-Flex-hM3Dq 
bilaterally injected into the PVH of CalcR2ACre mice (CalcR-Cre+3Dq). B) Two-hour food 
intake following i.p. injection of CNO (0.3 mg/kg) at start of the dark cycle. 
CalcR2ACre+Flex-hM3Dq and control mice were fasted for 90 minutes prior to i.p. 
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injection of CNO or saline, and were perfused 2 hours following the injection. IHC for 
3Dq-mCherry and FOS expression was conducted on CalcR2ACre+Flex-hM3Dq mice 
injected with saline (C), CalcR2ACre+Flex-hM3Dq mice injected with CNO (D), control 
mice injected with saline and control mice injected with CNO (not shown). FOS 
expression in the PVH was quantified and compared among the four groups (E). 
CLAMS measurements of energy expenditure (F), the respiratory exchange ratio (G) 
and total X-activity (H) following DREADD-mediated CalcRPVH activation. Average 
values ± SEM are shown. P values for feeding behavior and FOS quantification was 
determined by 2-way ANOVA followed by a Sidak’s multiple comparisons test; CLAMS 
measures, were compared using a paired-t-test. **p<0.01, ***p<0.001, 
PVH=paraventricular nucleus of the hypothalamus, 3V=third ventricle. 




Figure 3.4: Projection targets of CalcRPVH neurons using an anterograde tracer. A) 
Diagram of the Cre-dependent synaptophysin-GFP vector. The synaptophysin-GFP 
virus was unilaterally injected into the PVH of CalcR2ACre mice (CalcR-Cre+Syn). 
CalcRPVH axonal terminals were observed in the mPBN and lPBN, with an illustration 
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showing signal between Bregma 5.07mm and -5.63mm (B). Projections were observed 
in the NTS between Bregma -7.19mm and -7.67mm, with signal also shown in the AP 
and 10N (C). Projections were also found in the external zone of the ME (D). 
Illustrations are based on coronal images from the atlas Paxinos and Franklin's the 
Mouse Brain in Stereotaxic Coordinates 4th Edition. 3V=third ventricle, 4V=fourth 
ventricle, SCP=superior cerebellar peduncle, PVH=paraventricular nucleus of the 
hypothalamus, VMH= ventromedial nucleus of the hypothalamus, ME=median 
eminence, NTS=nucleus of the solitary tract, AP=area postrema, 10N=dorsal motor 
nucleus of vagus nerve, mPBN=medial parabrachial nucleus, lPBN=lateral parabrachial 
nucleus. 




Figure 3.5: Colocalization of CalcRPVH neurons with other PVH populations 
implicated in energy homeostasis. Representative immunofluorescent images taken 
of the PVH of CalcR2ACre+GFP mice. Mice were stained for Cre dependent GFP 
expression (A-F) shown in green. Sections were also stained using primary antibodies 
for NOS1 (B), OXT (C), AVP (D), Pro-TRH (E) and CRH (F) shown in red. Percent 
expression of the overlap (yellow) relative to the individual cell populations (green/red) 
were quantified in corresponding pie charts below their image. 3V=third ventricle.  
 




Figure 3.6: Physiological effects of silencing CalcRPVH neurons. A) Bilateral 
expression of AAV-TetTox-GFP in the PVH of CalcR2ACre mice (CalcR-Cre+TT). Effect 
of CalcRPVH silencing on body weight (B), body weight gain (C), fat and lean mass (D) 
and food intake during week 3 (E) and week 7 (F).  Two-hour food intake following i.p. 
injection of sCT (100 µg/kg) at the start of the dark cycle (G). CLAMS measurements of 
energy expenditure over a 24 hr period was compared to respective body weights (H). 
CLAMS measurements of respiratory exchange rate (I) and X-total activity (J). Average 
values ± SEM are shown. P values for BW, change in BW and sCT food intake were 
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determined using a 2-way ANOVA followed by Sidak’s multiple comparisons test, and 
for body composition, food intake and CLAMS measurements, an unpaired t test was 
used. For the energy expenditure measurements over a 24 hr period comparison, a 
simple linear regression and correlation analysis was used to determine the Pearson 
correlation (R) values. * p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. 




Figure 3.7: Physiological effects of silencing MC4RPVH neurons. A) In situ 
hybridization in WT mouse for CalcR (Blue) and Mc4R RNAs (red). Percent expression 
of CalcR in MC4R positive cells and percent expression of MC4R in CalcR positive 
    
150 
 
cells. B) Bilateral expression of AAV-TetTox-GFP in the PVH of MC4RCre mice (MC4R-
Cre+TT). Effect of MC4RPVH silencing on body weight (C), body weight gain (D), fat and 
lean mass (E). Food intake in MC4RPVH silenced mice during week 3 (F) and during 
week 7 (G) following injection. Average values ± SEM are shown for BW, change in 
BW, body composition and food intake. P values for BW and change in BW were 
determined using a 2-way ANOVA followed by Tukey’s multiple comparisons test, and 
for body composition and food intake, a one-way ANOVA followed by a Tukey’s multiple 

















MC4R Expression in CalcR Cells is Required for Maintaining Normal Body Weight 
and Feeding Behavior 
Abstract 
The expression of melanocortin-4-receptor (MC4R) in the paraventricular nucleus of the 
hypothalamus (PVH) is necessary to maintain normal body weight and food intake in 
mice. Further, re-expression of MC4R in the PVH of mice with a total knockout of MC4R 
expression normalizes feeding and reduces the obesity observed with systemic loss of 
MC4R. Nearly half the MC4RPVH neurons express calcitonin receptor (CalcR), a 
neuronal population of the PVH that we have demonstrated to regulate body weight and 
food intake. As CalcR neurons are a subpopulation of MC4RPVH neurons, we used the 
CalcR-2a-Cre transgenic mouse line and Cre/Lox technology to delete MC4R 
expression from CalcR neurons. Deletion of MC4R from CalcR neurons resulted in 
obesity in both males and females. Hyperphagia and increased body length were found 
in males, however no change in energy expenditure was observed. In male and female 
knockout mice, the anorectic response to peripheral MTII injection was still maintained. 
These findings indicate that MC4R expression in CalcR neurons is required for body 
weight and food intake regulation.  
 




The brain maintains energy homeostasis through the regulation of feeding and 
energy expenditure. It achieves this through the integration of peripheral and central 
signals that dictate the activity of neurons involved energy balance.1 The melanocortin-
4-receptor (MC4R) is a G protein-coupled receptor that is expressed in neurons 
throughout the brain and has been identified as essential to the maintenance of energy 
homeostasis.2,3 Deletion of MC4R expression in mice and mutation of the receptor in 
humans results in obesity, indicating the essential role this receptor plays in regulating 
energy balance.4-6 For MC4R null mice, obesity is due to both hyperphagia and a 
decrease in energy expenditure.4,7,8  
The paraventricular nucleus of the hypothalamus (PVH) is a region of the brain 
that has abundant expression of MC4R.9-11 The PVH regulates energy homeostasis 
through its regulation of feeding, energy expenditure and the regulation of glucose.12 
The PVH receives projections from agouti-related peptide (AgRP) and 
proopiomelanocortin (POMC) ARC neurons which release the MC4R antagonist and 
agonist, AgRP and α-MSH respectively.13,14 Microinjections of MC4R ligands into the 
PVH influences feeding and energy expenditure. 14-16 The PVH contains MC4R neurons 
that are glutamatergic and monosynaptically engage the lateral parabrachial nucleus 
(LPBN) and the dorsal motor nucleus of the vagus (DMV) of the hindbrain.17-19 MC4RPVH 
neurons are distinct from the oxytocin (OXT), corticotrophin-releasing hormone (CRH), 
arginine vasopressin (AVP) and prodynorphin (PDYN) neurons of the PVH.18 
Melanocortin action in the PVH is required for body weight regulation, as the deletion of 
MC4R from the PVH leads to hyperphagic obesity.20 Further, the re-expression of 
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MC4R in the PVH of mice with a total body knockout of MC4R reduces body weight 
gain and reduces hyperphagia, indicating that MC4R expression in the PVH is an 
important component of the regulation of feeding behavior.18 A total knock out of MC4R 
expression in mice results in the complete loss of the anorectic effects of the 
melanocortin agonist MTII when applied peripherally.21 However, re-expression of the 
MC4R in the PVH and amygdala restores the anorectic response of mice to MTII.20,22  
 Our in situ studies have found that calcitonin receptor (CalcR) expressing 
neurons in the PVH heavily overlap with the MC4RPVH neuronal population. Our 
previous studies indicate that CalcRPVH neurons regulate body weight and feeding 
behavior through activation and silencing techniques.23 Due to the co-localization of 
CalcRPVH and MC4RPVH neurons, we hypothesize that melanocortin action on CalcRPVH 
neurons is critical for homeostatic energy balance. The Olson laboratory developed a 
CalcR-2a-Cre transgenic mouse line, which will allow us to specifically manipulate and 
characterize CalcR expressing cells. We utilized Cre/Lox technology to genetically 
knockout MC4Rs from CalcR neurons and then examined the physiologic effects of 
deleting MC4Rs from CalcR neurons. We found that deletion of MC4R from all CalcR-
expressing neurons produces profound hyperphagic obesity indicating that CalcR-
expressing neurons play an important role in central melanocortin action. However, 
deletion of MC4R from CalcR neurons did not blunt the anorectic effects of MTII, 
suggesting the remaining MC4RPVH neurons still respond to the MTII to produce the 
anorectic phenotype. Our findings suggest that MC4R expression on CalcR neurons is 
essential for maintaining normal body weight and feeding behavior.  
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Material and Methods: 
Experimental Animals 
CalcR-2a-Cre (or CalcR2ACre) mice were previously generated and validated using 
previously described methods.24 Mice with Cre recombinase expressed in MC4R 
neurons (MC4RCre, JAX stock 030759; kindly provided by Dr. Brad Lowell) were used 
for the IHC study along with the CalcR-2a-Cre mice.25 For the MC4R deletion studies, 
LoxMC4R (JAX stock 023720; kindly provided by Brad Lowell) mice were crossed with 
our CalcR2ACre mice (JAX stock 006395).18 Male and female mice from these breeding 
crosses were studied starting at 3 weeks of age. In accordance with the Association for 
the Assessment and Approval of Laboratory Animal Care and National Institutes of 
Health guidelines, the procedures performed were approved by the University of 
Michigan Committee on the Care and Use of Animals. Our animals were bred and 
housed within our colony, with ad libitum access to food and water provided (unless 
specified otherwise) in temperature-controlled rooms that followed a 12-hour light/dark 
cycle. 
 
Long-term body weight, food intake and energy expenditure measurements 
MC4RLox/+ mice were crossed with CalcRcre/+ mice to generate CalcRcre/+; MC4RLox/Lox 
(CalcRΔMC4R) as well as CalcRcre/+, MC4RLox/Lox and WT (controls) mice. Mice for these 
studies were monitored between 4 and 16 weeks of age for body weight in males and 
females. Body composition for males and females was conducted between 16-18 
weeks of age (Minispec LF90 II, Bruker Optics). Weekly food intake of regular chow was 
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measured in singly housed males between 4 and 12 weeks of age and CLAMS was 
conducted at between 8 and 10 weeks of age. Body lengths of the males were 
measured at 22 weeks of age, after which they were deeply anesthetized using 
isoflurane and their brains were extracted for additional analyses. 
At 17 weeks of age, CalcRΔMC4R mice and their controls were acclimatized to receiving 
daily saline injections 3 days prior to the day of the feeding experiment. They were then 
fasted during the light cycle between 10AM and 6PM and at the beginning of the dark 
cycle (6PM), mice were given ad libitum access to food and either an i.p.  injection of 
melanotan-II (MTII, 150 ug/mouse, Bachem) or 0.9% sodium chloride (APP 
Pharmaceuticals, 63323-186-10). Food intake was then measured two and four hours 
following the injection. At least 4 days later, the injection treatments were switched, and 
food intake was measured. This same method was used to test the feeding suppression 
of MTII on MC4RCre and CalcR2ACre mice that received AAV-Flex-TetTox injections (as 
described in chapter 3) and the controls nine to ten weeks following viral injection.  
 
In situ hybridization and IHC studies 
Mice were overdosed with the inhaled anesthetic isofluorane, then the brains were 
removed and flash frozen in 2-methylbutane. The brains were cut using a cryostat 
(Leica CM 1950) into 16 μm sections onto glass slides and were immediately stored at -
80oC. The assays were conducted according to the protocol provided by the 
manufacturer of RNAscope (Advanced Cell Diagnostics). Sections were fixed for 1 hour 
in cold 10% formalin and then dehydrated in 50% and 75% ethanol, each for 5 minutes 
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followed by two times in 100% ethanol. The sections were then dried for 30 minutes at 
40oC. To determine the overlapping expression of MC4R and CalcR mRNA in the PVH, 
chromogen staining was performed with an RNAscope® 2.5 HD Duplex Reagent Kit 
(ACD 320701). Sections were then treated for 10 minutes with H2O2 and were then 
incubated for 30 minutes with protease K IV. Following hybridization of probes for 
MC4R and CalcR mRNAs, the sections were washed twice and then underwent 
amplification with Amp1 to Amp2 with 2 washes in between. The red signal component 
was detected through diluting Red-B 1:60 in component Red-A, which was then 
incubated on the tissue at room temperature for 10 minutes. The slides were rinsed two 
times in wash buffer in order to conclude the chromogen reaction. Amplification 
proceeded with Amp7 through Amp10, after which the green signal was detected by 
diluting Green-B 1:50 in component Green-A and incubating at room temperature for 10 
minutes. The tissue was then counter stained by immersing the slides into 50% 
hematoxylin for 30 seconds, after which they were dried and mounted in VectaMount 
mounting medium (Vector Laboratories, INC). Imaging for the chromogen stained tissue 
was conducted with an Olympus BX-51 microscope with a DP80 camera (Olympus). To 
quantify cells expressing probe signal, images from coronal sections were processed in 
a uniform manner with Photoshop (Adobe) in order to remove the background and 
better visualize the individual probes. Hematoxylin stained cells that were determined to 
be positive for each probe were quantified using ImageJ and overlapping expression 
was compared to the expression of a singular probe within each of the mouse groups. 
For the IHC studies in which we determined the brain regions which expressed MC4R 
and CalcR neurons, we used CalcRCre mice that expressed a Cre-dependent GFP 
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reporter and MC4RCre mice that expressed a Cre-dependent TdTomato reporter. To 
identify the CalcR neurons that express the GFP reporter, a primary antibody for GFP 
(chicken 1:1000, Aves GFP–1020) was used followed by a goat anti-chicken-Alexa 488 
(1:200, Invitrogen) secondary antibody. To identify the MC4R neurons that express a 
TdTomato reporter, we used a primary antibody for dsRed (rabbit 1:1000, Clontech, 
632496), followed by secondary immunofluorescence detection with donkey anti-rabbit-
Alexa 568 (1:200, Invitrogen).  
 
Data and Statistical Analysis 
Unpaired t-tests, paired t-tests, one-way and 2-way ANOVAs with Sidak’s or Tukey’s 
multiple comparisons test post-hoc tests (when appropriate), mixed model analyses and 
simple linear regression and correlation analysis were conducted using GraphPad 
Prism 8, as noted in the figure legends. P<0.05 indicates significance. 
 
Results 
Deletion of MC4R from CalcR cells produces hyperphagic obesity 
MC4R expression in PVH neurons is critical for normal feeding and body weight 
regulation.18,20 Given the hyperphagic obesity seen with silencing of CalcRPVH neurons, 
we examined the overlap of MC4R and CalcR transcripts in the PVH. In situ 
hybridization revealed that almost half of MC4RPVH neurons express CalcR mRNA 
(43.59 + 6.88%, n=3 mice) whereas less than a quarter of CalcRPVH neurons express 
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MC4R mRNA (16.72 + 1.33%, n=3 mice) (Figure 4.1 A, the in situ image was 
repurposed from my published manuscript in Chapter 3).23 Given the co-expression of 
CalcR and MC4R within the PVH, we examined the contribution of CalcR neurons in 
MC4R-mediated energy homeostasis by deleting MC4R from all CalcR-expressing cells 
(CalcRΔMC4R). In situ hybridization of brain tissue from CalcRΔMC4R mice demonstrated a 
substantial reduction in MC4R expression in the PVH compared to the controls (Figure 
4.1 A-C); cell counts indicate that MC4RPVH expression was reduced to 46.70% 
compared to control (MC4R Controls = 297.67 + 30.37, n=3; CalcRΔMC4R = 139 + 6.26, 
n=4). As expected MC4R expression was almost completely deleted from CalcRPVH 
cells (CalcR/MC4R cell counts: Controls = 132 + 28.16, n=3; CalcRΔMC4R = 11.25 + 
1.97, n=4) (Figure 4.1 B,C). CalcRΔMC4R mice developed profound obesity in both males 
and females during the first 16 weeks of life (Figure 4.1 D,E). This obesity phenotype 
was driven in large part by increased food intake (Figure 4.1 F). Body composition 
revealed increases in fat mass and lean mass in both male and female CalcRΔMC4R mice 
(Figure 4.1 G,H). Body length for males was also increased with deletion of Mc4R from 
CalcR neurons (Figure 4.1 I). These findings demonstrate that the deletion of MC4R 
from CalcR-expressing cells results in hyperphagic obesity; this is in part due to loss of 
MC4R from the PVH, although other regions that co-express CalcR and MC4R 
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CalcRΔMC4R mice maintain largely normal energy expenditure and anorectic response to 
MTII 
CLAMS assessments performed at 8-10 weeks of age revealed a slightly lower VO2 
relative to body weight in the CalcRΔMC4R mice suggesting a slight perturbation in energy 
expenditure (Figure 4.2 A). However, we did not observe a significant difference in 
oxygen consumption when adjusted for body weight (Figure 4.2 B) and lean body mass 
(Figure 4.2 C) when compared to the controls. There was a trend towards a significant 
decrease in RER during a 24 hour period (Figure 4.2 D); X-total activity increased 
during a 24 hour period (Figure 4.2 E). At 17 weeks of age, male and female 
CalcRΔMC4R mice underwent MTII feeding experiments that showed that the anorectic 
behavior induced by MTII was still maintained with the deletion of MC4R from CalcR 
cells (Figure 4.3 A). Interestingly, MTII feeding experiments in CalcR-Cre+TetTox and 
MC4R-Cre+TetTox mice also demonstrated a normal anorectic response to MTII, 
suggesting that potentially enough MC4RPVH neurons remained unsilenced and thus 
able to communicate downstream (Figure 4.3 B,C). Overall, these findings indicate that 
removal of MC4R expression in CalcR cells does not influence energy expenditure nor 
the ability of mice to respond to MTII. 
 
Discussion  
MC4R expression in the PVH is crucial to maintain energy homeostasis through 
food intake regulation.18,20 Through our previous investigation of the CalcRPVH neurons, 
we determined that they are both sufficient and necessary to regulate body weight and 
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food intake and our in situ hybridization studies indicate that they overlap with nearly 
half of the MC4RPVH neurons. When comparing silencing of CalcRPVH neurons to 
MC4RPVH neurons in mice, we determined that the body weight gain in the CalcRPVH 
silenced mice (Figure 3.6 C) was half that which was observed in the MC4RPVH silenced 
mice (Figure 3.7 D).23 This potentially indicates that the obesity observed in mice with 
CalcRPVH neurons silenced may be due to loss of signaling of the MC4R expressing 
subpopulation. To investigate this, we used Cre-loxP mediated deletion of MC4Rs from 
all CalcR-expressing cells, which leads to profound hyperphagic obesity in both male 
and female rodents. Loss of MC4Rs from CalcR neurons is associated with an increase 
in lean mass and overall body length, a distinct feature of MC4R knockout mediated 
obesity.18  
 The lack of change in energy expenditure measurements in CalcRΔMC4R mice is 
not surprising, as it has been determined that the deletion of MC4R expression from the 
PVH produces hyperphagic obesity without perturbing energy expenditure.18,20 The 
unaffected anorectic behavior produced by MTII in CalcRΔMC4R mice suggests that 
potentially other regions with neurons that express MC4R and not CalcR are still 
responding to MTII and are suppressing feeding behavior. Further, over half of the 
MC4RPVH neurons do not express CalcR, and thus are unaffected by the Cre/lox 
mediated deletion of MC4R, allowing for continued melanocortin signaling downstream. 
Because the anorectic behavior of MTII is maintained in mice with MC4RPVH neurons 
silenced by tetanus toxin, this may support the idea that other brain regions expressing 
MC4R are responsible for suppressing food intake behavior through MTII action. It is 
also possible that not enough of the MC4RPVH neurons expressed the virus and 
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therefore were not silenced. Alternatively, the tetanus toxin may not completely silence 
downstream communication and perhaps enough signal is able to be released to 
maintain the anorectic behavior produced by MTII.  
 There are a few potential issues in the study that should be considered, first of 
which is the potential compensation that may have occurred during development. The 
deletion of MC4R expression from CalcR cells happens very early in development and 
therefore it is possible that some compensatory changes may have occurred to combat 
the partial loss of MC4R expression. As such, it is possible that loss of MC4R 
expression from CalcR cells later in development would produce a variation on the 
phenotypes observed. Further, it is important to note that CalcR-cre expression is not 
confined to the PVH and the loss of MC4Rs from non-PVH CalcR-expressing cells likely 
also contributes to this obesity phenotype. We have conducted IHC studies identifying 
brain regions which consist of both CalcR and MC4R neurons, many of which are in 
regions important for the regulation of energy homeostasis, such as the ARC, 
ventromedial nucleus of the hypothalamus, PBN and solitary nucleus to name just a few 
(Table 4.1). While this only serves to suggest the potential existence of neurons with 
overlapping expression of MC4R and CalcR in the regions identified, it will be necessary 
to confirm and quantify this overlapping expression. Future experiments examining the 
overlap of CalcR and MC4R transcripts outside the PVH will be necessary to ascertain 
the contribution of non-PVH CalcR-expressing cells in central melanocortin action. 
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Figure 4.1: MC4Rs in CalcR-expressing neurons are required for body weight 
regulation. In situ hybridization of control (A) and CalcRΔMC4R (B) mice for Calcr (blue) 
and Mc4r RNAs (red). Quantification of Mc4r and Calcr co-expression in both 
CalcRΔMC4R and WT groups (C). Longitudinal body weight for males (D) and females 
(E). Cumulative food intake for CalcRΔMC4R and control male mice was taken between 4 
and 7 weeks of age (F). Fat mass and lean mass in males (G) and females (H) were 
measured at 16-18 weeks of age. Body length was conducted at 22 weeks of age (I). 
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Average values ± SEM are shown; for male BW and body composition: N=14-28/group, 
for female BW and body composition: N=15-19/group; for cumulative food intake of 
males: N=16-25/group; for body length: N=15-25/group. P values for BW, cumulative 
food intake were determined via 2-way ANOVA followed by Sidak’s multiple 










Figure 4.2: Deletion of MC4Rs in CalcR-expressing neurons has minimal effects 
on energy expenditure. The mice were placed in CLAMS at 8-10 weeks of age. Raw 
VO2 consumption over a 24 hour period was compared to their respective body weights 
(A). VO2 consumption adjusted to total body mass (B), VO2 consumption adjusted to 
LBM (C), RER (D) and X-total activity (E) were also measured. Average values ± SEM 
are shown, for CLAMS measurements: N=15-16/group. P values for body length and 
CLAMS measurements, unpaired t tests were used. For the Raw VO2 consumption 
over a 24 hr period comparison, a simple linear regression and correlation analysis was 
used to determine the Pearson correlation (R) values. * p<0.05, ****p<0.0001. 




Figure 4.3: Anorectic effect of melanocortin agonist in mice with the deletion of 
MC4R from CalcR cells or with silenced CalcRPVH neurons. Two-hour food intake 
was measured following the i.p. injection of the MC4R agonist MTII (150 ug/mouse) for 
CalcRΔMC4R (A), CalcR-Cre+TetTox (B) and MC4R-Cre+TetTox (C) mice. Average 
values ± SEM are shown; for the deletion experiment: N=15-25/group, for the CalcRPVH 
silencing experiment: N=9-20/group, and for the MC4RPVH silencing experiment: N=6-












Table 4.1: Brain regions that abundantly express MC4R and CalcR neurons. IHC 
was conducted on MC4R-Cre mice that expressed a Cre-dependent TdTomato reporter 
and on CalcR-Cre mice that expressed a Cre-dependent GFP reporter. Images were 
taken between Bregma 0.85mm and Bregma -8.15mm (coordinates obtained from the 
atlas Paxinos and Franklin's the Mouse Brain in Stereotaxic Coordinates 4th Edition) 
and regions were recorded based on the degree of expression of either MC4R or 
Regions of MC4R and CalcR Overlap Bregma (Start) Bregma (End)
STLV/STMV/STMA/STMPL/Stmpi/STMPM 0.73mm 0.61mm
AVPe 0.37mm  0.25mm






Aco -1.07mm -1.23mm 
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CalcR. The regions listed are those in which both CalcR and MC4R neurons were found 
in abundance and the rostral (start) to caudal (end) coordinate range is listed for each 
region. STLV= bed nucleus of the stria terminalis, lateral division, ventral part; STMV= 
bed nucleus of the stria terminalis, medial division, ventral part; STMA= bed nucleus of 
the stria terminalis, medial division, anterolateral part; STMPL= bed nucleus of the stria 
terminalis, medial division, posterolateral part; stmpi= bed nucleus of the stria terminalis, 
medial division, posterointermediate part; STMPM= bed nucleus of the stria terminalis, 
medial division, posteromedial part; AVPe= anteroventral periventricular nucleus; 
MPOM= medial preoptic nucleus, medial part; MPOL= medial preoptic nucleus, lateral 
part; MPA= medial preoptic area; STHY= striohypothalamic nucleus; AHA= anterior 
hypothalamic area, anterior part; AHP= anterior hypothalamic area, posterior part; 
AHC= anterior hypothalamic area, central part; LA= lateroanterior hypothalamic 
nucleus; PaV= paraventricular hypothalamic nucleus, ventral part; PaMM= 
paraventricular hypothalamic nucleus, medial magnocellular part; PaMP= 
paraventricular hypothalamic nucleus, medial parvicellular part; PaLM= paraventricular 
hypothalamic nucleus, lateral magnocellular part; PaDC= paraventricular hypothalamic 
nucleus, dorsal cap; RChL= retrochiasmatic area, lateral part; Aco= anterior cortical 
amygdaloid nucleus; BMA= basomedial amygdaloid nucleus, anterior part; Mtu= medial 
tuberal nucleus; ArcL= arcuate hypothalamic nucleus, lateral part; ArcM= arcuate 
hypothalamic nucleus, medial part; ArcMP= arcuate hypothalamic nucleus, medial 
posterior part; DM= dorsomedial hypothalamic nucleus; DMD= dorsomedial 
hypothalamic nucleus, dorsal part; LH= lateral hypothalamus; VMHVL= ventromedial 
hypothalamic nucleus, ventrolateral part; MePD= medial amygdaloid nucleus, 
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posterodorsal part; MePV= medial amygdaloid nucleus, posteroventral part; PH= 
posterior hypothalamic nucleus; PMV= premamillary nucleus, ventral part; LPAG= 
lateral periaqueductal gray; DMPAG= dorsomedial periaqueductal gray; DLPAG= 
dorsolateral periaqueductal gray; VLPAG= ventrolateral periaqueductal gray; PnO= 
pontine reticular nucleus, oral part; DRD= dorsal raphe nucleus, dorsal part; DRL= 
dorsal raphe nucleus, lateral part; LPB= lateral parabrachial nucleus; LPBV= lateral 
parabrachial nucleus, ventral part; LPBC= lateral parabrachial nucleus, central part; 
LPBl= lateral parabrachial nucleus, internal part; MPB= medial parabrachial nucleus; 
RMg= raphe magnus nucleus; Rpa= raphe pallidus nucleus; MVePC= medial vestibular 
nucleus, parvicellular part; PCRtA= parvicellular reticular nucleus, alpha part; IRT= 
intermediate reticular nucleus; SolC= solitary nucleus, commissural part; SOLIM= 
solitary nucleus, intermediate part; SOLV= solitary nucleus, ventral part; SOlDL= 
solitary nucleus, dorsolateral part; SOlVL= solitary nucleus, ventrolateral part; SOLM= 
solitary nucleus, medial part; SOLDM= solitary nucleus, dorsomedial part, SolL= solitary 
nucleus, lateral part; 10N= vagus nerve nucleus; AP= area postrema




Discussion: Delineating Physiologic Roles of PVH Neurons with an Anatomical 
Approach 
PVH neurons differentially regulate energy balance depending on their 
downstream projection targets 
The previously described projects served to identify novel neuronal populations 
in the PVH responsible for regulating energy homeostasis. However, these studies 
lacked the capability to identify the role these neurons specifically play through their 
downstream projection targets, as our activation and inhibition of these neurons 
influence all outputs rather than those that target a particular region. This distinction is 
crucial to understanding energy balance circuitry, as the downstream regions these 
neurons project to in the hindbrain have been found to regulate different aspects of 
energy balance through their own neuronal subpopulations. 
As a subpopulation of the Sim1PVH neurons, we have previously determined that 
NOS1PVH neurons project to regions of the hindbrain (PBN and NTS) and the upper 
thoracic spinal cord that are important in the regulation of food intake and energy 
expenditure.1 Further, chemogenetic activation of NOS1PVH neurons suppresses food 
intake in a similar manner to Sim1PVH neurons and increases energy expenditure.1 In 
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comparison, the OXTPVH neurons, as a subpopulation of the NOS1 neurons, send 
projections to the ChAT neurons of the IML but do not send dense projections to the 
PBN or NTS. OXTPVH neurons do increase energy expenditure when chemogenetically 
activated, although to a lesser degree than the NOS1PVH or Sim1PVH neurons, but do not 
influence feeding behavior when activated.1 This study makes it clear that 
subpopulations of the Sim1PVH neurons regulate different aspects of energy 
homeostasis, and highlights the variability of the physiological roles specific PVH 
neurons play in regulating energy homeostasis through their downstream projection 
targets. The studies presented here concerning the IRS4PVH and CalcRPVH neurons 
were made in an attempt to parse out the different ways in which the PVH regulates 
food intake and energy expenditure.2,3 However, they do not paint a complete picture 
and only hint to their downstream influences on energy balance, failing to discern which 
regions are responsible for feeding and energy expenditure regulation through the PVH. 
As such, studies which use chemogenetic activation of specific neuronal populations of 
the PVH gives the overall physiological effects generated by these neurons through all 
their downstream projection targets. This creates a problem in trying to determine the 
specific contributions of neural circuits targeting specific brain regions. Because the 
IRS4PVH, CalcRPVH and NOS1PVH neurons project to both the PBN and NTS, we are 
unable to discern the physiological effects associated with specific projections to the 
PBN or to the NTS alone.1-3  
Determining how these brain regions contribute to the physiological effects 
produced by the PVH will require the use of methods that either selectively manipulate 
PVH cells based on their projection targets or through activating specific PVH neurons 
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at their axon terminals. For the latter, it has been found that optogenetic activation of 
MC4RPVH neurons at their projection terminals in the PBN suppresses food intake 
without producing an aversive response.4 Stimulating MC4RPVH neurons at their 
terminals in the PBN in hungry mice promoted place preference, indicating that 
activating MC4RPVH neurons that project to the PBN produces an appealing or pleasant 
response.4 Termination of feeding is often associated with either a pleasant feeling of 
fullness (non-aversive) or with an unpleasant feeling of visceral illness (aversive). It is 
important to distinguish between anorectic treatments that produce non-aversive vs 
aversive responses, as therapeutic methods tend to favor those that produce non-
aversive responses.4,5 While projections from the PVH to PBN have suggested 
involvement in food intake regulation, there is little evidence to suggest that the PBN is 
involved in regulating energy expenditure. 
The NTS integrates satiety signals from the central nervous system, as well as 
hormonal signals from the peripheral system.6-10 The NTS contains both neuronal 
populations that suppress food intake in an aversive and non-aversive manner when 
activated.5  Optogenetic activation of CCKNTS neurons that project to the PBN 
suppresses food intake behavior in an aversive manner, while activating CCKNTS 
neurons that project to the PVH suppresses feeding non-aversively. Conversely, NTS 
projections to the PBN have been determined to suppress feeding through an aversive 
response.5 The NTS closely associates with the spinal cord and may serve to modulate 
the sympathetic nervous system through this interaction. The NTS also serves as an 
integrator of metabolic signals from regions of the forebrain and brainstem, potentially 
regulating BAT activity downstream.8 Several neuronal populations of the PVH send 
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projections to the NTS, and it is through these projections that the PVH may influence 
sympathetic output and energy expenditure.11-15  
 
Investigation of the contribution of PVH projections to specific hindbrain regions 
in energy homeostasis 
Given that the PBN and NTS regions are known to regulate energy homeostasis, 
it would be valuable to determine the contribution of PVH projections to these two 
regions to further clarify their role in energy homeostatic circuitry. We hypothesize that 
PVH to PBN projections would regulate food intake behavior but not energy expenditure 
while PVH to NTS projections could potentially influence feeding as well as energy 
expenditure. To investigate this, we have used retrograde viral methods to determine 
the contribution of PVH to PBN projecting cells vs PVH to NTS projecting cells in the 
regulation of energy balance. We used a novel Cre virus that is transported in a 
retrograde fashion (Retro-Cre) to transduce projection terminals and induce expression 
of Cre in the cell bodies of PVH neurons, allowing us to manipulate them with Cre-
dependent viruses.16 Optogenetics is typically the method of choice to investigate the 
activation of the projection terminals of specific neuronal populations, as it allows for 
immediate and direct stimulation of the desired pathway. This is not always feasible, as 
there are cases where an optic fiber cannot be easily implemented without skull 
coverage, such as caudal areas of the hindbrain or the spinal cord. In these instances, 
injection of a Retro-Cre virus would be the preferable method. 
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To determine the sufficiency of PVH neurons projecting to the PBN or NTS in 
modulating food intake and energy expenditure, we stereotaxically injected an AAV 
Retro-Cre virus bilaterally into the PBN (coordinates relative to bregma: A/P= -5.400, 
M/L=+/- 1.200, D/V= -2.900; 50 nL/side) or NTS (D/V= -0.500; 50 nL/side) of adult male 
mice between the ages of 8-12 weeks to induce Cre expression in neurons that project 
to either region. This allowed us to utilize a Cre-dependent AAV-FLEX hM3Dq-mCherry 
DREADD virus injected bilaterally into the PVH (coordinates relative to bregma: A/P= -
.500, M/L= +/- .200, D/V= -4.77; 50nL/side) to selectively activate PVH neurons that 
project to the PBN or NTS. The mice were given at least two weeks to recover from the 
surgeries and to allow for sufficient viral expression before running any experiments. To 
investigate the role of PVH to PBN (PVH>PBN) or PVH to NTS (PVH>NTS) circuitry in 
the regulation of food intake circuitry, several food intake experiments were conducted.  
For the mice with Retro-Cre injected into the PBN and hM3Dq injected into the 
PVH (PVHhM3Dq>PBNRetro-Cre), they were singly housed and injected IP with saline for 
three consecutive days prior to the food intake experiment to acclimate them to 
receiving injections (Figure 5.1 A-C). On the day of the experiment, food was removed 
from the cages and the animals were fasted for 8 hours. At the start of the dark cycle, 
either saline or CNO (0.3 mg/kg) was IP injected into the mice (N=6). Food pellets were 
weighed and placed into the cages, with measurements being taken 2, 4 and 16 hours 
after the injection to determine food intake. The treatments were then reversed the 
following week to compare the food intake between the CNO and saline treatments. For 
the PVHhM3Dq>PBNRetro-Cre mice, we determined that 2 hours after injection, food intake 
was suppressed due to CNO activation of the PVH neurons that project to the PBN 
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(Figure 5.1 D). This finding supports the previously discussed optogenetic experiment in 
which MC4RPVH neurons were stimulated at the axon terminals in the PBN, which 
resulted in a trend towards significant reduction in food intake (significance determined 
using a paired t-test).4 PVH neurons projecting to the PBN are therefore sufficient to 
suppress food intake acutely. 
 For the mice with Retro-Cre injected into the NTS and hM3Dq injected into the 
PVH (PVHhM3Dq>NTSRetro-Cre), we conducted the same food intake experiment described 
previously and found that food intake was unaffected by CNO induced activation of the 
PVH>NTS neurons (N=4) (Figure 5.2 A-D). Additionally, we conducted a longer-term 
experiment in which we injected the PVHhM3Dq>NTSRetro-Cre mice with either CNO or 
saline twice daily (once at 8:00AM and again at 5:30PM) over the course of three days 
and found that while food intake was unaffected by the CNO activation, body weight 
was significantly reduced on the second day of injections (Figure 5.2 E-F). This 
difference in body weight was less on the third day and may have been due to a 
compensatory mechanism to maintain body weight (Figure 5.2 F). This suggested that 
while PVH>NTS neurons did not influence neurons responsible for regulating food 
intake in the NTS, they may have played a role in regulating energy expenditure.  
 For our energy expenditure experiments, the PVHhM3Dq>NTSRetro-Cre mice were 
placed in a Comprehensive Laboratory Animal Monitoring System (CLAMS, Columbus 
Instruments) which is managed by the University of Michigan Small Animal Phenotyping 
Core. The PVHhM3Dq>NTSRetro-Cre mice were given a day to acclimate to the CLAMS 
chamber and on the second day, food was removed at 9:00AM. Just prior to 12:00PM, 
the mice were then injected with either CNO or saline (N=4) and measurements were 
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taken over the next 4 hours and at 5PM the mice were refed. This was repeated on the 
fourth day, with the CNO and saline treatments switched. From our CLAMS 
measurements, we found that while RER remained unaffected, energy expenditure, 
oxygen consumption and ambulatory activity significant increased four hours after the 
injection of CNO (significance determined using a paired t-test) (Figure 5.2 G-J). This 
supports our pervious findings, as the weight loss experienced may have been due to 
the increase in energy expenditure as a result of CNO activation of PVH>NTS neurons. 
This strongly suggests that the PVH engages the sympathetic nervous system through 
the NTS to regulate energy expenditure.11-15  
 Not yet conducted, but still of interest are experiments that test whether 
activating PVH>PBN or PVH>NTS neurons result in an aversive or non-aversive 
response. To test whether stimulation of these neurons is aversive, we would run a 
conditioned taste aversion (CTA) assay.17 The PVHhM3Dq>PBNRetro-Cre or 
PVHhM3Dq>NTSRetro-Cre mice would be singly housed with cages receiving water from two 
water bottles. With a three-day acclimation period, followed by a 7-day routine of timed 
water-restriction, mice would receive access to two water bottles for two 1-hour 
sessions each day. This serves to habituate the mice to consuming water only during 
these two periods of time. For the conditioning day, the mice will receive two water 
bottles, one of which contains 0.15% saccharin during the morning session. Groups of 
mice will then receive subcutaneous injections of either saline, CNO or lithium chloride 
(0.3M), with lithium chloride serving as a positive control for inducing an aversive 
response.18 For the afternoon session and the sessions the following day, the mice can 
be rehydrated with regular water. The next day, the mice will have access to two bottles 
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in the morning, with one containing saccharin and the other with water. The water and 
saccharin volumes ingested during that hour will be measured and a preference ratio 
will be determined as the volume of saccharin consumed divided by the total volume of 
liquid consumed. A lower preference ratio for saccharin will be interpreted as an 
aversive response.17  
 In contrast to the previous experiment, if we find that activation of PVH>PBN or 
PVH>NTS neurons is non-aversive, we would also want to conduct a conditioned place 
preference (CPP) assay, to determine if activation of PVH>PBN or PVH>NTS neurons 
is associated with positive valence. For this experiment, the mice would be placed 
individually into a two chambered apparatus and undergo 30 minute sessions over 3 
days to freely habituate to the apparatus and remove its novelty. For each mouse during 
these sessions, we will determine which chamber is designated as “preferred” or “not 
preferred”. The mice will then receive six days of conditioning, during which they will be 
given IP injections of CNO or saline followed by containment in the “not preferred” 
chamber for 30 minutes. For the test day, the mice will be placed in the chamber and 
allowed to travel between them freely. We will then determine the percentage of time 
the mouse spends in each chamber. A high percentage of time spent in the “not 
preferred” chamber would be interpreted as the mouse showing preference and would 
therefore be an indication of positive valence. The treatments would then be switched 
and the assay repeated.4,19 
 Our preliminary findings support much of what we have learned concerning the 
downstream projection targets of the PVH in the hindbrain.1,7,20 Previous studies have 
demonstrated that many neuronal populations of the PVH that regulate feeding send 
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projections to the PBN and optogenetics studies have demonstrated that activating 
axon terminals of specific PVH neurons in the PBN suppresses food intake.4 Our 
preliminary studies using chemogenetics have reinforced this finding. While the NTS 
serves as an integrator of satiety signals primarily from the periphery, we have 
demonstrated that stimulating PVH neurons that project to the NTS do not suppress 
feeding. However, stimulating PVH neurons projecting to the NTS does promote 
increased energy expenditure and increased oxygen consumption, potentially due to its 
sympathetic output to brown adipose tissue as well as other peripheral sites influenced 
by the sympathetic nervous system.11-14 We do not expect that the PBN would influence 
energy expenditure, but this is an experiment that has yet to be conducted.4 Additional 
future experiments include those of the CTA and CPP assays. We expect that activating 
PVH neurons that project to the PBN would produce an appetitive response without 
aversion, as this was found to be true of optogenetic stimulation of MC4RPVH neurons 
that project to the PBN.4 In contrast, stimulating PVH neurons that project to the NTS 
could be aversive, as cell types such as the CCKNTS neurons that project to PBN 
suppress feeding through associated aversion when activated.5 
 
Further considerations and future directions for the investigation of PVH neurons 
While the Retro-Cre virus is a useful tool, there are a few considerations and 
limitations that need to be addressed. The most concerning issues is that it appears that 
the PVH contains neurons that send collateral projections to both the PBN and NTS. 
For our experiment in which we injected Retro-Cre into the PBN and hM3Dq into the 
PVH, we conducted a DAB stain for mCherry (a reporter for hM3Dq expression) (Figure 
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5.3 A). As expected, we found expression in the PVH (Figure 5.3 B) and found signal at 
the neuronal terminals in the PBN (Figure 5.3 C). We also found mCherry expression in 
the NTS, indicating that at least some of the PVH>PBN neurons also project to the NTS 
(Figure 5.3 D). This could confound our attempts to parse out the specific role the PBN 
and NTS play in PVH mediated energy homeostasis. As this data is preliminary, we can 
more definitively confirm and quantify this overlap through the use of two differently 
labeled retrograde viruses applied to the PBN and NTS.  
Optogenetics would be a viable alternative to our studies using Retro-Cre and 
hm3Dq, as we could stimulate the axon terminals of all PVH neurons that project to the 
PBN. This method becomes less viable when investigating the physiological role of the 
PVH to NTS circuitry. Implanting the fiberoptic into the NTS would be difficult, as its 
location is so caudal that the skull would not be present to anchor it in place. Another 
issue to consider is that the PVH neurons that project to either the PBN or NTS may be 
composed of both aversive and non-aversive subpopulations. This could result in 
opposing responses that cancel each other out and therefore other genetic tools might 
need to be developed to manipulate specific PVH neuronal populations that project to 
these downstream regions.  
Fortunately, the Olson laboratory is developing such tools in the form of viral 
systems that require the expression of both Cre and flippase (Flp) recombinase. Flp 
recombinase recognizes flippase recognition target (FRT) sites in a similar manner in 
which Cre recognizes LoxP sites.21 We could generate a hM3Dq or hM4Di (inhibitory 
DREADD) virus that requires the excision of a STOP cassette flanked by FRT sites and 
a STOP cassette flanked by LoxP sites in order for hM3Dq/hM4Di to be expressed. The 
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problem with a method that uses several STOP cassettes is that STOP cassette 
sequences are rather large and are not likely to fit within the limits of a viral capsid.22 
Alternatively, we could use an INTronic Recombinase Sites Enabling Combinatorial 
Targeting (INTRSECT) system to reduce sequence size. INTERSECT can be used to 
produce viruses that have inverted Cre dependent and Flp dependent domains that 
require the expression of both Cre and Flp to be converted to the proper orientation and 
express the desired sequence.23 This virus could then be placed in the PVH of a mouse 
that expresses Flp in conjunction with the desired genetic marker, such as CalcR or 
IRS4. With the cells of the PVH transduced with a Cre/Flp dependent virus, we could 
then inject a retrograde Cre virus into a downstream projection target of the PVH, such 
as the PBN or NTS. With Cre expression traveling back to the cell bodies of the PVH, 
we would now have Cre expressed in PVH cells that project to our region of interest, 
and Flp expressed in our PVH neuronal subpopulation of interest. This combination 
would result in expression of hM3Dq/hM4Di in the desired cell type that projects to the 
desired location, allowing us to activate CalcRPVH neurons that project only to the NTS 
as an example. This technique would allow us to selectively activate or inhibit neuronal 
subpopulations of neurons in the CNS that project to specific downstream targets, 
making it easier to identify the activity of specific circuits. 
 
Overview 
Many regions of the hypothalamus and hindbrain receive peripheral signals that 
indicate the energy and nutrient demands of the body.6 These peripheral signals are 
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then converted to neuronal outputs that project centrally to integrative nodes within the 
CNS. The PVH is one such node, which in turn produces outputs that regulate feeding, 
energy expenditure, glucose regulation and the neuroendocrine system through 
projections to the forebrain, hindbrain, pituitary and spinal cord.24 Such integration within 
a singular node is important, as it takes into account the summation or negation of 
various signals to maintain a homeostatic system, which has been evolutionarily honed 
to support survival. This could be furthered by the potential interconnectivity and 
crosstalk between several neurons within the PVH.25,26 This suggests the PVH may 
regulate various aspects of energy balance as well as other physiological processes 
through interconnected circuits, with the combination of signal inputs modulating a given 
physiological process. It is also interesting that the PVH contains several neuronal 
populations that regulate energy balance through similar means, such as feeding 
behavior, but are non-overlapping.27 This suggest that there may be redundancies in the 
regulation of feeding circuitry, which would be crucial as maintaining energy balance is 
essential to survival. Under conditions in which one of these pathways are altered, one 
of these redundant systems could compensate for impaired function. This redundancy 
creates a rigid yet malleable system of homeostatic control, allowing for internal 
changes in response to environmental pressures, but still maintaining a level of stability. 
Through therapeutic techniques, we may be able manipulate these alternative 
pathways, shifting a faulty system towards a healthy energy balance and compensating 
for the impairment. 
The PVH is composed of diverse neuronal populations that have been defined in 
part through their expression of various neuropeptides, enzymes and cell surface 
    
183 
 
receptors. Many of these neuronal subgroups within the PVH manipulate energy 
homeostasis differently based on their downstream projection targets, engaging in 
circuitry that influences aversive and non-aversive food intake behavior, as well as 
energy expenditure through sympathetic output or the neuroendocrine system.1-4,24 The 
body engages with each of these energy homeostatic neurocircuits based on the 
current need, whether through engaging aversive feeding circuitry to deter consumption 
of a potentially harmful substance or through burning energy through BAT to aid in 
thermoregulation.1,6 Identifying and mapping the neuronal subgroups of the PVH that 
engage in particular aspects of energy balance will allow us to develop therapeutics that 
target desired means of energy balance, such as drugs that activate appetitive 
pathways with positive valence or activating neurons that promote passive energy 
expenditure. 
Our laboratory and others have investigated the unique roles of the various PVH 
cell types in energy homeostasis with an ongoing goal to better understand energy 
balance circuitry. IRS4 is highly expressed in the PVH and acts synergistically with IRS2 
in the hypothalamus to preserve regular body weight and thus became a neuronal 
population of interest in the PVH.28 We have determined that activation of IRS4PVH 
neurons suppresses food intake and increases energy expenditure, while silencing 
these neurons results in obesity.3 These IRS4PVH neurons are distinct from OXTPVH and 
NOS1PVH neuronal populations and project to the hindbrain regions PBN and NTS, as 
well as the median eminence and the ChAT neurons of the IML of the spinal cord.3 This 
study demonstrates that IRS4PVH neurons are a valuable component of energy 
homeostatic circuitry. It is still unclear, however, through which mechanism these 
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IRS4PVH neurons maintain energy balance via endogenous systems. Whole body 
deletion of IRS4 alone does not perturb food intake or the ability to maintain body 
weight, but hyperphagic obesity results when coupled with the deletion of IRS2.28 It 
would therefore be interesting to assess whether this synergy exists in the PVH, 
perhaps through the duel deletion of IRS4 and IRS2 expression in Sim1 expressing 
neurons. Additionally, we observed MC4R expression in a population of the IRS4PVH 
neurons, presenting another possible means through which feeding behavior is 
regulated through the IRS4PVH neurons. It would therefore be interesting to investigate 
the effects of deleting MC4R from IRS4 neurons on feeding behavior and body weight. 
The PDYN subset of the IRS4PVH neurons may also contribute to the regulation of 
feeding behavior observed.27 Finally, IRS4PVH neurons overlap with TRHPVH neurons 
and may influence energy expenditure through the autonomic nervous system or via the 
pituitary-thyroid axis.3 
Because calcitonin and amylin suppress food intake when applied peripherally 
and centrally, we investigated CalcR expression in the PVH through the deletion of 
CalcR expression from Sim1 neurons, which are heavily expressed in the PVH.29-32 Our 
findings indicated that CalcR expression in the PVH and other regions that express 
Sim1 is dispensable in maintaining energy homeostasis and its deletion does not 
influence the anorectic effects of sCT.33 Although deletion of CalcR expression from the 
PVH did not produce a notable difference in energy homeostasis, it would be valuable 
to investigate other potential physiological process that may have been influenced by 
the deletion of CalcR from the PVH. While deletion of CalcR from the PVH did not 
appear to influence energy balance, we investigated CalcR neurons as a subpopulation 
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of the PVH and their role in regulating energy homeostasis. We found that activating 
CalcRPVH neurons suppressed feeding and promoted ambulatory activity, while 
silencing these neurons produces increased feeding and weight gain, although to a 
lesser extent than when the MC4RPVH neurons were silenced.2 Similar to the IRS4PVH 
neurons, the CalcRPVH neurons project to the PBN and NTS as well as the median 
eminence. When investigating the overlap of CalcRPVH neurons with other neurons in 
the PVH, we found that CalcR neurons most notably expressed MC4R and CRH.2 As 
CalcRPVH neurons project to the pituitary, this suggests that the CRH expressing 
subpopulation may influence the neuroendocrine release through the release of CRH. It 
would be worthwhile to investigate the influences CalcRPVH neurons have on 
corticosterone and glucose levels due to their potential interaction with the 
hypothalamic-pituitary-adrenal axis.34 Due to the overlap between CalcR and MC4R 
neurons in the PVH, we deleted MC4R expression from CalcR cells to determine if 
MC4R expression is necessary for the regulation of energy balance. Through our 
studies, we found that deletion of MC4R from CalcR neurons caused hyperphagic 
obesity in male and female mice without influencing the anorectic effects of MTII. While 
compelling, we determined that our method of deletion potentially deleted MC4R from 
CalcR neurons beyond the PVH, as there are many regions of potential overlap in the 
hypothalamus and hindbrain. It is for this reason that further investigation of the overlap 
of these neurons in other regions through in situ hybridization or other means would be 
necessary. 
We have done much to characterize the neuronal populations of the PVH and 
their roles in energy homeostasis, however there are many neuronal populations in this 
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diverse nucleus that have yet to be explored or thoroughly defined. Further, as the PVH 
is an integrator of signaling within the central nervous system, and in turn exerts 
influence on many downstream regions in the hindbrain and hypothalamus through its 
projections, more studies need to be done to delineate the contribution of these 
downstream projections to the regulation of energy homeostasis. In doing so, we 
improve our understanding of the physiological roles of defined PVH cell types and the 
neural circuitries in which they operate. Characterizing neuronal populations of the PVH 
that play a known role in regulating energy homeostasis could aid in the identification of 
receptors that could be targeted by specific synthetic ligands as well as identify sites 
downstream that can be characterized and targeted. As we unravel the cellular and 
neurobiological mechanisms used by subpopulations of the PVH to regulate energy 
balance, we further our efforts to identify therapeutic targets to help manage obesity and 
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Figure 5.1: Effect of acute activation of PVH>PBN neurons using DREADDs on 
food intake. A) Diagram depicting simultaneous injection of AAV-Retro-Cre into the 
PBN and AAV-hM3Dq-mCherry into the PVH of mice expressing a Cre dependent GFP. 
The AAV-Retro-Cre was taken up by the PVH axons that project to the PBN. IHC was 
used to detect expression of AAV-hM3Dq-mCherry bilaterally injected into the PVH (B) 
and AAV-Retro-Cre bilaterally injected bilaterally into the PBN (C) of mice. D) Two-hour 
food intake following i.p. injection of CNO (0.3 mg/kg) at start of the dark cycle. Average 
values ± SEM are shown. P values for feeding behavior (N=6) was determined by a 
paired-t-test. PVH=paraventricular nucleus of the hypothalamus, 3V=third ventricle, 
LPBN=lateral parabrachial nucleus, MPBN=medial parabrachial nucleus, 4V=fourth 
ventricle. 
 




Figure 5.2: Effect of acute activation of PVH>NTS neurons using DREADDs on 
food intake and energy expenditure. A) Diagram depicting simultaneous injection of 
AAV-Retro-Cre into the NTS and AAV-hM3Dq-mCherry into the PVH of mice 
expressing a Cre dependent GFP. The AAV-Retro-Cre was taken up by the PVH axons 
that project to the NTS. IHC was used to detect expression of AAV-hM3Dq-mCherry 
bilaterally injected into the PVH (B) and AAV-Retro-Cre bilaterally injected into the NTS 
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(C) of mice. D) Two-hour food intake following i.p. injection of CNO (0.3 mg/kg) at start 
of the dark cycle. Long-term feeding (E) and body weight (F) experiments in which CNO 
was injected twice daily for three days. CLAMS measurements of VO2 consumption (G), 
energy expenditure (H), the respiratory exchange ratio (I) and total X-activity (J) 4 hours 
following DREADD-mediated activation of PVH>NTS neurons. Average values ± SEM 
are shown. P values for feeding behavior and CLAMS measurements (N=4) were 
determined by a paired-t-test; P values for long-term feeding and body weight 
experiments (N=4) were determined using a 2-way ANOVA followed by Tukey’s multiple 
comparisons test. *p<0.05, ***p<0.001, PVH=paraventricular nucleus of the 











Figure 5.3: A subset of PVH>PBN neurons also project to the NTS. A) Diagram 
depicting simultaneous injection of AAV-Retro-Cre into the PBN and AAV-hM3Dq-
mCherry into the PVH of mice expressing a Cre dependent GFP. The AAV-Retro-Cre 
was taken up by the PVH axons that project to the PBN and hM3Dq-mCherry 
expression was induced in the PVH. hM3Dq-mCherry terminals were found in both the 
PBN and NTS. DAB immunohistochemistry staining was used to detect expression of 
AAV-hM3Dq-mCherry in the bilaterally injected PVH (B) and hM3Dq-mCherry terminals 
were detected in the PBN (C) and NTS (D). 
 
